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STELLINGEN / PROPOSITIONS 
1) Concurrent deficiency of different micronutrients is the norm rather than the 
exception (this thesis). 
2) Zinc plays an important role in the conversion of P-carotene to retinol (this thesis). 
3) The subject "Nutrition" should only be practised from within a scientific 
discipline. On its own, the subject will not only lack in theoretical depth, but also 
in context and relevance. 
4) Wat voor gedichten geldt, zou ook moeten gelden voor proefschriften en 
wetenschappelijke publicaties in het algemeen: "Een gedicht is beter naarmate 
men de woorden ervan minder merkt." (J.C. Bloem, 1887 - 1966) 
5) "As in medicine the severity of surface symptoms and the severity of underlying 
pathology are not always in close correlation, so in sociology the drama of public 
events and the magnitude of structural change are not always in precise accord". 
(Clifford Geertz. The Interpretation of Cultures). 
6) Als partners gezamelijk wetenschappelijk onderzoek doen, dan geldt 1 + 1 > 2 
7) Het is belangrijk voor zeilers op zee om de opkomst- en ondergangstijden van de 
heldere planeten uit het hoofd te kennen, zodat ze niet verward kunnen worden 
met de navigatieverlichting van grote schepen. 
8) If a global one child policy would be launched tomorrow, many of the world's 
problems would solve itself over the next three generations. 
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STELLINGEN / PROPOSITIONS 
1) In infants, iron supplementation should not be given without measures to improve 
vitamin A status also (this thesis). 
2) Supplementation of single micronutrients in a population with concurrent 
deficiencies of various micronutrients has adverse effects (this thesis). 
3) The statement of Primo Levi that "Zinc ...is not an element which says much to 
the imagination, it is grey and its salts are colourless, it is not toxic, nor does it 
produce striking chromatic reactions; in short, it is a boring metal" does not take 
into account the fascinating biochemical role of zinc. 
(Primo Levi. The Periodic Table). 
4) Genetically modified foods are an inappropriate answer to world hunger. The 
solutions should be political rather than scientific, and aimed at the abolition of 
the perpetuated unequal distribution of resources and technology. 
5) Writing a thesis is like building a sailing boat. The merits but especially the faults 
will emerge only after launching. 
6) Buitensporig ingewikkelde statistische berekeningen verhogen misschien wel de 
significantie van de bevindingen, maar verzwakken tegelijkertijd de sterkte van de 
conclusies. 
7) Wij zijn slaven geworden van het snelle leven, dat onze gewoontes verstart, onze 
huizen binnendringt, en ons dwingt "Fast Food" te eten: Onze verdediging moet 
aan tafel beginnen met "Slow Food". 
(Slow Food Manifest) 
8) The observation: "The more Indonesia changes, the more it remains the same", 
has never been more true than the last four years. (F) 
(Daan Mulder. Inside Indonesian Society). 
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ABSTRACT 
Vitamin A, Iron and Zinc Deficiency in Indonesia. Interactions and 
Effects of Supplementation. 
Ph.D. thesis by Marjoleine A. Dijkhuizen and Frank T. Wieringa, Division of Human 
Nutrition and Epidemiology, Wageningen University, The Netherlands. 18 June 2001. 
Deficiencies of various micronutrients are prevalent in many developing 
countries, especially in infants and women. The research described in this thesis 
investigates the extent of deficiency of vitamin A, iron and zinc in pregnant and 
lactating women, and in infants in Indonesia. Furthermore, the effects of 
supplementation with p-carotene, iron and zinc on micronutrient status, growth, 
pregnancy outcome and immune function, and interactions between micronutrients are 
reported. 
The research described in this thesis comprises a cross-sectional survey in 197 
lactating mothers and their infants; a supplementation trial in 607 infants, who were 
supplemented from 4 months of age onwards; and a supplementation trial with 229 
pregnant women, who were supplemented from 10-20 weeks gestational age until 
delivery, and followed with their newborn infants for 6 months post-partum. 
An important finding is that deficiency of vitamin A, iron, and zinc are 
prevalent in infants and mothers, and that these deficiencies are likely to occur 
concomitantly. Furthermore, micronutrient status of the mother is strongly related to 
that of her infant, and breastmilk is a key connecting factor between mother and infant 
for vitamin A status. 
Supplementation of infants with iron and zinc was effective in reducing the 
prevalence of anemia, and deficiencies of iron and zinc. Although there was some 
inhibitory effect of zinc on iron absorption, combined supplementation of iron and zinc 
was more beneficial than supplementation with one nutrient alone. 
Supplementation of zinc in addition to p-carotene during pregnancy was found 
to improve vitamin A status in mothers and their infants 6 months post-partum. This 
indicates that zinc plays an important role in the conversion of P-carotene. Intriguingly, 
the synergistic effect of zinc on P-carotene supplementation is not apparent in infants, 
perhaps because infants have less capacity to metabolise or store P-carotene. 
Importantly, iron supplementation was found to have an antagonistic effect on vitamin 
A status in infants, possibly due to a redistribution of retinol to the liver. Therefore, 
iron supplementation in infants should not be given without measures to improve 
vitamin A status. 
Supplementation of pregnant women with (3-carotene and zinc improved birth 
weight, but only in boys. However, growth performance of neither the supplemented 
infants nor of the infants born of mothers supplemented during pregnancy, was 
improved, indicating that additional factors are involved in the growth impairment of 
these infants. 
Various micronutrients have profound, albeit different effects on immune 
function. Vitamin A deficiency in infants was associated with lower ex vivo type-1 
cytokine production, but higher in vivo macrophage activity, whereas in zinc deficient 
infants reduced white blood cell numbers, as well as lower type-2 cytokine production 
were seen. Supplementation of infants with iron resulted in higher type-1, and lower 
type-2 cytokine production, whilst supplementation with (3-carotene and zinc appeared 
to have opposite effects on immune function. 
In conclusion the research described in this thesis shows that concomitant 
deficiencies of various micronutrients are very prevalent, and that supplementation 
with single micronutrients is not optimal. The expected effectiveness of 
supplementation with one micronutrient will not be achieved if the utilisation of the 
micronutrient is impaired by deficiency of another micronutrient. Health benefits of 
supplementation will also fall short of expectations as long as deficiencies of other 
micronutrients are not addressed. Therefore supplementation with more than one 
micronutrient is recommended both for infants and for pregnant women. 
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Chapter 1 
BACKGROUND 
Malnutrition is still one of the major health problems in developing countries, 
affecting billions of people. Malnutrition can be caused not only by insufficient 
quantity of food, but also by poor food quality. The quality of the diet relates to the 
balance of amino acids and protein content, and to micronutrient content. Qualitative 
inadequacy of diets leading to deficiency of various micronutrients is very widespread, 
although signs or symptoms are often lacking. Micronutrient deficiency is therefore 
also referred to as the "hidden hunger"(l). 
"Micronutrients" is the collective term used to describe vitamins and trace 
elements, which are required in only small amounts by the body. Vitamins may be 
present in the diet as such, but some vitamins can also be derived from provitamins. 
For instance vitamin A can be present in the food as retinol, or formed from provitamin 
A carotenoids. Trace elements, such as iron, zinc and copper serve many metabolic 
functions, often as part of protein complexes such as haemoglobin and metallo-
enzymes. 
Severe micronutrient deficiency often gives distinct signs and symptoms, and 
can be directly life threatening, but is not very prevalent. The manifestations of 
marginal micronutrient deficiency often appear minor and not specific, but can impair 
development and increase the risk of morbidity and mortality. However, marginal 
deficiency of various micronutrients is much more prevalent than severe deficiency, 
affecting health, growth and development of populations in an insidious way. 
Therefore, the overall burden of marginal deficiency on health and development is 
much greater than that of severe deficiency. The most vulnerable groups in the 
population are preschool children, and pregnant and lactating women. Marginal to 
moderately severe iron deficiency for example affects over 30% of all women (2). 
Micronutrient requirements during pregnancy and lactation are increased, and diets in 
developing countries often do not meet these higher requirements. Therefore during 
pregnancy and lactation micronutrient stores often become depleted, leading to 
impairment of micronutrient status, affecting both mother and infant. Marginal 
deficiency of various micronutrients in children has direct consequences for 
psychomotor development, immune function and growth. For example, children with 
marginal vitamin A status have higher morbidity and mortality of infectious diseases 
(3-5). Many studies have shown that deficiency of various micronutrients during 
pregnancy is associated with unfavourable pregnancy outcomes such as maternal 
mortality, congenital abnormalities and low birth weight (6-8). 
Most intervention and research efforts in the field of micronutrient nutrition 
have concentrated on deficiencies of vitamin A, iron and iodine, in concordance with 
the priorities set by the World Summit for Children in 1990, the Ending Hidden 
Hunger Conference in 1991, and the International Conference on Nutrition in 1992. 
However, other micronutrients such as zinc, copper, and riboflavin, also warrant 
attention, not in the least because of the interactions among many micronutrients, and 
their interwoven roles in metabolic processes (9). People are likely to be deficient with 
respect to more than one micronutrient concurrently, as the same causative factors can 
underlie the aetiology of deficiency for different micronutrients. A cereal-based diet, 
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rich in phytate and low in animal products is common in most developing countries, 
including Indonesia. Such a diet predisposes to insufficient absorption of both iron and 
zinc (10). Furthermore, the amount of retinol and the absorption of provitamin A 
carotenoids from such a diet will be low (11). This is illustrated by the finding that 
vitamin A deficient infants and lactating women in Indonesia are 2 to 4 times more 
likely to be deficient in iron and/or zinc than vitamin A sufficient infants and women 
(12). 
Vitamin A. 
Vitamin A can be obtained from the diet either directly as retinol, or derived 
from provitamin A precursors. The term "vitamin A" specifically refers to the fat-
soluble substance of all-trans retinol, but generically used also includes other oxidation 
states of retinol, retinal and retinoic acid, and fatty acid ester forms of retinol, such as 
retinyl palmitate. Together, these compounds provide the biological basis of all aspects 
of vitamin A activity in the body, and each compound fulfils a specific role. However, 
retinol has a pivotal role and can be converted to all other compounds. Hopkins first 
identified the dietary factor leading to vitamin A deficiency in 1912, McCollum and 
Davies subsequently isolated vitamin A in 1913, and by 1931 its structure was 
completely elucidated by Karrer et al. (13,14). In addition to the retinoids, of which 
vitamin A compounds are a subgroup, there is the group of carotenoids, some of which 
are precursors to vitamin A. These are often referred to as the provitamin A 
carotenoids. Carotenoids are brightly coloured, and most colours in living nature are 
based on carotenoid pigments. Vitamin A itself is found only in animal tissues. Hence, 
carotenoids are far more abundant in nature than vitamin A, and are the main source of 
vitamin A in diets in developing countries (15). However the availability from the diet 
and conversion of provitamin A carotenoids to vitamin A are highly variable and often 
less than generally assumed (11). 
Vitamin A has an important role in many metabolic processes. The most well-
known function is in the visual processes in the eye. 1 l-cis Retinaldehyde, a derivative 
of retinol, is an essential component of rhodopsin, the pigment of the retina especially 
important in dim light vision (9). Hence, one of the first signs of vitamin A deficiency 
is night blindness. However, vitamin A, mostly as retinoic acid, is involved in the 
functioning of many other cells and tissues, including epithelial cells and cells of the 
immune system, and important for foetal development (16). Retinoic acid and 
derivatives play an important role in the regulation of cell differentiation and 
proliferation, by binding to the nuclear retinoic acid receptor and retinoid X receptor, 
which are then activated. The activated receptors form dimeric complexes that bind to 
specific elements of target genes, and regulate gene expression on transcriptional level 
(17). 
Humans cannot synthesise vitamin A and have to rely on adequate intake of 
vitamin A or provitamin A carotenoids in the diet. Animal products generally contain 
vitamin A, and good sources are dairy products and liver, especially of fish. Plant 
foods contain no vitamin A, but large amounts of carotenoids, some of them with 
provitamin A activity. (3-Carotene is the most important provitamin A carotenoid 
because its chemical structure can provide two vitamin A molecules, and therefore 
contributes most efficiently to vitamin A nutrition. a-Carotene and (3-cryptoxanthin 
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also contribute, but to a lesser extent because with their chemical structure, they can 
only provide half the amount of vitamin A of (3-carotene. Yellow and orange fruits and 
vegetables seem to be the best sources of provitamin A carotenoids in the diet (18). 
Although the P-carotene content of dark green leafy vegetables is high, they are a less 
efficient source of vitamin A than fruits because of lower bioavailability. The many 
factors affecting bioavailability and conversion of provitamin A carotenoids have been 
described and categorised but have not been fully quantified yet (11). 
Retinol is readily absorbed (70%-90%) by the cells of the intestinal mucosa by 
facilitated diffusion. Carotenoids are often firmly encapsulated in insoluble complexes, 
and need to be released first before being available for absorption by the intestinal 
mucosal cells via a process of diffusion which does not seem to involve specific 
transporters. Hence absorption is less than for retinol and highly variable (5%-50%). In 
the mucosal cells, P-carotene can be converted to retinol by enzymatic cleavage, but in 
humans a significant proportion is absorbed intact into the body (16). As both retinol 
and carotenoids are fat-soluble, fat in the diet considerably improves absorption 
efficiency. Retinol and carotenoids are transported from the intestine to the tissues in 
chylomicrons, which are converted to chylomicron remnants in extra-hepatic tissues 
such as adipose tissue and muscle. In the liver, retinol is taken up by the parenchymal 
cells as retinyl esters, hydrolysed, and then bound to cellular retinol-binding protein 
(RBP). Retinol is then either secreted into the circulation bound to RBP and 
transthyretin or transferred to the hepatic stellate cells where it is stored as retinyl 
esters, mostly as retinyl palmitate (19). Mobilisation of retinol from liver cells is still 
not completely understood, but involves close cooperation between the liver 
parenchymal and stellate cells, with the parenchymal cells producing most of the RBP 
necessary for mobilising retinol from hepatic stores. Adipose tissue appears to be an 
important storage site for p-carotene, and recently was shown also to store retinol (20). 
Although vitamin A deficiency encompasses a wide range of changes in 
biochemistry, tissue and cell function and immunocompetence, the importance of 
vitamin A for public health has only recently been recognised (21). Historically, 
vitamin A deficiency was synonymous with a syndrome of ocular and epithelial 
damage, starting with night blindness and cumulating in destruction of the cornea 
(keratomalacia) and blindness. Already the Roman physician Celsus (25 BC-50 AD) 
used the term xerophthalmia to describe what we now know are the ocular signs of 
severe vitamin A deficiency (22). However, vitamin A deficiency is also important for 
immunity. This is illustrated by a meta-analysis of studies on vitamin A deficiency 
reporting 20%-30% reduction of mortality after vitamin A supplementation of children, 
even in populations without severe vitamin A deficiency (5). 
Vitamin A status is determined by retinol stores in the liver. As these are 
difficult to measure directly, several other indicators are used to assess vitamin A 
status. Plasma or serum retinol concentration is the most widely used indicator. A 
plasma retinol concentration of <0.35 mol/L is considered deficient, and a plasma 
concentration of <0.70 molTL is used to indicate marginal or subclinical vitamin A 
deficiency. In populations vitamin A deficiency is considered a severe public health 
problem if the prevalence of plasma retinol concentrations <0.70 umol/L is >20%, and 
moderate if the prevalence is >10%. Other indicators of vitamin A status are plasma 
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concentrations of RBP, breast milk retinol concentrations, but stable isotope dilution 
techniques and several cytological and functional tests are also used to measure 
vitamin A status. These indicators are less often used because of technical difficulties 
or problems with validation. There are also some tests that offer an indirect measure of 
liver retinol stores. The relative dose response (RDR) measures the increase in plasma 
retinol concentration 5 hours after a small loading dose of retinol. The modified 
relative dose response (MRDR) test uses the ratio of the concentrations of 3,4-
didehydroretinol to retinol, 5 hours after a loading dose of 3,4-didehydroretinol. When 
vitamin A liver stores are low, more retinol (RDR) or 3,4-didehydroretinol (MRDR) 
appears in the blood relative to initial or circulating plasma retinol concentrations (23). 
Vitamin A supplementation is used worldwide to combat vitamin A deficiency. 
Intermittent high dose supplementation of children (100,000 IU between 6 and 12 
months of age, 200,000 IU above 1 year of age) with capsules has been successful in 
many countries to virtually eliminate xerophthalmia. However, vitamin A can have 
toxic effects in high concentrations, and excessive dosing should be avoided. In 
pregnant women, vitamin A can have teratogenic effects on the foetus, so in women 
only low dosing (< 10,000 IU/day or 25,000 IU/week) or a single high dose 
immediately post-partum (200,000 IU within 4 weeks of delivery) is recommended 
(24). p-Carotene has no toxic or teratogenic effects, but is not commonly used in 
supplementation. 
X A A A A / C H 2 ° 
I II Retinol 
:tin I II Re al 
P-Carotene 
a-Carotene 
(3-Cryptoxanthin 
Formulae of retinol, retinal, retinoic acid, and some carotenoids 
with pro-vitamin A activity. 
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Iron. 
Iron is the one of the most abundant minerals on earth, and the human body 
requires only minute quantities. Yet iron deficiency is the most prevalent micronutrient 
deficiency, with about 2 billion people affected worldwide. Iron is easily oxidised, and 
in nature it is mainly found in the most oxidised state, Fe3+. Iron is a transition metal; it 
can readily undergo reversible oxidation and reduction, and as such plays an important 
role in the metabolism of living organisms. Free iron is highly reactive, and living 
organisms have developed ingenious ways of storing and handling iron safely, 
primarily by binding iron to proteins. In adult humans, two-thirds of the iron in the 
body is present bound to haemoglobin in the erythrocytes. Haemoglobin is a protein 
essential for the transport of oxygen to the cells. Other important iron-binding proteins 
are myoglobin in muscle tissue, the cytochrome enzymes mainly in the mitochondria, 
and the proteins involved in iron transport and storage, transferrin and ferritin. Breast 
milk contains large amounts of the iron-binding protein lactoferrin (25). 
Because of the poor solubility of Fe3+, the availability of iron for living 
organisms is limited. Humans generally only absorb between 5% and 15% of the iron 
ingested. However, absorption of iron from the diet is highly variable and depends on 
many factors, including the iron status of the individual (26). One of the most 
important factors affecting iron absorption is the oxidation state of iron. Haem iron 
(Fe2+) is more readily absorbed than non-haem iron (Fe3+), but haem iron is only found 
in meat products. Interactions with other minerals such as calcium, zinc and copper can 
impair absorption by competitive uptake in the intestinal wall, whereas vitamin C and 
citrate can enhance uptake. Because iron is a cation, it can also form complexes in the 
gut lumen with other substances in food such as phytates, tannins, oxalates and fibres, 
making it inaccessible for absorption. Diets low in animal products, and comprising 
primarily cereals and vegetables (and thus also high in phytate, fibre and other 
chelating agents) are common in most developing countries. From such a diet only 
about 5% of the iron is absorbed, compared to over 15% from diets with abundant 
meat as consumed in most developed countries (27). 
In cells, iron is bound to ferritin as a soluble complex, and macrophages, 
principally in the spleen, bone marrow and liver, are the largest depot of iron in the 
body after the erythrocytes. Mobilisation of iron from intracellular stores involves 
mainly transfer of iron from ferritin to transferrin, which transports iron in the plasma. 
The iron stores in the body contain enough iron to prevent iron deficiency for up to 3 
years in adult men, but only up to 6 months in women, because of the iron losses 
through menstruation in women (27). The iron reserves of the newborn infant are 
usually depleted in 4 to 6 months, and the infant is then dependent on dietary intake. 
Iron deficiency is defined by the absence of iron stores. One of the indicators of 
iron deficiency that is easiest to measure is haemoglobin concentration. Iron deficiency 
leads to reduced and iron deficient erythropoiesis, resulting in microcytic hypochromic 
anaemia. There are many other causes of anaemia however, and measuring only 
haemoglobin concentration does not differentiate between them. Also, haemoglobin 
concentrations decline only as an end stage of iron deficiency. Iron deficiency is most 
accurately determined by the absence of stainable iron in macrophages in bone marrow 
smears, however usually more practical indicators are used, which may give similar 
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information on iron status. In the absence of infection, plasma ferritin concentrations 
are directly related to iron stores. However, during infection the plasma concentrations 
of ferritin rise and are not directly related to iron status anymore (28). Also, the degree 
of iron deficiency cannot be assessed using plasma concentrations of ferritin, as these 
reach a nadir just before iron stores are completely empty. Another indicator that has 
been recently developed is serum soluble transferrin receptor concentration. It is 
considerably less affected by the inflammatory response. However, in replete and 
semi-replete situations, the concentration of serum soluble transferrin receptor seems to 
be less indicative of iron stores than ferritin. Also cut-off values are not clear yet. 
Many other indicators have been developed, but all have limitations because of the 
wide range of biochemical changes that occur during iron depletion. As none of the 
indicators is completely satisfactorily, the use of several indices of iron status 
simultaneously is probably necessary to obtain an accurate indication of iron status 
(29). In infancy, the situation is even more complex. In the first months of life, iron is 
relatively abundant due to neonatal iron stores, and iron is rapidly metabolised and 
recycled as the infant changes from foetal haemoglobin to normal haemoglobin. Also, 
iron requirements are high to support rapid growth. Plasma concentrations of ferritin 
are high at birth but decrease steadily during the first year of life, and haemoglobin 
concentrations in infancy are lower than in later life. 
Iron deficiency leads to functional impairment of many tissues. Reduced 
erythropoiesis resulting in the development of anaemia is the most well-known 
example. However, iron deficiency of functional significance can already be present 
before erythropoiesis is affected. Iron deficiency impairs physical work capacity, not 
only as a result of reduced delivery of oxygen to the tissues because of anaemia, but 
also as a result of impaired cellular oxygen transport and oxidative metabolism in the 
tissues. The importance of iron for brain development is only recently emerging. Iron 
deficiency in infancy can lead to delayed psycho-motor development, and impaired 
learning. There is concern that these effects are, at least partially, irreversible (30). 
Also, iron plays an important role in the immune system, and iron deficiency leads to 
impaired immune function, especially a decreased cell-mediated immunological 
response (31). 
Iron supplementation is commonly used to treat and prevent iron deficiency. It 
is standard practice in many countries to supplement pregnant women with iron (in 
combination with folic acid), because of the high prevalence of iron deficiency in 
pregnancy. Iron deficiency is associated with pregnancy complications, but a direct 
causal relationship has not been established (32). Iron supplementation programmes for 
children are being contemplated because of the high prevalence of iron deficiency and 
the important role of iron for brain development. Iron supplementation can cause 
gastro-intestinal irritation and obstipation, and ingestion of large amounts (>1 gram) 
has serious toxic effects and can be lethal in children. 
Zinc. 
Nutritional zinc deficiency was first described by Prasad et al. in relation to a 
distinct clinical syndrome of dwarfism and delayed sexual maturation in Iranian 
adolescent boys (33). Since then, the importance of zinc in human metabolism has 
been extensively documented. Zinc is an essential trace element involved in the 
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function of over 300 enzymes and proteins in the human body. These proteins are 
involved in a wide range of metabolic functions, including DNA transcription ("zinc-
finger-motifs", a DNA binding domain with zinc as active metal, are present in many 
transcription factors), protein synthesis (zinc is part of tRNA synthetase, and has been 
detected in RNA, t-RNA, and ribosomes), catalytic enzymes such as alcohol 
dehydrogenase and alkaline phosphatase, hormone receptors (including the nuclear 
steroid and retinoid receptors), and in the stabilisation of cell membranes both zinc-
containing protein complexes as well as membrane-bound zinc play a critical role(34). 
The biological role of zinc is always as a bivalent cation, and unlike iron, it does not 
undergo reduction or oxidation under physiological conditions, making zinc a stable 
component of protein complexes. Furthermore, zinc is a transition metal, allowing zinc 
to be bound in a large number of different constellations, enabling the formation of a 
wide variety of ligand binding sites. Therefore, zinc is a very versatile component of 
enzymes. 
The absorption of zinc varies widely (5%-40%) and depends not only on the 
dietary content of zinc, but also on the bioavailability of zinc in the diet. Animal 
products are usually rich in readily available zinc, whereas zinc content in plant foods 
depends on soil zinc content. The bioavailability of zinc from plant foods can be 
markedly reduced by phytates, which form insoluble complexes with bivalent cations 
such as zinc, and other compounds which interfere with the absorption of zinc either by 
binding (folic acid) or competing for absorption (calcium or iron) (35). Zinc from 
galvanised cooking utensils and water pipes may be an important additional source of 
zinc (27). 
In the body, zinc is subject to very strict homeostasis, and unlike iron or 
vitamin A, there are no known stores of zinc. However, zinc is present in all cells and 
tissues in the body, sometimes in high concentrations. In this context, the concept of 
type I and type II nutrients facilitates the understanding of zinc homeostasis and 
distribution. Type I nutrients are involved in certain specific metabolic functions, and 
deficiency will lead to specific clinical signs. There are well-defined stores, and in 
deficiency tissue concentrations will decrease. In contrast, type II nutrients are 
fundamental to the composition of cells and essential for the basic function of tissues. 
Hence, deficiency of a type II nutrient will primarily lead to generalised metabolic 
dysfunction, and eventually catabolism. Tissue concentrations of type II nutrients 
however are not decreased during deficiency. Furthermore, there are no well-defined 
stores of type II nutrients, and therefore requirements are continuous, but usually small. 
The primary response to deficiency is growth failure or loss of tissue. Examples of type 
II nutrients are essential amino acids, nitrogen, potassium, magnesium and also zinc 
(36). 
Therefore, it is not surprising that the assessment of zinc status is wrought with 
difficulties. Plasma zinc concentration is often used as an indicator of zinc status, but 
does not satisfactorily reflect individual zinc status. The variation in plasma 
concentrations of zinc due to changes in zinc status are small, and can easily be 
overshadowed by other factors such as diurnal and inter-individual variation (37). 
However plasma zinc concentrations appear to give a reasonable indication of zinc 
status at the population level (38). Another problem is that plasma concentrations of 
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zinc decrease during infection, as a result of the acute phase response. Many other 
indicators of zinc status have been used, but all have severe limitations. In infants and 
children, improved growth performance after zinc supplementation remains the golden 
standard for demonstrating pre-existing zinc deficiency. Isotope dilution techniques 
can be used to measure body pools of zinc, which would indicate zinc status. However 
cost prevents widespread use of this technique. 
Although the prevalence of zinc deficiency is difficult to assess, indirect 
indications suggest that zinc deficiency might be very widespread as the same dietary 
factors leading to iron deficiency also result in inadequate zinc nutriture. Even though 
the symptoms of zinc deficiency are not very specific, the consequences of zinc 
deficiency should not be underestimated. Zinc deficiency can lead to increased 
incidence and severity of infection because of impaired immunocompetence, impaired 
growth and development of children, increased incidence of pregnancy complications 
including increased maternal and perinatal mortality, and lower birth weight. 
Supplementation with zinc is effective in alleviating or preventing zinc 
deficiency. However, zinc supplementation is not yet widely implemented, as the 
extent of zinc deficiency and the benefits of supplementation are not clear in many 
populations. Gastro-intestinal irritation can occur, especially at higher doses (>30 mg). 
Zinc is not very toxic, although doses of more than 60 mg/day in pregnant women 
caused premature births in one study (39). Rare instances of zinc poisoning (>1 g/day) 
are usually associated with food contaminated with zinc leached from galvanised food 
containers. 
Micronutrients and growth. 
Impaired growth is one of the most consistent signs of malnutrition, and is 
associated with poverty and poor health, and increased morbidity and mortality, and 
developmental impairment. In infants, not only energy and/or protein deficiency will 
lead to growth impairment, but also a poor dietary quality leading to deficiency of one 
or more micronutrients. Growth can be measured in various ways, and expressed in 
different units. Height (or length) and weight are the most important measures, 
indicating linear and ponderal growth. They can be standardised against standard 
growth curves, and then expressed as Z-scores for age. Linear and ponderal growth are 
not necessarily simultaneous processes, in fact, there are indications that ponderal 
growth precedes linear growth (40). Also, growth impairment can exhibit specific 
patterns. This is best illustrated with the terms 'stunting' and 'wasting', with stunting 
being a length growth deficit, relative to the standard length for age ("short"), and 
'wasting' an insufficient weight relative to height ("skinny"). However, a stunted child 
is not necessarily wasted and vice versa. The exact mechanisms behind growth 
faltering are not clear. Studies on nutritional growth impairment indicate that the onset 
of linear growth faltering is probably within a few months of birth, and that the most 
sensitive period for intervention is prior to 18 months of age (41). The influence of 
nutrition on growth already starts before birth, and maternal nutritional status is an 
important factor, affecting birth weight, neonatal nutritional status and breast milk 
quality. 
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Zinc deficiency is classically associated with impaired growth, and many 
studies have found a positive effect of zinc supplementation on growth performance. A 
meta-analysis of such studies showed that zinc supplementation improved growth most 
in stunted children, children under the age of 24 months, and children with initial low 
plasma concentrations of zinc (42). Also, zinc supplementation has been shown to 
increase growth rates in severely malnourished children, but also in breast-fed infants 
from low-income families in France (43), and in growth limited, well-fed children in 
the United States and Canada (35). 
The relation between vitamin A status and growth is less clear, although there 
is evidence that vitamin A deficiency is associated with stunting. Studies with vitamin 
A supplementation in children have had variable effects on growth, ranging from no 
effect at all, to significant increases in weight and/or height. A possible explanation for 
these differing results is the concomitant existence of deficiency of several 
micronutrients, together impairing optimal growth and muting potential effects of 
supplementation (41). Also, vitamin A supplementation often reduces morbidity, and 
this will indirectly lead to improved growth. There are some reports that (3-carotene 
supplementation can improve growth performance, independent of improvements in 
vitamin A status. 
Although iron deficiency is associated with wasting, there is little evidence that 
iron supplementation can directly improve growth. Indirectly, the conditions that lead 
to iron deficiency such as hookworm infection also impair growth, and improved iron 
status can enhance appetite (41). There is some evidence that iron supplementation can 
improve growth in anaemic children (44). 
Micronutrients and immune function. 
The immune system consists of a non-specific or innate component, forming a 
constant defence mechanism that does not adapt to the invading agent, and a specific 
immune defence, capable of responding in an antigen-specific way. The most basic 
innate defence mechanisms include integrity of the epithelial surface and mucosal 
barrier function. Humoral components of non-specific immunity include opsonins, 
complement activation and the acute phase response. Non-specific, cell-mediated 
immunity is formed by macrophages and other phagocytic cells. Innate immunity is not 
improved by repeated exposure to infectious agents. 
Lymphocytes are central to the specific or adaptive immune response. T-
lymphocytes (T because these cells mature in the thymus) are essential in the 
regulation of immune responses, and can be divided into different subpopulations 
according to their function, or rather according to specific markers. Main classes of T-
cell that can be distinguished are the cytotoxic T-cells, which can kill target cells, and 
the T-helper cells, which can activate macrophages and B-lymphocytes. B-
lymphocytes (B from Bursa Fabricius, an organ associated with the gut specific for 
birds where these cells were first identified) mature in the bone marrow, and can be 
induced to produce antibodies in response to specific antigens, and/or T-helper cell 
stimulation. Cytokines are produced by the cellular components of the immune system 
to specific stimuli, and play a key role in the modulation and regulation of immune 
function. Cytokines induce responses in a wide range of effector cells, and can initiate, 
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stimulate and suppress immune reactivity. Responses induced by cytokines can be very 
specific such as proliferation or activation of particular subpopulations of T-cells, or 
more generalised such as fever or suppression of erythropoiesis. 
Immune System 
Innate Immune Response 
(non-specific) 
—> Barrier Function 
(e.g. epithelia and mucosa) 
—> Humoral Component 
(e.g. acute phase response) 
—> Cell-mediated Component 
(e.g. macrophages, granulocytes) 
Schematic outline of the immune system. 
Adaptive Immune Response 
(specific) 
—> Central Role for Lymphocytes 
(e.g. T-helper cells, cytokines) 
—> Cellular Immunity 
(e.g. cytotoxic T-cells, NK cells) 
—> Humoral Immunity 
(e.g. B-cells, antibody production) 
The immune system of newborn infants is still immature, develops during the 
first year of life, reaching adequate immunocompetence at about one year of age. 
During the first few months of life, maternal antibodies (especially IgG), acquired in 
utero, still circulate and protect the newborn. Also, via breast milk, the infant acquires 
considerable amounts of immunoglobulins (mostly slgA) and perhaps also other 
humoral and cellular components of the mother's immune defence. The protective 
effect of slgA in breast milk is restricted to the gut, but the precise role of the other 
components remains unclear. 
The important role of micronutrients in immune function has only emerged 
recently, although vitamin A has been known as the "anti-infective vitamin" since the 
1920's. Vitamin A deficiency has been shown to increase morbidity and mortality of 
infectious diseases, and vitamin A supplementation in children can reduce mortality by 
as much as 20%-30% (45). Vitamin A deficiency appears to affect both the innate and 
specific immune system, as vitamin A is necessary for cell differentiation, 
phagocytosis and the modulation of cytokines. Studies, mostly in animal models, have 
shown specific effects of vitamin A deficiency on the immune system, however often 
with conflicting results. A general depression of T-cell activation is reported by some 
studies, supported by findings of decreased interferon-7 (IFN-7) production and 
decreased natural killer cell activity, as well as suppression of the delayed type 
hypersensitivity response (46-48). Other studies have found overproduction of IFN-7 
and reduced antibody production, fitting with a Thl predominance in vitamin A 
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deficiency (49,50). In humans with vitamin A deficiency, decreased cell-mediated 
(type-1) immune function, reduced natural killer cell activity, impaired phagocytosis, 
reduced type-1 cytokine production and reduced antibody titres, have all been reported 
(51). Hence, the underlying immune defects in vitamin A deficiency remain elusive. 
Severe zinc deficiency is accompanied by a marked increase in susceptibility to 
infections, but the effects of marginal zinc status are less well documented (52). In 
population studies, zinc supplementation gave a marked reduction in morbidity of 
diarrhoeal diseases, respiratory infections, as well as malaria (53-56). Zinc deficiency 
results in a striking depletion of both B- and T-cells, and also decreases numbers of 
neutrophilic granulocytes, natural killer cells and macrophages, as well as cytokine 
production and antibody response (53,57). Zinc has been shown to affect the function 
of T-cells directly at the cellular level (58). Furthermore, animal studies have shown 
that prenatal zinc deficiency can result in a persistent disturbance of the offspring's 
immune system (52). 
The role of iron in immune function has been the subject of much debate. On 
the one hand, iron is needed for various immunological functions, not in the least 
cytotoxicity and phagocytosis. Cellular functions such as cytotoxicity can already be 
reduced in marginal iron deficiency, before anaemia is present (59). On the other hand, 
iron is essential for the proliferation of most bacteria. Thus iron deficiency not only 
impairs immunological functions, but also suppresses bacterial growth. In humans, 
anaemia and iron deficiency are both associated with depressed cell-mediated 
immunity (59,60). Studies in animals suggest that an inadequate supply of iron restricts 
optimal T-lymphocyte proliferation. Humoral immune function or antibody response is 
probably less impaired. To complicate matters, supplementation with iron can enhance 
immune reactivity to such an extent that damage arises from the exacerbated 
inflammatory response (61). In population studies, the effects of iron supplementation 
on immune function has not been consistent, with some studies reporting increased 
immunocompetence while others report increased incidence and severity of infections 
(56,62). 
Interactions between micronutrients. 
Interactions among micronutrients occur at several different levels, but are often 
disregarded for the sake of simplicity, and because they are often difficult to study or 
quantify. Interactions may occur in food, in the absorption phase or once absorbed in 
the body. Food is a complex mixture of nutrients and other substances, and storage and 
cooking may cause losses of the more reactive micronutrients. In the absorption phase, 
food is digested, and nutrients are released to enable absorption. During digestion, 
micronutrients can affect the availability or absorption of other micronutrients, e.g. by 
enhancement of solubility, by competitive uptake, or by modulation of gut function. 
For example, iron bioavailability is enhanced by concurrent consumption of vitamin C, 
as vitamin C reduces Fe3+ to the more soluble Fe2+. Bioavailability of both iron and 
zinc is reduced by high calcium intake, as they all compete for absorption via the same 
bivalent ion channel (63-65). In the same way, iron and zinc can mutually antagonise 
the absorption of each other, especially when present in higher concentrations (66). 
The integrity of intestinal mucosa can be impaired in vitamin A deficiency and zinc 
deficiency, thereby reducing nutrient uptake. 
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Once absorbed in the body, metabolic interactions can play an important role. If 
micronutrients function in the same metabolic pathway, deficiency of one 
micronutrient may impair the utilisation of the other micronutrient or micronutrients. 
For example, vitamin B)2, iron and folate are all needed in erythropoiesis, and 
deficiency of one of these micronutrients will lead to a dysfunction of the whole 
erythropoietic pathway, resulting in anaemia. In this manner one micronutrient 
deficiency can also mask the presence of deficiency of one or more other 
micronutrients, and correction of only one micronutrient deficiency will be ineffective. 
Another example is in the visual processes of the eye. Vitamin A is necessary for the 
synthesis of retinal, whilst zinc is part of the retinal dehydrogenase enzyme. Deficiency 
of either can thus give rise to night blindness (67). Another mechanism of interaction 
between vitamin A and zinc is via RBP. Zinc is essential for RBP synthesis in the liver, 
and RBP is essential for transport of vitamin A from the liver to peripheral tissues 
(68,69). Hence, severe zinc deficiency can lead to impaired vitamin A transport. Some 
metabolic interactions, such as the role of vitamin A in iron metabolism, have not yet 
been completely elucidated. Vitamin A can reduce the prevalence of anaemia, and 
improves the utilisation of iron (70,71). Also, zinc metallo-enzymes are involved in the 
conversion of p-carotene to retinol, suggesting another potential mechanism for 
interaction between vitamin A and zinc (9). However, the exact mechanisms are still 
unclear. 
The effects of interactions between micronutrients can be exacerbated when 
micronutrients are supplemented in relatively high doses, and in situations where 
micronutrient nutrition is already marginal or deficient. For example, iron 
supplementation can impair zinc uptake, and this can induce zinc deficiency in 
populations with marginal zinc nutriture. Deficiency of several micronutrients often 
occur concomitantly in the same populations or even in the same person. This is not 
only because of the above mentioned interactions between micronutrients, but also 
because the same dietary factors leading to deficiency of one micronutrient often cause 
deficiency of other micronutrients. A rice-based diet, low in animal products as is 
common in Indonesia for instance, predisposes to both iron and zinc deficiency 
because of the high phytate content. Furthermore, the low fat content of the diet 
combined with the low intake of animal products can also cause inadequate vitamin A 
intake and absorption. 
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DESCRIPTION OF THE STUDY 
Study site. 
The studies described in this thesis were all conducted in kecematan 
(subdistrict) Cibungbulang of kabupaten (district) Bogor, West Java, Indonesia 
between September 1996 and December 1999. The area is rural, with most people 
dependent on farming for income and produce, and traditional in the sense that local 
traditions and customs are still important. Also, the traditional Sundanese diet 
consisting of mainly rice and vegetables, with some fish, tahu or tempe, and very little 
meat is adhered to. It is a fertile area, with three rice crops a year. The population is 
almost entirely Muslim. The study area fell under the responsibility of two health 
centres (Puskesmas). For the cross-sectional study, lactating mothers and their infants 
were recruited from two adjacent villages (Situ Udik and Situ Ilir). For the intervention 
study in infants, an additional four villages were included to supply a sufficient number 
of subjects (Sukamaju, Cemplang, Galuga and Dukuh). All these six villages fell under 
the responsibility of the same Puskesmas. For the intervention trial with pregnant 
women, another seven villages (Ciaruteun Udik, Leuweungkolot, Cimanggu I and II, 
Cibatok I and II, and Girimulya) were included. These were adjacent to the first six 
villages, but fell under the responsibility of the other Puskesmas. 
In the course of this project, the political and economical situation in Indonesia 
changed dramatically. In the summer of 1997, an economic crisis was developing in 
the whole South-East Asian region, but at the start of the intervention trial in infants, 
the consequences were not yet apparent in the villages. At the beginning of 1998, the 
economic situation deteriorated quickly, and this economic crisis was felt intensely 
throughout Indonesia. By this time, the Indonesian rupiah had fallen from an exchange 
rate of 1,200 to 1 Dfl. to less than 7,000 to 1 Dfl. Imports stagnated, and millions of 
workers were made redundant. Several banks went bankrupt, and many shops and 
workplaces were simply closed. For instance in Cilebut, a small village of artisans and 
craftsmen and a regional centre for boatbuilding near Bogor, nearly 50% of the men 
became unemployed within two months (personal observations). In May 1998, after 32 
years of being in power, President Suharto stepped down after a week of fierce riots, 
following the shooting on the Trisakti-university campus of 6 students, of whom 4 
died. The Vice-President, Mr. Habibie, was appointed President, and new elections 
were called for. The year that followed was dominated by political changes, commonly 
referred to as "reformasi", but also the continuing economic crisis. After the elections 
of spring 1999, with a new President and Vice-President, Indonesians felt ready to 
make a new start. However, at the writing of this thesis (spring 2001), the economical 
problems have not yet been resolved, and the new political era has not yet brought the 
changes that were expected of it (72). 
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OUTLINE OF THE THESIS 
Below, a brief outline of the thesis is given. The studies described in this thesis 
were conducted between November 1996 and January 2000. For each chapter the 
subject of the research described in the paper is specified. 
Chapter 2 describes the results of the cross-sectional survey with regard to 
micronutrient status of lactating mothers and their infants. 
Chapter 3 describes immune response of Indonesian infants in relation to 
micronutrient status. 
Chapter 4 describes the effects of iron and zinc supplementation of Indonesian 
infants on micronutrient status and growth. 
Chapter 5 reports the effect of iron supplementation on vitamin A status in 
Indonesian infants. 
Chapter 6 describes immune function in Indonesian infants supplemented with 
P-carotene, iron and zinc. 
Chapter 7 shows the effects of inflammation on indicators of micronutrient 
status in Indonesian infants. 
Chapter 8 describes the effects of supplementation of Indonesian pregnant 
women with P-carotene and zinc, in combination with iron and folic acid on pregnancy 
outcome, including pregnancy complications and birth weight. 
Chapter 9 reports the effects of supplementation during pregnancy with P-
carotene and zinc, in combination with iron and folic acid on micronutrient status of 
mother and infant, and growth of the newborn 6 months post-partum. 
Chapter 10 discusses the main findings of the studies described in this thesis, 
and draws conclusions with implications for policy, programmes, and future research. 
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Djenkol. 
During the cross-sectional survey described in this thesis, we were alarmed by the high 
prevalence of, what we thought were urinary tract infections, as indicated by bright 
red discolouration of urine samples of the mothers. However, dipstick testing of the 
urine samples showed neither blood, nor other signs of urinary tract infection. The 
only explanation we could think of at the time was that the urine was discoloured by 
food additives excreted via the urine. However, Professor R. Luyken drew our attention 
to a whole body of literature from the 1930's and 1940's on the subject of "djengkol". 
Djenkol beans (Pithecolobium lobatum) are edible beans, in taste and smell not unlike 
peteh beans, eaten in relatively large quantities by the Sundanese. A disadvantage of 
the bean however is the presence of a sulphur-containing amino acid, djenkolic acid, 
which not only gives rise to the peculiar smell of the beans, but also colours the urine 
red, and can give toxic cystitis and nephritis when too many djenkol beans have been 
eaten. Normally, "djenkol-poisoning" is rare and appears to be mild, although fatal 
cases in children have been reported. Small crystals of djenkolic acid can be found in 
the urinary tract of people with djenkol poisoning. Individual susceptibility to djenkol-
poisoning varies widely, and most people know their own limit of how many beans can 
be eaten before side effects occur. Before consumption, the beans are usually 
fermented for a couple of days and then either roasted or braised with spices. Only one 
other bean is known that also contains djenkolic acid, the boea kabau (Pithecolobium 
bubalinum), which is used in cooking in Sumatra. Besides containing this toxic 
substance, djenkol beans are a good source of vitamin Bj and make a rather tasty side 
dish of semur. 
Hijman AJ, van Veen AG. Over het djengkolzuur, een nieuwe zwavelhoudend amino-
zuur. Geneeskundig Tijdschrift van Nederlands Indie. 1936;76:840-59. Van Veen AG, 
Hijman AJ. Het giftige bestandeel van de djengkol. Geneeskundig Tijdschrift van 
Nederlands Indie. 1933;73:991-1001. Van Veen AG, Latuasan HE. The state of 
djenkolic acid in the plant. Chronica Naturae. 1949;105:288-9. West CE, Perrin DD, 
Shaw DC, Heap GJ, Soemanto. Djenkol bean poisoning (djenkolism): proposals for 
treatment and prevention. South East Asian Journal of Tropical Medicine and Public 
Health. 1973;4:564-70. 
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ABSTRACT 
Background: Deficiencies of vitamin A, iron and zinc are prevalent 
worldwide, affecting vulnerable groups such as lactating women and infants. However, 
the existence of concurrent deficiencies has received little attention. 
Objective: The aim was to investigate the extent of coexistence of deficiencies 
of vitamin A, iron and zinc, and also the nutritional relationship between lactating 
mothers and their infants. 
Design: In a cross-sectional survey in rural West Java, Indonesia, 155 lactating 
mothers and their healthy infants were assessed anthropometrically, and blood, urine 
and breast milk samples were obtained. 
Results: Marginal vitamin A deficiency was found in 54% of the infants and 
18% of the mothers. More than 50% of the mothers and infants were anemic, and 17% 
of the infants and 25% of the mothers were zinc deficient. There was a strong 
interrelation between the micronutrient status of mothers and infants, and the 
concentrations of retinol and P-carotene in breast milk. Vitamin A deficiency in infants 
led to an increased risk for anemia and zinc deficiency (odds ratios: 2.5 and 2.9, 
respectively), whereas in mothers the risk for anemia and iron deficiency (odds ratios: 
3.8 and 4.8, respectively) increased. In infants, concentrations of insulin-like growth 
factor 1 were related to concentrations of plasma retinol and P-carotene but not to zinc. 
Conclusions: Micronutrient deficiencies were prevalent in West Java. The 
micronutrient status of lactating mothers and that of their infants were closely related; 
breastmilk was a key connecting factor for vitamin A status. Furthermore, 
micronutrient deficiencies appeared to be the norm. 
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INTRODUCTION 
Micronutrient deficiencies are still a major public health problem in many 
developing countries, with infants and pregnant women especially at risk (1). Infants 
warrant extra concern, because they require extra micronutrients to maintain optimal 
growth and development. In this context, the nutritional relation between lactating 
mothers and their infants is of special interest. 
Deficiencies of vitamin A, iron and zinc often coexist and have independent 
and interacting effects on health, growth and immunocompetence (2,3). It is well 
known that severe vitamin A deficiency leads to xerophthalmia. However, vitamin A is 
important in many other tissues and metabolic processes, and the considerable effects 
of vitamin A deficiency on morbidity and mortality have become clear (4,5). It is 
important to note that in populations with only marginal vitamin A deficiency, effects 
on metabolism and immune function are already present (4). Also, vitamin A 
deficiency was shown to contribute to the development of anemia and stunting (6,7). 
People in developing countries derive most of their vitamin A from provitamin A 
carotenoids, of which |}-carotene is the most important. However, absorption, 
conversion, and mobilization of carotenoids and retinol are variable and dependent on 
many factors (8). 
Iron deficiency is the most important cause of nutritional anemia, and is the 
most common micronutrient deficiency worldwide; it leads to impairment of health, 
growth, development and performance (9). Iron supplementation is currently the most 
important tool for combating iron deficiency. However, a high intake of iron, 
especially as a supplement, was shown to be an antagonist to zinc absorption (3,10). 
The extent of zinc deficiency and its consequences are not yet clear. Zinc status 
is difficult to assess because plasma zinc concentrations do not sufficiently reflect 
individual zinc status because of strong homeostasis (11). In infants, improved growth 
performance after zinc supplementation is the most accurate measure of preexisting 
zinc deficiency but, on a population level, plasma zinc is still the most practical and 
reliable indicator of zinc status (12). 
The manifestations of zinc deficiency range from an increased incidence and 
severity of infection and impaired growth and development of children to pregnancy 
complications, low birth weight and increased perinatal mortality (13-16). Zinc is also 
thought to play a role in vitamin A and (3-carotene metabolism. Zinc supplements were 
shown previously to improve dark adaptation and intestinal integrity and zinc 
deficiency was found to aggravate the clinical effects of vitamin A deficiency (2). 
Most public health and nutrition programs focus on one micronutrient only, 
whereas many populations can be expected to be deficient in several micronutrients at 
the same time. The aim of this study was to investigate the prevalence of concurrent 
micronutrient deficiencies in lactating mothers and their infants to elucidate the 
nutritional interrelation between the mothers and their infants, and the relation of 
micronutrient deficiencies with growth. 
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SUBJECTS AND METHODS 
Subjects. 
One hundred ninety-seven mothers-infants pairs (>90% of the eligible 
population of two rural villages in the Bogor District of West Java, Indonesia) were 
recruited over 2 mo (November and December 1996) by health volunteers to 
participate in the cross-sectional study. Forty-two of these pairs were excluded because 
of chronic or severe illness (n=2), severe clinical malnutrition (n=2), congenital 
anomalies (n=2), fever or other signs of mild systemic acute illness (n=15), twin birth 
(n=l), or incomplete data (20x). Complete data sets from 155 mother-infant pairs were 
available for statistical analyses. The excluded mother-infant pairs did not differ 
significantly from the subjects for whom data are reported. As is customary in 
Indonesia, all mothers were breast-feeding their infants, but most not exclusively so. 
Mothers were informed of the procedures and purpose of the study. After 
written informed consent was given by the mother, infants and mothers were 
anthropometrically assessed, and a short history concerning socioeconomic status, 
dietary and lactation habits, and health was taken. Furthermore, a series of blood, 
urine, and breast milk samples from both the mothers and the infants were obtained as 
completely as possible. The protocol was approved by the Ethical Committee of the 
National Health Research and Development Institute of Indonesia and by the Ethical 
Committee of the Royal Netherlands Academy of Arts and Sciences. 
Methods. 
Anthropometry included measurement of weight, height and midupper arm 
circumference by a trained anthropometrist using standard methods, z scores for 
weight and height [weight-for-age (WAZ), height-for-age (HAZ) and weight-for-
height (WHZ)] were calculated by using EPI-Info (version 6.02; Centers for Disease 
Control and Prevention, Atlanta) with the use of the WHO recommended growth 
curves (17). A fasting 3-mL venous blood sample was taken from the mothers and a 
non-fasting 5-mL venous blood sample was taken from the infants. A closed-tube 
heparin-containing vacuum system was used to avoid zinc contamination. Blood 
samples were stored immediately at 4°C to prevent microhemolysis and were separated 
within 5 h. 
Breast milk was obtained from the right breast, 45-60 min after the last feeding 
from that breast. The breast was completely expressed and all milk collected. The 
manual breast milk pumps and containers were washed with acid to prevent zinc 
contamination (18). Urine samples were collected in acid-washed containers (mothers: 
midstream samples; infants: samples taken after the genital area was washed). 
Zinc in blood, urine, and breastmilk was analyzed with flame atomic absorption 
spectrophotometry (Varian Australia Ltd, Clayton South, Australia), by using certified 
control sera (J. Versieck, Department of Internal Medicine, University Hospital, Gent, 
Belgium) as a quality control. For plasma and urinary zinc, the inter-assay CV was 
typically <5%, however breast milk zinc analyses showed more variability (10%), 
probably because of matrix effects. Urinary zinc concentrations were measured in 
casual urine samples in 104 infants and 130 mothers. 
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Retinol and P-carotene were analyzed using standard HPLC procedures. 
Hemoglobin concentrations were measured by using the standard cyanoblue method 
(Humalyzer, Tanusstein, Germany). Hematocrit in blood and creamatocrit in breast 
milk - a measure of breast milk fat - were determined according to standard practice. 
The fat content of breast milk was calculated on the basis of the creamatocrit content 
according to the method of Lucas et al(19). Ferritin, C-reactive protein (CRP), and 
insulin-like growth factor-I (IGF-I) were measured using commercial enzyme-linked 
immunosorbent assay kits (MP-products, Amersfoort, The Netherlands). Urinary 
creatinine was measured colorimetrically (Randox, Antrim,UK) and retinol binding 
protein (RBP) turbidimetrically (Behring Diagnostics Benelux NV, Rijswijk, The 
Netherlands). Because a close interrelation between indicators of micronutrient status 
of mothers and their infants was expected, the relation between hemoglobin, and 
plasma retinol, P-carotene, and zinc concentrations in the mother-infant pairs was 
examined. 
Because many commonly used indicators of micronutrient status [eg, plasma 
concentrations of zinc, retinol, ferritin and RBP (20)] are altered by the acute phase 
response, subjects were screened for the presence of inflammation (12,20). Because a 
clinical examination often does not exclude the presence of minor or low-grade chronic 
infections, subjects with an acute phase response - as indicated by CRP concentrations 
> 10 mg/L or ferritin concentrations > 150 (Ag/L (> 400 \lg/L in infants aged <6-mo) -
were excluded from the statistical analyses (21). 
Statistical analysis. 
Data were checked for normal distribution by using the Kolmogorov-Smirnov 
test of normality. Relationships were analyzed by using multiple linear regression 
analysis; confounders were controlled for when necessary by using a backward 
deletion procedure (threshold P > 0.1). When no confounders were found, Pearson's 
correlation were used. Odds ratios and CIs were determined by using chi-square tests. 
Differences between groups were checked using Student's t test for parametric or log-
transformed variables. Statistical analysis was carried out with EPI-Info (version 6.02) 
and SPSS (version 7.5.2; SPSS Inc, Chicago) software packages. 
RESULTS 
The infants ranged in age from 2.4 to 10.5 mo (Table 1), with an equal age 
distribution for both sexes; the sample included 78 males and 77 females. The mean 
HAZ was negative (- 0.73) whereas the mean WHZ was positive (0.24), indicating that 
in general the infants were short but not wasted. Eleven infants (7%) had a HAZ < -2, 
whereas one infant (0.6%) had a WHZ < -2. An HAZ > 2 and WHZ > 2 were found in 
1% and 3% of the infants, respectively. Furthermore, all z scores were significantly 
negatively correlated with age after sex was controlled for (P < 0.01; HAZ: r = -0.34, 
WHZ: r = -0.29, WAZ: R = -0.48), implying that growth faltering in these infants 
started within the first months of life and progresses with age, as observed frequently 
in developing countries. 
41 
Chapter 2 
TABLE 1 
General characteristics of the study population. 
Age1 
BMI (kg/m2)2 
z Scores 
Weight-for 
Height-for-
Weight-for 
-age 
age 
-height 
Mothers 
(n=155) 
25 y (15-41) 
21.2 (19.7-23.0) 
Infants 
(n=155) 
6.6 mo (2.4 -10.5) 
-0.36 ±1.08 
-0.73 +1.08 
0.24 ±0.88 
Median; range in parentheses. 
Median; interquartile range. 
3
 x + SD. 
Micronutrient deficiencies were prevalent in both the infants and mothers 
studied; >50% of the infants and mothers being anemic, and >50% of the infants had 
marginal plasma retinol concentrations (<0.70 nmol/L) (Table 2). Seventeen infants 
and 12 mothers were excluded because of having an acute phase response: either 
elevated CRP concentrations only or both elevated CRP and ferritin concentrations; 
none had elevated ferritin concentrations only. As expected, plasma retinol 
concentrations were significantly lower, and plasma ferritin concentrations were 
significantly higher in the excluded subjects. Plasma zinc and RBP concentrations, 
however, did not differ significantly in the excluded subjects. 
In the infants there was a strong, linear correlation between plasma retinol and 
RBP concentrations (r = 0.71, P < 0.01; multiple regression analysis, no confounders 
were found; Figure 1). There was a positive correlation between concentrations of 
plasma zinc and urinary zinc (related to creatinine) in infants only (r = 0.23, P < 0.05, 
Spearman's rank test). The urinary zinc concentration is considered a more sensitive 
indicator of early zinc deficiency than is the plasma zinc concentration (14); however, 
in the present study it was found to be less suitable in the field setting, where sampling 
conditions were difficult. Usually only casual urine samples can be obtained in a field 
setting and it is often difficult to obtain samples from young infants. These factors 
contribute to the large variation in urinary zinc concentrations; therefore, this 
measurement is not very useful as a marker for zinc status. 
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There was a strong correlation between concentrations of hemoglobin, plasma 
retinol, plasma p-carotene, and plasma zinc in the mother-infant pairs (Table 2). 
Similarly, in lactating mothers breast milk was an important link between the 
nutritional status indicators of mothers and infants. Breast milk concentrations of 
retinol and P-carotene were significantly correlated to those in plasma of both mothers 
and infants (Table 3), accounting to a large extent for the strong interrelation between 
the vitamin A status of the mothers and infants. Concentrations of zinc in breast milk, 
however, were not significantly correlated with those in the plasma of either the 
mothers or infants. The fat content of breast milk [calculated on the basis of a median 
creamatocrit content of 3.7%; (interquatile range 2.8-5.0%)], was significantly 
positively correlated with both breast milk retinol and p-carotene (r=0.53 and r=0.24 
respectively; P < 0.01 by multiple regression analysis). However conflicting findings 
on changes in micronutrient concentration during lactation were reported previously 
(22-25). In the present study, there was no significant effect of the duration of lactation 
on retinol, P-carotene, or zinc concentrations in breast milk. 
Vitamin A deficient infants had a 2.5-fold greater risk of anemia and a 2.9-fold 
greater risk of zinc deficiency than did non-deficient infants, whereas the vitamin A 
deficient mothers were especially at risk of anemia (3.8-fold greater risk) and iron 
deficiency (4.8-fold greater risk) (Table 4). 
^^  g 
o S 
w 
s 
_o 
A 
u 
a 
4> 
c 
o 
u 
c 
*-§ 
o 
a. 
M 
'•3 
s 3 
"3 
e 
0? 
u 
a S 
W 
a E 
2 -
1.5-
1 -
0.5-
0 -
• 
• 
• 
• 
• • 
• • 
• 
• 
• +f 
• • / *t^40> 
• «»^. 
• *_*f^ 
• *•$&£* 
«**<•»*»«» 
• jr%*» « • • 
• + ±,itimm m» • 
- * • » • • « • 
«•»• 
» • • 4» 
4» 
• • 
• 
• • 
*» 4. 
> ^— • ^***^ 
-«*v • 
• • 
0.4 0.8 1.2 
Plasma retinol concentration (|xmol/L) 
FIGURE 1. Relation between plasma concentrations of retinol and 
retinol binding protein in Indonesian infants, y = 0.73x + 0.30; R2 = 0.46. 
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TABLE 3 
Relationship between concentrations in breastmilk and plasma of retinol, 6-carotene, and zinc 
in Indonesian lactating mothers and their infants. 
Fat (g/L) 
Retinol concentration (umol/L) 
(3-Carotene concentration (umol/L) 
Zinc concentration (|imol/L) 
Breast milk 
21.3 (15.1-30.2) 
0.37 (0.21 - 0.67) 
0.006 (0.004-0.011) 
30.3 (20.5 - 47.2) 
Correlation with 
plasma concentration 
Mother 
^^ _ 
0.37 4 
0.49 
NS 
Infant 
0.27 4 
0.58 
NS 
Median; interquartile range in parenthesis. One hundred fifty breast 
milk samples were available for vitamin A analyses and 105 of these were analyzed for zinc. 
Partial correlation coefficient, with control for fat content, no other confounders were found. Subjects 
with missing creamatocrit values were excluded from analysis (12 mothers). P < 0.01 
Pearson's correlation coefficient (with linear regression analysis, no confounders were found). P < 0.01 
4
 Subjects with an acute phase reaction were excluded from analysis (n-14 mothers, 17 infants). 
TABLE 4 
Risk of vitamin A deficient infants and mothers of having deficiencies of other micronutrients . 
Micronutrient 
deficiency indicator 
Vitamin A 
deficient infant 
OR (95% CI) 
Vitamin A 
deficient mother 
OR (95% CI) 
Anemia 
Iron deficiency 
Zinc deficiency 
Iron and/or zinc deficiency 
Anemia and/or zinc deficiency 
2.5 (1.3-5.0) 
2.4 (1.0-6.0) 
2.9 (1.1 -7.8) 
2.6 (1.2-5.5) 
2.6 (1.3-5.3) 
3.8 (1.4-10.0) 
4.8 (2.0-11.6) 
1.9 (0.7-4.6) 
2.8 (1.2-6.8) 
3.1 (1.1-8.9) 
' Odds ratio; 95% CIs in parentheses. Subjects with an acute phase response were excluded 
from the statistical analysis. 
Defined as a hemoglobin concentration <110 g/L (in infants) and <120 g/L (in mothers). 
Defined as anemia and a plasma ferritin <15 plg/L 
Plasma zinc < 10.7 p:mol/L 
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Long-term growth performance can be monitored by taking anthropometric 
measures, whereas IGF-1 concentrations provide a measure of current growth activity. 
In the infants studied, the median plasma IGF-1 concentration was 18.8 |j.g/L 
(interquartile range: 10.3 - 34.7), and IGF-1 concentration were negatively correlated 
with age, as were WAZ, HAZ and WHZ scores (Table 5). Furthermore, a clear 
relation was observed between IGF-1 and plasma retinol and P-carotene 
concentrations, but not with zinc. No relationship was found between the indicators of 
micronutrient status and the anthropometric measurements. 
TABLE 5 
Relations between plasma concentrations of insulin-like growth factor 1 
(IGF-1) in infants and indicators of anthropometric and micronutrient status 
Correlation 
Age 
Z scores 
Weight-for-height 
Weight-for-age 
Height-for-age 
Plasma retinol concentration 
Plasma P-carotene concentration 
Hemoglobin concentration 
Plasma zinc concentration 
- 0.28 2 
0.18 3 
NS 
NS 
0.25 4 
0.21 4 
0.17 3 
NS 
n=155. The median IGF-1 concentration 18.8 (ig/L (interquartile range 
10.3 - 34.7). 
P < 0.01 (Pearson's correlation coefficient) 
P <0.05 (partial correlation coefficients with control for age) 
P <0.01 (partial correlation coefficients with control for age) 
DISCUSSION 
This study showed that deficiencies of vitamin A, iron and zinc occur 
concurrently in lactating mothers and their infants in rural villages in West Java, 
Indonesia. Vitamin A deficient mothers and infants had a 2-3-fold greater risk of also 
being deficient for iron or zinc than did non-deficient mothers and infants. Furthermore 
the interrelation between the micronutrient status of lactating mothers and their infants 
was shown clearly, with breast milk being a key connecting link, especially for vitamin 
A nutrition. One of the first effects of suboptimal nutrition in young infants is growth 
impairment, and the observed relation between plasma concentrations of IGF-1 and of 
retinol and P-carotene was intriguing. 
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Even though the population studied was not very deprived, merely rural and 
having traditional habits and diets, they have a high prevalence of marginal-to-severe 
micronutrient deficiencies, especially iron and vitamin A. On the basis of the current 
cutoff indicating zinc deficiency (plasma zinc <10.7 \imoVL; 26), the prevalence of 
zinc deficiency in the present study was almost similar to the prevalence of iron 
deficiency. This is despite the fact that zinc deficiency is less readily assessed than is 
iron deficiency. At the population level, the plasma zinc concentration is a useful 
indicator of zinc status (12). However current cutoff values for deficiency have been 
defined without considering the effect of infection on plasma zinc concentrations. 
Hence, the estimate of zinc deficiency in this population was conservative because 
subjects with an acute phase reaction were excluded. 
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FIGURE 2. Relation between plasma retinol concentrations and the 
ratio of retinol to retinol binding protein in Indonesian infants. 
ln(y) = 0.24 - 0.24x_1; R2 = 0.54. 
The plasma RBP concentration was advocated recently as an alternative to the 
plasma retinol concentration for assessing vitamin A status. However, the relation 
between the plasma retinol concentration and the retinol-RBP ratio (Figure 2), showed 
that this ratio is constant and close to 1 only above marginal concentrations of retinol: 
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the ratio is <1 at lower plasma retinol concentrations. This lower ratio probably reflects 
an increase in plasma apo-RBP concentration in vitamin A deficiency (27). Hence, 
RBP becomes a less sensitive indicator for vitamin A status at lower plasma retinol 
concentrations. Therefore, substituting RBP for retinol as an indicator of vitamin A 
status may lead to an underestimate of deficiency. Methods that specifically measure 
holo-RBP circumvent this drawback (28), but are not yet generally available. It is 
important to establish reliable indicators for micronutrient status, especially when 
assessing a population for multiple micronutrient deficiencies, because confounding 
factors such as infection can easily complicate the overall picture. 
Micronutrient deficiencies coexist and overlap because of common etiology 
and underlying mechanisms. For instance, a diet rich in phytate and low in animal 
proteins, as is common in most developing countries, including Indonesia, predisposes 
to insufficient intake and absorption of both iron and zinc (14, 29). Also direct 
interactions between micronutrients were described previously, such as the positive 
effect of vitamin A supplementation on iron-deficiency anemia (6), and the 
antagonistic effect of iron supplementation on zinc uptake (14). The mechanisms 
underlying these interactions are not yet fully understood. Focussing on several 
micronutrients instead of just one is important not only for treating micronutrient 
deficiencies but also for screening and identifying high-risk groups. This was 
illustrated clearly by the results reported here. Vitamin A deficient subjects had a much 
increased (2.4 - 4.8) risk of being deficient in iron also. The increased risk of a 
deficiency of both vitamin A and iron was described previously (30); thus hemoglobin 
screening is used to identify people at risk of vitamin A deficiency (6). Furthermore, 
this study showed an almost 3-fold greater risk of zinc deficiency in vitamin A 
deficient infants than in infants without a vitamin A deficiency, whereas there was a 
tendency toward an increased risk of zinc deficiency in vitamin A deficient mothers. 
Whether there is a common underlying cause of these micronutrient deficiencies, or 
whether one micronutrient deficiency leads to another deficiency could not be 
answered here. 
The nutritional status of the mother is an important factor both prenatally and 
after birth. Prenatal maternal nutritional status affects birth weight, neonatal morbidity 
and mortality, and the micronutrient status of newborns. Postnatal maternal status can 
affect the quality of breast milk and thus the nutrient intake of infants (31). In the 
present study, indicators of the micronutrient status of the lactating mothers were 
clearly related to those of the infants. Concentrations of hemoglobin, plasma retinol, 
plasma P-carotene, and plasma zinc were all strongly correlated between the mother-
infant pairs. For retinol and P-carotene this relationship was attributable to the breast 
milk link referred to above. The close relation between maternal vitamin A status and 
vitamin A concentration in breast milk was described previously (32, 33), but few data 
are available on the link between vitamin A concentration in breast milk and the 
vitamin A status of infants. The present study showed clearly that the concentrations of 
vitamin A and p-carotene in breast milk were closely related to those in plasma of the 
infants. No relation was found between zinc concentrations in the plasma of the 
mothers and in breast milk, reflecting earlier evidence for mammary zinc secretion is 
independent of maternal zinc status (23, 24). 
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Impaired growth in infants is in itself not hazardous to health but is associated 
with higher morbidity and mortality and with impaired cognitive and psychomotor 
development (34). The findings in the present study indicate that growth was 
suboptimal in these infants, with length more affected than weight. In accordance with 
findings in similar populations, HAZ scores were lower with increasing age. Growth 
failure is a consistent sign of zinc deficiency, and zinc supplementation was shown to 
improve growth, especially in stunted children (35). Ninh et al. (36) reported increased 
IGF-1 concentrations after zinc supplementation in stunted Vietnamese infants. In the 
present study, however, IGF-1 was found to be related to plasma concentrations of 
retinol and p-carotene in the infants, and to a lesser extent to hemoglobin 
concentrations, but not to plasma zinc concentrations. 
There is clear evidence of a direct effect of vitamin A on cellular and tissue 
growth (37). However, supplementation with either retinol or p-carotene improved 
growth performance in some studies but not in others, and the underlying mechanisms 
are not clear (7,38-40). IGF-1 is a relatively new indicator for growth activity and the 
relationship between plasma concentrations of retinol and p-carotene and those of IGF-
1 has not been reported. Thus, further investigation is required to establish whether this 
relation can be confirmed and to test whether the effect is causal. Other factors such as 
infection, nutrient status with respect to other nutrients, and genetic background could 
also be implicated (41). For instance, vitamin A status has profound effects on 
morbidity and could thereby indirectly influence growth (4). 
The results of this study provide clear evidence that the concurrent occurence 
of deficiencies of a number of micronutrients is the norm rather than the exception. Of 
special significance is the strong interrelation between the micronutrient status of 
mothers and their infants; hower, the mechanisms involved have not yet been 
elucidated satisfactorily. In a future trial of P-carotene, iron and zinc supplementation, 
we will investigate interactions between vitamin A, iron and zinc and interrelations 
between micronutrient deficiencies in infants and pregnant women in West Java, 
Indonesia. 
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Some Like It Hot. 
There is an intriguing relation between climate and spiciness. Billman and Sherman 
analysed over 4,500 recipes, covering 36 countries for the use of spices in food. They 
found a strong correlation between the mean annual temperature of a country and the 
mean number of spices used, ranging from two in Norway, to ten in India. They argue 
that the greater spice use in warm climates is not because of the availability of spices, 
nor to disguise food spoilage, but that "the ultimate reason is most likely that spices 
help cleanse food of pathogens and thereby contribute to health, longevity and 
reproductive success of people who find their flavors enjoyable" Furthermore, they 
speculate that common spice combinations bring together complementary 
antimicrobials. There are several drawbacks to the study of Billing and Sherman 
however. For example, they only used cookbooks written in English, resulting in no 
recipes using indigenous African spices, Japanese wasabi, or Szechwan pepper that is 
often used in Chinese cooking. Also, being a cross-sectional survey of recipes, their 
"hygienic theory" can only be confirmed by infecting different traditional foods from 
around the world, ranging from say "Coq au Vin" to "Madras Chicken Curry", and 
following pathogen growth. However, that certain spices have antimicrobial as well as 
inflammatory modulating properties is without doubt. Curcumin for example inhibits 
the formation of prostaglandins, and eugenol, a spice principle from cloves, has anti-
inflammatory properties, maybe explaining the custom of chewing on a clove to relieve 
tooth-ache. 
Billing J, Sherman PW. Antimicrobial functions of species: why some like it hot. 
Quarterly Review of Biology. 1998;73:1-38. McGee H In victu Veritas. Nature. 
1998;392:649-50. PullaReddy ACh, Lokesk BR. Studies on anti-inflammatory activity 
of spice principles. Annals of Nutrition and Metabolism. 1994;38:349-58. 
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CHAPTER 3 
Reduced Production of Pro-Inflammatory Cytokines 
in Vitamin A and Zinc Deficient Infants. 
Frank T. Wieringa, Marjoleine A. Dijkhuizen, Johanna van der Ven-
Jongekrijg, Clive E. West, Muhilal, Jos W.M. van der Meer. 
Submitted for publication. 
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ABSTRACT 
This study investigates the effects of vitamin A and zinc deficiency in infants 
on the production of pro-inflammatory cytokines. In 59 Indonesian infants, age 3 to 
10 mo, the production of interferon-7 (IFN-7), interleukin-12 (IL-12), interleukin-18 
(IL-18) and interleukin-6 (IL-6) was measured after stimulation with 
lipopolysaccharide (LPS) and phytohaemagglutinin (PHA) in an ex vivo whole blood 
culture system. Circulating neopterin concentrations were determined as indicator of in 
vivo macrophage activity. Vitamin A deficient infants had significantly reduced ex vivo 
production of IFN-7. Production of IFN-7 was strongly correlated to IL-12, but not to 
IL-18 . Intriguingly, vitamin A deficient infants had significantly raised circulating 
neopterin concentrations. Zinc deficiency was accompanied by significantly reduced 
white blood cell counts, as well as a significantly reduced ex vivo production of IL-6. 
Overall, this study shows that vitamin A deficiency and zinc deficiency have marked 
albeit divergent effects on the immunocompetence of infants. 
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Reduced Cytokine Production in Micronutrient Deficiency 
Micronutrient deficiencies are prevalent worldwide and especially affect 
vulnerable groups such as infants and pregnant women [1]. Syndromes as 
xerophthalmia in vitamin A deficiency and nutritional anemia are the most obvious 
manifestations of micronutrient deficiency. However, it is becoming increasingly clear 
that the effects of micronutrient deficiencies are more generalised and widespread. 
Profound effects on growth, development, and immunocompetence can be present in 
even marginal micronutrient deficiency [2,3]. For example, vitamin A-deficient 
populations have markedly increased rates of morbidity and mortality from infectious 
diseases, and vitamin A supplementation can reduce infant mortality by as much as 
25%, even in populations with a low prevalence of xerophthalmia [2]. 
It is tempting to attribute the immunedefects at least in part to a disturbed 
response of pro-inflammatory cytokines. Studies in animals have given conflicting 
results on this issue. A general depression of T-cell activation is reported by some 
studies, supported by findings of decreased interferon-7 (IFN-7) production and 
decreased natural killer cell activity, as well as suppression of the delayed type 
hypersensitivity response [4-6]. Other studies have found overproduction of IFN-7 and 
reduced antibody production, fitting with a Thl predominance in vitamin A deficiency 
[7,8]. 
In humans with vitamin A deficiency, decreased cell-mediated (type-1) 
immune function, reduced natural killer cell activity, impaired phagocytosis, reduced 
type-1 cytokine production and reduced antibody titres, have all been reported [9]. 
Hence, the underlying immune defects in vitamin A deficiency remain elusive. 
Another micronutrient that has profound effects on the immune system is zinc. 
The same dietary factors leading to nutritional anemia, the most common micronutrient 
deficiency worldwide, contribute to inadequate zinc nurtiture, indicating that zinc 
deficiency may be very widespread also. In population studies, zinc supplementation 
gave a marked reduction in morbidity of diarrheal diseases, respiratory infections, as 
well as malaria [3,10,11]. Zinc deficiency in both humans and animals causes a 
striking depletion of both B- and T-cells, and also decreases numbers of neutrophilic 
granulocytes, natural killer cells and macrophages, as well as cytokine production and 
antibody response [3,12,13]. Zinc has also been shown to directly affect function of T-
cells on the cellular level [14]. Furthermore, animal studies have shown that prenatal 
zinc deficiency can result in a persistent disturbance of the offspring's immune system. 
This study investigates whether vitamin A deficiency and zinc deficiency in 
infants impair the ability to produce cytokines. The production of several pro-
inflammatory cytokines was measured after stimulation of whole blood with LPS and 
PHA in an ex vivo culture system. Given the putative role of interferon-7 (IFN-7), 
interleukin-12 (IL-12) and interleukin-18 (IL-18) in cell-mediated immunity, and 
interleukin-6 (IL-6) in humoral immunity, we investigated the production of these 
cytokines in a cohort of infants with carefully defined nutritional status. In addition, 
circulating neopterin concentrations were determined as indicator of in vivo 
macrophage activity induced by IFN-7. 
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MATERIALS AND METHODS 
Subjects and procedures. 
Infants, 3 to 10 mo old, were recruited from two adjacent villages in rural West 
Java, Indonesia for a nutritional survey and further in depth immunological testing was 
done when field circumstances allowed (availability of electricity). All children studied 
were deemed healthy by clinical assessment. Mothers were informed of the procedures 
and purpose of the study. After written informed consent was given by the mother, a 
short history was obtained, infants were anthropometrically assessed, and a blood 
sample was taken from the infants. 
Sample collection. 
A non-fasting 5 mL venous blood sample was taken using a closed-tube 
vacuum system (Becton and Dickinson, Leiden, The Netherlands). The EDTA blood 
sample (2 mL) was used for hematological analyses as well as for the ex vivo whole 
blood cultures. The heparinized blood sample (3 mL) was used for the measurement of 
plasma concentrations of retinol, zinc, ferritin, C-reactive protein (CRP) and neopterin. 
Ex vivo whole blood cytokine production. 
Cytokine production was measured using the ex-vivo whole blood cytokine 
production after stimulation assay as described by Van Crevel et al. [15]. The 
concentrations used, as well as the incubation time, were chosen to give an optimal 
response in this system. Within 15 min of collection of the blood sample, a mixture of 
phytohaemagglutinin (PHA-P, Sigma, Zwijndrecht, The Netherlands) in a final 
concentration of 30 mg/L, and lipopolysaccharide (LPS, E. coli serotype 055:b5; 
Sigma) in a final concentration of 10 |ig/L, was added directly to the closed vacuum 
EDTA blood collection tube and then incubated at 37°C for 10 h. After incubation, 
supernatant was collected and cytokine concentrations determined. Blood was 
incubated with a combination of PHA and LPS in order to achieve a stimulation as 
complete as possible. 
Hematological and biochemical analyses. 
Hemoglobin concentration was measured by the standard cyanoblue method 
(Humalyzer, Germany). Total white blood cell (WBC) and differential counts were 
done by an experienced technician using standard microscopy methods. Retinol was 
analysed using high performance liquid chromatography (Thermo Separation Products, 
San Jose, CA, USA) and zinc was analysed with flame atomic absorption 
spectrophotometry (Varian, Clayton South, Vic, Australia) using trace-element free 
procedures, as described in an earlier paper [16]. The CV for both retinol and zinc 
analyses was <5%. Ferritin, CRP, and neopterin were measured using commercial 
ELISA-kits (MP Products, Amersfoort, The Netherlands) according to the guidelines 
of the manufacturer. The cytokines IFN-7, IL-6, IL12-p70, and IL-18 were also 
measured with ELISA (Pelikine, CLB, Amsterdam, The Netherlands and (IL-18 only) 
R&D Systems, Minneapolis, MN, USA) according to the manufacturer's guidelines. 
IL-12 p70 was determined because this is the heterodimer responsible for the 
biological activity [17]. The CV for all ELISA assays was <10%. 
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Ethical approval. 
The protocol was approved by the ethical committee of the National Health 
Research and Development Institute of Indonesia, and by the ethical committee of the 
Royal Netherlands Academy of Arts and Sciences. 
Statistical Analysis. 
Data was checked for normal distribution using Kolmogorov-Smirnov test of 
normality. For data not normally distributed, non-parametric tests were used. 
Relationships between not normally distributed data were analysed using Spearman's 
rank test. Differences between groups were analysed with the Student's t test for 
parametric data and Mann Whitney U test for non-parametric data. When necessary to 
control for confounding variables, analysis of covariance was used, with age as a 
covariate. Statistical analysis was carried out with SPSS 7.5.2 software package (SPSS 
Inc, Chicago, IL, USA). 
RESULTS 
Subjects, general characteristics and micronutrient status. 
In total, blood for the measurement of ex vivo cytokine production was 
collected from 60 infants, and complete data was available from 59 infants. The infants 
(32 boys and 27 girls) ranged in age from 3 to 10 mo, and the age distribution was the 
same for both sexes (Table 1). 
As the plasma concentrations of both retinol and zinc fall during an acute phase 
reaction, these indicators in the presence of inflammation, might not reliably reflect 
micronutrient status [18]. As clinical examination does often not exclude the presence 
of minor or low-grade chronic infection, seven infants with an acute phase response, as 
indicated by a plasma CRP concentration >10 mg/L, were excluded from the statistical 
analyses of micronutrient indicators. 
Plasma retinol concentrations were significantly lower in the excluded subjects 
as expected (mean 0.44 vs 0.69 (O.mol/L, P < 0.01, Student's t-test), but plasma zinc 
and ferritin concentrations were not significantly different (Mann Whitney U). 
Marginal deficiency of vitamin A was defined as a plasma retinol concentration 
<0.70 |imol/L. Zinc deficiency was defined as a plasma zinc concentration <9.95 (X 
mol/L (non-fasting blood samples) [19]. Of the 52 infants, 25 (48%) were vitamin A 
deficient, and 9 (17%) were zinc deficient (Table 1). 
Ex vivo cytokine production reduced in vitamin A and zinc deficiency. 
The production of the pro-inflammatory cytokines EFN-'y, IL-12, IL-18, and IL-
6 after ex vivo stimulation of whole blood with LPS and PHA was measured. There 
was a strong positive correlation between the production of 1FN-7, IL-12 and IL-6 
(r's>0.47, P < 0.001, Spearman's rank). IL-18 production was negatively correlated to 
IL-12 (r= -0.42, P < 0.01) and IL-6 production (r=-0.30, P < 0.05, Spearman's rank). 
In vitamin A deficient infants the production of IFN-7 was significantly lower than in 
infants with adequate vitamin A status (Fig.l, P < 0.05, Mann Whitney U). Production 
of IL-12 was also lower in vitamin A deficient infants, but this effect failed to reach 
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Reduced Cytokine Production in Micronutrient Deficiency 
significance (Fig.l, P < 0.10, analysis of covariance, with age as covariate). There was 
a trend towards higher IL-12 production with increasing age (P =0.10, Spearman's 
rank), whereas the production of the other cytokines was not related to age. In contrast 
to IL-12, there was no correlation of IL-18 production with IFN-7 production 
(Spearman's rank). Also, IL-18 production was not different between the vitamin A 
deficient and non-deficient groups (Mann Whitney U). IL-6 production in vitamin A 
deficient infants was also lower than in non-deficient infants, but not significantly 
(Fig.l, P <0.10, Mann Whitney U). 
Although only 9 infants were zinc deficient, IL-6 production was significantly 
decreased in the zinc deficient infants as compared to non-deficient infants (Fig.2, P 
<0.05, Mann Whitney U). There was no significant effect of zinc deficiency on IFN-7, 
IL-12, or IL-18 production, although there was a tendency towards lower production 
for all cytokines in zinc deficiency (Fig.2, Mann Whitney U). The exclusion of the 7 
infants with a raised CRP did not change the observed relationships between cytokine 
production and vitamin A or zinc status. 
White blood cell counts lower in zinc deficiency, but not in vitamin A deficiency. 
WBC counts and differentiation were similar in the vitamin A deficient and 
non-deficient groups (Table 2). Zinc deficient infants however had significantly 
decreased WBC counts (Table 2, P <0.05, Mann Whitney U), with especially lower 
counts of neutrophilic granulocytes (P <0.05, Mann Whitney U). Eosinophilic 
granulocytes and lymphocyte counts also tended to be lower, but not significantly. 
Total lymphocyte, monocyte and neutrophilic granulocyte counts correlated 
significantly with IL-6 production (r=0.37, P <0.01; r=0.51, P <0.01; and r=0.31, P 
<0.05 respectively, Spearman's rank), but not with the other cytokines. In a multiple 
regression model with the lower WBC differential counts included, zinc deficiency 
remained an important determinant of IL-6 production (R= -0.23, P <0.10, multiple 
regression analysis). 
Circulating neopterin higher in vitamin A deficiency. 
Circulating plasma neopterin concentrations were significantly related to the 
age of the infants (r=0.30, P <0.05, Spearman's rank). Vitamin A deficient infants had 
significantly higher neopterin concentrations than non-deficient infants (Table 2, P 
<0.05, analysis of covariance, with age as covariate). There was no relation between 
zinc deficiency and circulating neopterin concentrations. 
Iron status, as indicated by plasma ferritin concentration and hemoglobin, was 
neither correlated with any of the cytokines studied, nor with circulating neopterin 
concentrations. 
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DISCUSSION 
In this study, infants with marginal vitamin A status had a reduced production 
of the type-1 cytokine IFN-7 in whole blood after stimulation with PHA and LPS. The 
production of IFN-7 is under the control of the more proximal cytokines such as IL-12 
and IL-18. Of these, IL-12 showed a tendency of reduced production in vitamin A 
deficiency. However, the production of IL-18 in vitamin A deficient infants was not 
different from infants with a normal vitamin A status. These data, supported by the 
finding that IL-12 and IFN-7 production were strongly correlated, suggest that the fall 
in IFN-7 production in vitamin A deficiency is due to decreased production of IL-12, 
and not to IL-18 production since that appears not to be affected in vitamin A 
deficiency. The lower production of IFN-7 would imply less activation of the cell-
mediated arm of the immune system. 
In this respect, our finding that circulating neopterin concentrations were higher 
in the vitamin A deficient infants is intriguing. It is generally believed that elevated 
neopterin concentrations reflect increased macrophage activity, as it is regulated by 
IFN-7 [20]. How can this paradox of decreased ex vivo IFN-7 production and increased 
in vivo neopterin concentrations be explained? One explanation could be that the 10 h 
culture system used, reflects only the first non-proliferative phase of the cellular 
response. Whether more prolonged cultures with proliferating T-cells would give a 
different IFN-7 response remains to be investigated. However, in the field situation in 
which these studies were carried out, large blood samples, cell separation and 
prolonged incubation are not readily feasible. Another explanation for the apparent 
discrepancy of ex vivo IFN-7 production and circulation neopterin concentrations is 
that there is an upregulation of IFN-7 receptors and/or of the IFN-7 signalling pathway 
in vitamin A deficiency. 
Irrespective of the mechanism, our findings suggest a type-1 cytokine 
dominance in a steady state, as indicated by elevation of neopterin concentrations, 
accompanied by an impairment of IFN-7 response during stimulation as may occur 
during infection. In this context, it is important to note that these infants were selected 
to have no acute phase reaction, to exclude coincident active infection or inflammation 
as much as possible, as this could modify both immune response and indicators of 
nutritional status. 
Even while only 9 infants were zinc deficient, a significant reduction of IL-6 
production in whole blood cultures after stimulation was found in this group. No 
significant effect of zinc deficiency on either IFN-7, IL-12, or IL-18 production was 
found, but the small group size may have obscured an effect. 
These results suggest a decreased type-2 cytokine response in zinc deficiency. 
Consistent with this finding are earlier reported results in both human and animal 
studies, showing an impaired production of antibodies and antibody response [3]. 
Other studies however, have reported no effect on humoral immunity and significant 
reduction of type-1 cytokine production [13]. 
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It should be noted that the whole blood cultures were done in the presence of 
EDTA, which binds most soluble zinc (>99%) in the culture. The means that the lower 
IL-6 production in the zinc deficient infants is due to the pre-existent effects of zinc 
deficiency. The results suggest that cytokine production is reduced not only because of 
a reduced WBC count, but also because of impaired cytokine production by each 
leucocyte. 
The fact that there was no clear relationship between iron status and immune 
function in this study, can probably be attributed to the large physiological changes in 
iron status indicators during the first year of life. 
Thus, this study has shown that vitamin A deficiency has marked effects on the 
cell-mediated immune response, with decreased ex vivo type-1 cytokine production 
after stimulation, and with increased in vivo macrophage activity. Zinc deficiency also 
has distinct effects on immune function, resulting in reduced circulating leukocytes, 
and reduced ex vivo cytokine production after stimulation. The implication of these 
findings is that when infants are micronutrient deficient, it is likely that immune 
function is also impaired. The extent to which either of these arms is impaired appears 
to be determined by the specific micronutrient deficiency. These changes probably 
bear direct relevance for susceptability to infections. 
ACKNOWLEDGEMENTS 
We would like to thank the mothers and the infants who participated in this 
study, and we are grateful for the enthusiastic help we received from Dr.Hendra and 
his staff and from all the health volunteers from Situ Udik and Situ Hir. Furthermore 
we like to thank all the members of our field team, and the staff from the laboratories 
in Bogor, Nijmegen and Wageningen, for their untiring efforts and warm co-operation. 
Especially, we would like to thank Dr. R. Hermsen for the analysis of IL-12p70. 
Financial support for this study was received from the Netherlands Foundation for the 
Advancement of Tropical Research (WOTRO), and Ter Meulen Fund (Royal 
Netherlands Academy of Arts and Sciences). 
REFERENCES 
1. FAO/WHO. International conference on nutrition. World declaration and plan of 
action. Rome. FAO. 1992; 
2. Bates, C.J. (1995) Vitamin A, Lancet. 345, 31-35. 
3. Shankar, A.H., Prasad, A.S. (1998) Zinc and immune function: the biological basis 
of altered resistance to infection, Am J Clin Nutr.68, 447(S)-463(S). 
4. Bowman, T.A., Goonewardene, I.M., Pasatiempo, A.M., Ross, A.C., Taylor, C.E. 
(1990) Vitamin A deficiency decreases natural killer cell activity and interferon 
production in rats, J Nutr.120,1264-1273. 
5. Ross, A.C., Stephensen, C.B. (1996) Vitamin A and retinoids in antiviral 
responses, FASEB J.10, 979-985. 
6. Sijtsma, S.R., Rombout, J.H., West, C.E., van der Zijpp, A.J. (1990) Vitamin A 
deficiency impairs cytotoxic T lymphocyte activity in Newcastle disease virus-
infected chickens, Vet Immunol Immunopathol.26, 191-201. 
63 
Chapter 3 
7. Cantoma, M.T., Nashold, F.E., Hayes, C.E. (1994) In vitamin A deficiency 
multiple mechanisms establish a regulatory T helper cell imbalance with excess 
Thl and insufficient Th2 function, J Immunol.152, 1515-1522. 
8. Wiedemann, IL, Hanson, L.A., Kahu, H., Dahlgren, U.I. (1993) Aberrant T-cell 
function in vitro and impaired T-cell dependent antibody response in vivo in 
vitamin A-deficient rats, Immunology.80, 581-586. 
9. Semba, R.D. (1994) Vitamin A, immunity, and infection, Clin Infect Dis. 19, 489-
499. 
10. Bhutta, Z.A., Bird, S.M., Black, R.E., Brown, K.H., Meeks Gardner, J., Hidayat, 
A., Khatun, F., Martorell, R., Ninh, N.X., Penny, M.E., Rosado, J.L., Roy, S.K., 
Ruel, M., Sazawal, S., Shankar, A.H. (2000) Therapeutic effects of oral zinc in 
acute and persistent diarrhea in children in developing countries: pooled analysis of 
randomized controlled trials. Am J Clin Nutr.72, 1516-1522. 
11. Umeta, M., West, C.E., Haidar, J., Deurenberg, P., Hautvast, J.G. (2000) Zinc 
supplementation and stunted infants in Ethiopia: a randomised controlled trial, 
Lancet.335, 2021-2026. 
12. Beaton, G.H., Martorell, R., and Aronson, K.J. Effectiveness of vitamin A 
supplementation in the control of young child morbidity and mortality in 
developing countries. Paper no. 13. Geneva: United Nations. 1993; 
13. Beck, F.W., Prasad, A.S., Kaplan, J., Fitzgerald, J.T., Brewer, G.J. (1997) Changes 
in cytokine production and T cell subpopulations in experimentally induced zinc-
deficient humans, Am J Physiol.272, E1002-E1007. 
14. Driessen, C, Hirv, K., Kirchner, H., Rink, L. (1995) Zinc regulates cytokine 
induction by superantigens and lipopolysaccharide, Immunology.84, 272-277. 
15. Van Crevel, R., Van der Ven, J., Netea, M.G., De Lange, W., Kullberg, B.J., Van 
der Meer, J.W.M. (1999) Disease-specific ex vivo stimulation of whole blood for 
cytokine production: applications in the study of tuberculosis, J Immunol 
Meth.222, 145-153. 
16. Dijkhuizen MA, Wieringa FT, West CE, Muherdiyantiningsih, Muhilal. 
Concurrent micronutrient deficiencies in lactating mothers and their infants in 
Indonesia. Am J Clin Nutr 2001;73:786-91 
17. Jansen, P.M., van der Pouw Kraan, T.C., de Jong, I.W., van Mierlo, G., Wijdenes, 
J., Chang, A.A., Aarden, L.A., Taylor, F.B.J., Hack, C.E. (1996) Release of 
interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to 
plasma levels of interleukin- 10 and interferon-gamma, Blood.87, 5144-5151. 
18. Filteau, S.M., Tomkins, A.M. (1994) Micronutrients and tropical infections. Trans 
R Soc Trop Med Hyg.88, 1-3. 
19. Gibson, R.S. (1990) Principles of nutritional assessment, Oxford University Press, 
Oxford, UK. 
20. Huber, C, Batchelor, J.R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., 
Reibnegger, G., Swetly, P., Troppmair, J., Wachter, H. (1984) Immune response-
associated production of neopterin. Release from macrophages primarily under 
control of interferon-gamma, J Exp Med.160, 310-316. 
64 
Reduced Cytokine Production in Micronutrient Deficiency 
65 
Marginalia 
Growth Patterns. 
Most people consider growth as a slow but continuous process, the end result of 
millions of unsynchronised cell replications. This idea was challenged however by 
Lampl et al. who measured 31 infants, aged 4 to 15 months, daily or weekly for almost 
2 years. They reported that linear growth of these infants occurred in short bursts, 
followed by long periods of stasis. On average, the infants only grew on 1 out of 11 
days, whereas on the other days the infants did not grow or even shrank. The mean 
increment on the day of growth however was 0.95 cm. Variability was high with some 
infants not growing for a long time (up to 63 days) and one child growing an 
astonishing 1.65 cm in one day. They propose a model of "saltation and stasis", 
although they do not offer an explanation for their findings and cannot specify which 
(hormonal) signal would be responsible for the synchronisation of cell division. Of 
course, their model has been challenged by others, who argue that a continuous model 
of growth fits the data just as well. By using very short measurement intervals the 
authors might have inadvertently introduced extra noise or error. Also, infants do not 
always cooperate. By comparison, daily measurements of growth in rabbits did not 
show any saltatory pattern. Karlberg et al proposed another model of human growth, 
but on a larger time scale, distinguishing three different phases of growth. The first 
exponential growth phase is during infancy and is nutrient dependent. This is followed 
by an almost linear growth phase during childhood in which growth hormone is 
important. Finally during puberty, growth can be modelled as a logistic function, 
driven by sex hormones. The overall growth curve is then the cumulative result of these 
three phases. A delay in the onset of the childhood phase seems to be the main 
determinant of early growth faltering. However, Karlberg et al could not identify any 
causal factor in neither Swedish nor Pakistani infants, which caused this delay. Also, 
growth faltering in Indonesia appears to start within the first months of life. Human 
growth remains a fascinating phenomenon. 
Lampl M, Veldhuis JD, Johnson ML. Saltation and stasis: a model of human growth. 
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Iron and Zinc Supplementation in Indonesian Infants: 
Effects on Micronutrient Status and Growth. 
Marjoleine A. Dijkhuizen, Frank T. Wieringa, Clive E. West, Sri Martuti, 
Muhilal. 
Submitted for publication. 
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information on interactions between iron and zinc when supplemented together in 
infancy. 
Deficiencies of micronutrients often coexist and have independent as well as 
interacting effects (Whittaker 1998; Dijkhuizen et al. 2001). Deficiencies can share a 
common etiology, but can also aggravate each other. In populations with a marginal 
iron and zinc status, the negative effects of high intake of iron (e.g. with 
supplementation) on zinc uptake and vice versa are important issues. Currently, in 
view of the serious consequences of iron deficiency in children, large-scale iron 
supplementation of under five children is being contemplated to combat iron 
deficiency. In this respect however, the possible negative effects on zinc status are a 
major concern. 
The aim of this study is to investigate whether the supplementation of iron, 
zinc, or iron and zinc combined can improve iron status and zinc status and reduce the 
prevalence of deficiencies of iron and zinc, and whether supplementation can prevent 
growth faltering in the first year of life. Also, the interaction between iron 
supplementation and zinc supplementation and possible negative effects of 
supplementation on iron status and zinc status are investigated. This study collaborated 
in the UNICEF-coordinated Multi-Country Iron and Zinc Intervention Trials 
Collaborative Group. 
SUBJECTS AND METHODS 
Study design and location. 
The study was designed as a randomised, double-blind, placebo-controlled 
supplementation trial in infants aged 4 mo at recruitment. Supplementation, not very 
different from the RDA (FAO/WHO 1988), was given 5 days per week for 6 mo by 
trained village health volunteers. Four groups of infants were supplemented with a 
syrup containing either iron (10 mg/day), zinc (10 mg/day), iron+zinc (10 mg of 
each/day) or placebo. Supplements were made by a local pharmaceutical company in 
cooperation with UNICEF-Jakarta. The study was carried out in a rural area of Bogor 
District, West Java, Indonesia between October 1997 and March 1999. 
Subjects and procedures. 
Eligible infants were identified by the village health volunteers, and the 
mothers invited to participate in the study. Mothers were informed of the procedures 
and purpose of the study. After written informed consent was given by the mother, 
infants were assessed anthropometrically, and a short history concerning socio-
economic status, dietary and lactation habits, and health of the mother and infant was 
taken. 
Exclusion before recruitment was on grounds of chronic or severe illness, 
severe clinical malnutrition, or congenital anomalies. Infants were assigned to one of 
the four supplementation groups on basis of individual randomization, using a block 
randomized group allocation list, which was computer generated before the study was 
commenced. 
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Supplementation was double-blind, the supplements were coded with a letter at 
production, and the code-allocation was safe-kept at the Wageningen University in The 
Netherlands. The codes were not known at the study site in Indonesia. The code was 
made known only after all subjects had completed the trial. 
At recruitment, every subject received a personal bottle with a dosing syringe, 
labeled with the subject's name, subject number, health volunteer's name, and date. 
The bottles were kept safe by the health volunteer who gave the supplement each day, 
also to prevent accidental intoxication or overdosing. Supplements (2 mL of syrup) 
were given 5 days per week, and every dose given was tallied. Bottles were weighed 
before emission, replaced every month with a new bottle, and weighed again after 
return to estimate the dose given to the infant as a measure of compliance. 
At the monthly follow-up, the infant was assessed anthropometrically, and a 
short history concerning health, diet and lactation and possible adverse effects was 
taken. After 6 mo of supplementation, in addition to the usual follow-up procedure, a 
blood sample was taken of the infant for biochemical assessment of nutritional status, 
as well as a stool sample to check for parasite infestation. All infants with a 
hemoglobin concentration of <110 g/L were given iron supplementation treatment. 
Methods. 
Anthropometry included measurement of weight, height and mid-upper-arm 
circumference by trained anthropometrists using standard methods. In addition, knee-
heel length was measured with a knemometer. Z-scores for weight and height (weight-
for-age WAZ; height-for-age, HAZ; and weight-for-height, WHZ) were calculated 
with EPI-Info 6.02, using WHO recommended growth curves (WHO Working Group 
1986). 
A non-fasting 5 mL venous blood sample was taken from the infants. A 
closed-tube heparanized vacuum system was used to avoid zinc contamination (Becton 
and Dickinson. Leiden, The Netherlands). Blood samples were immediately stored at 
4°C to prevent microhemolysis and separated within 5 h. Plasma samples were 
aliquoted and stored at -30°C until analysis. 
Hemoglobin concentrations were measured by the standard cyanoblue method 
(Humalyzer, Germany). Plasma zinc concentrations were analysed with flame atomic 
absorption spectrophotometry (Varian, Clayton South, Vic, Australia) using trace-
element free procedures, as described in an earlier paper (Dijkhuizen et al. 2001). The 
CV (10% duplicate analysis and pooled control samples) for zinc analyses was <5%. 
Ferritin and insulin-like growth factor 1 (IGF-1) were measured using commercial 
ELIS A-kits (IBL-Hamburg, Germany) according to the guidelines of the manufacturer. 
C-reactive protein (CRP) was measured using immunoturbidimetric techniques at the 
Northern Ireland Centre for Diet and Health, University of Ulster, Northern Ireland 
(Cobas Fara analyzer, Roche Products, Welwyn, UK). The CV for the ferritin, IGF-1 
and CRP assays was <10%. Plasma CRP concentrations were analyzed to assess 
occurrence of the acute-phase reaction, which will lower plasma concentrations of zinc 
and raise plasma concentrations of ferritin (Filteau and Tomkins. 1994). Stool samples 
were screened for the most commonly occurring parasites (hookworm, Trichuras, and 
Ascaris) by an experienced microscopist. 
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Ethical approval. 
The protocol was approved by the ethical committee of the National Health 
Research and Development Institute of Indonesia and by the ethical committee of the 
Royal Netherlands Academy of Arts and Sciences. 
Statistical analysis. 
Data was checked for normal distribution using the Kolmogorov-Smirnov test 
of normality. Plasma concentrations of ferritin and zinc were transformed to logarithms 
before statistical analysis. Differences in prevalence were tested with Pearson's chi-
square test, differences between infants who did not complete the study and those who 
did were tested with Student's t-test, and differences between baseline and end-point 
anthropometry were tested for each supplementation group with paired t-tests. 
Differences for biochemical indicators between supplementation groups were 
analyzed using analysis of variance (ANOVA) or analysis of covariance (ANCOVA). 
Plasma concentrations of CRP were used as covariate in the analysis of plasma 
concentrations of ferritin and zinc, to control for the effects of the acute phase response 
on plasma concentrations of both ferritin and zinc. Differences between the 
supplementation groups for anthropometry at recruitment (0 mo), after 3 mo, and 6 mo 
of supplementation were analysed with repeated measurements multivariate ANOVA 
statistics. For HAZ, sex (2 groups) and HAZ at recruitment (divided into 3 classes: 
HAZ<-2.0; -2.0< HAZ< -1.0; HAZ>L-1.0) were used as additional between-subject 
factors to correct for possible effects of differences among groups at baseline. For the 
analysis of WAZ and WHZ over time, only sex was added as between-subject factor. 
When the overall F-test was significant, differences between the groups were 
further investigated with post-hoc multiple comparisons for ANOVA, and in a general 
linear model for ANCOVA. Statistical analysis was carried out with EPI-Info, Version 
6.04b (CDC, Atlanta GA) and SPSS 7.5.2 (SPSS Inc, Chicago, IL) software packages. 
RESULTS 
In total 478 infants were recruited from six adjacent villages in rural West Java, 
Indonesia. In total 360 infants completed the supplementation trial, and of 348 infants a 
complete blood sample was collected. 
Of the recruited infants, 26 (5%) never came back for follow-up and are 
considered non-sincere recruits. A further 92 infants (19%) dropped-out during the 
study for various reasons (non-cooperation 13%, moving house 5% and mortality 3 
cases (<1%), Fig. 1). The infants who dropped out did not differ from the infants who 
completed the trial for any of the characteristics at recruitment (Student's t-test). 
However, the drop-out in the group receiving the combination of iron and zinc was 
significantly higher than that in the other groups (36% vs. 18% - 22%, P <0.01, chi-
square). 
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7 non-sincere 
6 moved 
15 withdrew 
ldied 
478 infants recruited 
5 non-sincere 
8 moved 
13 withdrew 
Odied 
119 assigned to: 
Placebo 
120 assigned to: 
Iron 
119 assigned to: 
Zinc 
120 assigned to 
Iron+zinc 
I 
3 non-sincere 
4 moved 
13 withdrew 
ldied 
11 non-sincere 
10 moved 
20 withdrew 
ldied 
| 90 completed trial | | 94 completed trial \ | 98 completed trial | | 78 completed trial 
| 87 blood samples \ | 90 blood samples \ | 97 blood samples \ | 74 blood samples | 
Figure 1. Trial profile. 
The mean age of the infants at recruitment was 4.2 mo, and there were no 
significant differences between the groups at recruitment for any of the parameters 
measured (chi-square and ANOVA, Table 1). The mean WHZ of the infants were 
positive, whilst the mean HAZ were negative, indicating that especially length growth 
is suboptimal in these infants. Of the infants, 25 (5%) had a HAZ of < -2, and only one 
infant had a WHZ < -2 at recruitment. Mean knee-heel length (+ SD) at recruitment 
was 16.4 (+ 0.9) cm and did not differ among the groups (ANOVA). 
Monthly compliance was measured by comparing the weights of the bottles before 
emission with the weights after return, and for every subject an overall compliance was 
calculated. Mean overall compliance (+ SD) was 86% (+ 16%) of the total intended 
dose, and was similar for all groups (chi-square). 
At the end of the 6 mo supplementation period, the infants had a mean age (+ SD) of 
10.1 (+ 0.6) mo. The hemoglobin concentrations of the infants who received iron alone 
or in combination with zinc, were significantly higher than of the infants who received 
placebo (Table 2, P <0.01 and P <0.05 respectively, ANOVA). Also, the hemoglobin 
concentrations of the infants receiving iron alone, were significantly higher than of the 
infants receiving zinc alone (Table 2, P <0.01, ANOVA). The proportion of infants 
with anemia (hemoglobin concentration <110 g/L) in the iron group was significantly 
lower than in placebo and zinc groups (P < 0.01, chi-square) but also lower than in the 
iron+zinc group (P < 0.05, chi-square, Table 2). Furthermore, the prevalence of 
anemia in the iron+zinc group was significantly lower than in the placebo and zinc 
groups (P < 0.05, chi-square, Table 2). Plasma ferritin concentrations were 
significantly higher in the iron and iron+zinc supplementation groups as compared to 
both the placebo and zinc groups (P < 0.01, ANCOVA with CRP as covariate). The 
proportion of infants who were iron deficient (hemoglobin concentration < 110 g/L and 
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plasma ferritin concentration <12 (Ag/L) was significantly lower in the iron and 
iron+zinc supplementation groups (P <0.01, chi-square, Table 2). Plasma zinc 
concentrations were significantly higher in the zinc and iron+zinc supplementation 
groups than in the placebo and iron groups (P <0.01, ANCOVA with CRP as covariate, 
Table 2). The proportion of infants with a low plasma zinc concentration (< 10.7 
|imol/L) was significantly lower in the zinc and iron+zinc groups than in the placebo 
group (P <0.01, chi-square, Table 2). 
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Figure 2. Hemoglobin concentration frequency distribution curves (smoothed) 
of infants supplemented with iron and zinc. 
The effect of iron and zinc supplementation on hemoglobin and plasma zinc 
concentration is clearly illustrated by the frequency distribution curves (fig. 2 and fig. 
3). For hemoglobin concentrations, the iron group curve is clearly shifted to higher 
hemoglobin concentrations as compared to the placebo and zinc group curves, whilst 
the iron+zinc group curve is intermediate between the iron and placebo group curves. 
The distribution curves for zinc concentration are somewhat less smooth, and the effect 
of supplementation is clearest when comparing the areas under the curve below a 
plasma zinc concentration of <10.7 \imol/L for the different groups. The placebo group 
curve has the largest area with low plasma zinc concentrations, whereas both the zinc 
and iron+zinc group curves have the smallest areas below the cut-off for zinc 
deficiency. Interestingly, the zinc group curve seems to be shifted more towards higher 
plasma zinc concentrations than the iron+zinc group curve. 
76 
Iron and Zinc Supplementation in Infants 
J U • 
25-
20-
a 
<u 
1 0 -
5 -
0 -
Ml 
if ' 
Ml' 
/ ' 
1 '• 
I I'l 
/ J .1 
v y * 
/A? 
1 •/•*.! 
f ' \ 
t « 
/ 
/ 
r \ 
\\ \ ** 
iron 
- - - iron+zinc 
placebo 
— - -zinc 
1 1 ^ I** 1 ' ' P » — ' 
10 14 18 22 26 30 34 
Plasma zinc concentration (|imol/L) 
Figure 3. Plasma zinc concentration frequency distribution curves (smoothed) 
of infants supplemented with iron and zinc. 
Anthropometry Z-scores of the four supplementation groups were compared at 
recruitment (0 mo), after 3 mo of supplementation (3 mo) and at the end of the 6 mo of 
supplementation (6 mo). All groups had a significant decrease in HAZ (fig. 4), WHZ 
(fig. 5) and WAZ (all P <0.01, paired t-test). For comparison of the HAZ changes over 
time between the different supplementation groups, sex and HAZ at recruitment were 
included in the analysis as between subject factors. There was no effect of either iron 
or zinc supplementation on changes in HAZ over time (fig. 4). The baseline factors did 
not interact significantly with the height changes per group. Differences in changes in 
WHZ over time among the groups were analyzed, taking sex into account. There was 
also no effect of either iron or zinc supplementation on ponderal growth (fig. 5). There 
was no significant interaction of sex on changes in WHZ per supplementation group. 
After 6 mo of supplementation, stunting (HAZ < -2.0) was found in 24% of the infants 
in the placebo group, 19% of the iron group, 18% of the zinc group and 21% of the 
iron+zinc group. There was no difference in prevalence of stunting between the groups 
(chi-square). 
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Figure 4. Linear growth , expressed as Z scores for height for age (HAZ), of 
infants supplemented with iron and zinc. 
The knee-heel length after 6 mo of supplementation did not differ among the 
groups (mean (+ SD) for the placebo group: 18.6 (+ 0.9) cm; for the iron group: 18.8 
(+ 1.0) cm; for the zinc group: 18.9 (+ 0.9) cm; for the iron+zinc groupl8.7 (+ 0.9) cm 
respectively, ANOVA). Plasma IGF-1 concentrations were measured after 6 mo of 
supplementation as an indicator for growth activity. There were no significant 
differences among the supplementation groups (overall mean (+ SD): 20.5 (+ 16.3) 
Hg/L, ANOVA). 
Parasitological examination of stool samples gave an infection rate of <5%, and 
was not different among the groups, hence parasite infestation was not considered a 
major factor in the outcome of the study. 
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Figure 5. Ponderal growth, expressed as Z scores for weight for height (WHZ) 
of infants supplemented with iron and zinc. 
DISCUSSION 
This study shows that anemia, iron deficiency, and zinc deficiency are very 
prevalent in these infants, and that supplementation with iron and zinc is very effective 
to combat these deficiencies. The combined supplementation of iron and zinc was 
found to be slightly less efficient than either supplement alone, but still effective in 
reducing both iron deficiency and zinc deficiency. 
An important finding is that iron supplementation alone does not seem to have 
negative effects on zinc status, as the plasma zinc concentrations in the iron 
supplementation group are very similar and certainly not lower than those of the 
placebo group. Furthermore, the prevalence of zinc deficiency is not increased in the 
iron group. This indicates that iron supplementation in young infants given daily in a 
dosage (10 mg/day), not very different from the RDA (8.5 mg/day), will not imperil 
zinc nutriture. Also, zinc supplementation given alone does not affect iron status to any 
extent. It would seem that in these infants, supplementation of iron as well as zinc has 
the largest benefits, reducing the prevalence of both iron as well as zinc deficiency to 
less than one third of the prevalences in the placebo group. However, for the combined 
supplement of iron and zinc, the effectiveness appears to be somewhat less than for 
either supplement alone, as the combined supplement did not reduce anemia as much 
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as did supplementation with iron alone. Also the plasma zinc concentration distribution 
curve of the group supplemented with zinc alone seems to be shifted more effectively 
towards higher plasma zinc concentrations. 
A combined supplement seems the most desirable in these infants considering 
the high prevalence of anemia (66%), iron deficiency (30%) and zinc deficiency (24%) 
in this population. It is cause for concern that the drop-out in the iron+zinc 
supplementation group is almost double that of the other supplementation groups. This 
could indicate an acceptability problem of the combined supplement. Gastro-intestinal 
complaints are the most likely cause of this higher drop-out, as minor complaints such 
as bad taste of the supplement would have affected compliance also, but this was the 
same in all groups. Perhaps this acceptability problem is in part due to the composition 
of the supplement used, with iron and zinc as sulphate salts in a 1:1 weight ratio. 
Sulphate salts are the least well tolerated, as they are more likely to cause gastro-
intestinal complaints, and also an 1:1 weight ratio of iron and zinc might not be the 
most favorable. This study was not designed to investigate the optimal composition of 
the supplements, but this area certainly merits further attention. 
The anthropometrical assessment of these infants showed a striking decrease in 
Z-scores from the age of 4 mo to the age of 10 mo. Although supplementation with 
both iron and zinc was very effective in decreasing the prevalence of deficiencies of 
iron and zinc, there was no effect of supplementation of either iron or zinc on growth. 
Even though supplementation was started before significant growth impairment had 
occurred, supplementation with iron, zinc or both was not able to prevent progressive 
stunting. After 6 mo of supplementation, 21% of the infants were stunted. In all 
groups, growth was impaired to the same extent and followed the same pattern. The 
lack of effect of supplementation of iron and zinc on growth is further confirmed by 
the lack of effect on plasma IGF-1 concentration, which is an indicator of growth 
activity. There were no differences in growth activity among the groups. 
Ninh et al. (1996) showed that zinc supplementation of Vietnamese children 
increased plasma IGF-1 concentrations as well as growth performance, but only 
stunted children were supplemented. In Ethiopia, growth of both stunted and non-
stunted infants benefited from zinc supplementation, although the effect in stunted 
infants was larger (Umeta et al. 2000). Iron intake in Ethiopia however is very high, 
possibly creating exceptional conditions for zinc nutriture. Rosado et al. (1997) found 
no effect of either zinc or iron supplementation on growth in Mexican children, aged > 
1 y. There was a small but significant effect of zinc supplementation on morbidity, but 
no interaction between iron and zinc. From a meta-analysis of published randomized 
trials, Brown et al. (1998) conclude that zinc supplementation had a significant but 
small effect on growth, especially in stunted children. In the present study, the infants 
were not selected for stunting, and supplementation was started at an age when 
stunting is not yet prevalent. This study aimed to prevent stunting, and not to improve 
growth in already stunted infants. 
In conclusion, the results of this study show that even though there is a high 
prevalence of deficiencies of iron and zinc, combating these deficiencies is not 
sufficient to allow optimal growth in these infants. There must be additional underlying 
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factors in the diet or circumstances of these infants that effectively impair growth. In 
view of the detrimental effects of iron deficiency on development, and of zinc 
deficiency on morbidity and possibly growth, supplementation of iron and zinc to 
combat the high prevalence of these deficiencies can play an important role in 
improving infant health. This study shows that supplementation with a combination of 
iron and zinc can be safe and effective. 
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Marginalia 
Yellow Gecko Eyes. 
In humans, retinol binding protein (RBP) is the main transport protein of retinol. 
During evolution, several forms of RBP have emerged to allow optimal function as 
transport protein of retinol in either the plasma or intracellularly. However, RBP can 
fulfil other functions also. Recently, it was shown that the lens of the eye of diurnal 
geckos contain up to 12% of a protein very similar to cellular RBP type I. 
Interestingly, this protein does not have retinol as ligand but 3,4 didehydroretinol 
instead. The 3,4 didehydroretinol-RBP complex gives the lens a yellow colour, and 
absorbs short-wave radiation, thereby protecting the retina. Retinol, in contrast to 3,4 
didehydroretinol, is unsuitable as ligand as it fluoresces in the range of visible light 
and is not photostable. The authors speculate that during evolution, nocturnal geckos 
have changed to diurnal habits, resulting in exposure to often intense ambient light. 
Unlike humans, geckos cannot regulate light intensity by changing the diameter of the 
pupil, hence they need other ways to protect the retina. Mutations resulting in the 
expression of cellular RBP-I with 3,4 didehydroretinol as ligand in the lens may thus 
have conferred evolutionary benefits. In this respect it is important to note that 3,4 
didehydroretinol is found in the lenses of diurnal, but not in nocturnal geckos. As 3,4 
didehydroretinol normally doesn't occur in terrestrial vertebrates, it is probably 
converted from retinol in the eye of diurnal geckos especially for this purpose. 
Interestingly, 3,4 didehydroretinol is also used in the modified relative dose response 
test, which measures liver retinol stores. 
Werten PJL, Roll B, Van Aalten DMF, De Jong WW. Proceedings of the National 
Academy of Sciences (USA). 2000;97:3282-87. 
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Iron Supplementation Can Induce Vitamin A 
Deficiency in Infants with Marginal Vitamin A Status. 
Frank T. Wieringa, Marjoleine A. Dijkhuizen, Clive E. West, David I. 
Thumham, Muhilal, Jos W.M. van der Meer. 
Submitted for publication. 
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ABSTRACT 
Background. Deficiencies of iron and vitamin A are still very prevalent 
worldwide. Supplementation, mostly with single micronutrients, is widely used to 
combat these deficiencies. However, various micronutrient deficiencies often occur 
concurrently, and there are many interactions between micronutrients. This study 
investigates the interactions between 3 important micronutrients, iron, vitamin A and 
zinc, when supplemented alone or combined. 
Methods. In a randomised, double-blind, placebo-controlled supplementation 
trial, 387 Indonesian infants, aged 4 months, were supplemented daily for 6 months 
with iron (10 mg), zinc (10 mg), P-carotene (2.4 mg), iron+zinc (10 mg each), zinc+(3-
carotene (10 mg +2.4 mg) respectively, or placebo. From the 271 infants who 
completed the trial, complete data on micronutrient status, using haemoglobin, ferritin, 
retinol, zinc and the modified relative dose response (MRDR, a measure of liver retinol 
stores), was available from 256 infants. 
Findings. Iron supplemented infants had significantly lower plasma retinol 
concentrations, and thus significantly higher prevalence of vitamin A deficiency than 
all other groups. In contrast, the MRDR of the iron supplemented infants indicated 
higher liver stores of vitamin A. Furthermore, iron supplementation improved iron 
status while zinc supplementation improved zinc status but p-carotene supplementation 
failed to significantly improve vitamin A status. 
Interpretation. In this study, iron supplementation of a population marginally 
deficient for vitamin A led to a significant increase in the prevalence of vitamin A 
deficiency. The finding of increased vitamin A liver stores after iron supplementation 
suggests that there is a redistribution of retinol. Therefore, supplementation of infants 
with iron should be accompanied by measures to improve vitamin A status. 
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INTRODUCTION 
Iron deficiency and its associated anaemia, as well as vitamin A deficiency are 
still very prevalent worldwide, with children and pregnant women being the most 
vulnerable groups. Anaemia and iron deficiency in children can lead to delayed 
psychomotor development and impaired health (1). Vitamin A deficiency is associated 
with a markedly higher morbidity of infectious diseases and mortality, and severe 
deficiency leads to xerophthalmia and blindness (2). Zinc deficiency leads to growth 
impairment, and zinc supplementation has been shown to decrease morbidity and 
mortality of infectious diseases in children (3-5). In many countries, major efforts are 
being made by governments supported by international organisations, to reduce 
micronutrient deficiencies. For example, high dose vitamin A supplements are globally 
distributed to children under five years of age, and WHO/UNICEF recommend 
supplementation with iron for infants from 6 months onwards in countries with a high 
prevalence of iron deficiency anaemia (6). 
Micronutrient deficiencies often occur together in populations, because the 
same dietary patterns and socio-economic factors are associated with deficiency of 
many different micronutrients. In many developing countries, diets are mostly cereal-
based, low in animal products and high in phytate, thus giving a high risk of 
micronutrient deficiencies. In Indonesia, deficiencies of iron, vitamin A, and zinc are 
prevalent and often concurrent (7). 
Interactions between iron, vitamin A and zinc nutriture are of great 
consequence, especially in the context of micronutrient supplementation. Iron 
supplementation is widely used to combat iron deficiency, however high iron intake is 
known to impair zinc uptake (8). Furthermore, vitamin A supplementation affects iron 
metabolism. It has been shown to decrease anaemia prevalence, and has a synergistic 
effect with iron supplementation in reducing anaemia (9). Provitamin A carotenoids, 
especially P-carotene are the most important sources of vitamin A in Indonesia, but 
absorption, especially from green leafy vegetables, is insufficient (10). Severe zinc 
deficiency can impair vitamin A status (11), and zinc supplementation may be able to 
improve uptake of P-carotene, its subsequent bioconversion to retinol and the 
mobilisation of vitamin A from body stores in populations with marginal zinc status 
(12). 
This study investigated whether supplementation of micronutrients, alone or in 
combination, enhances or impairs status with respect to other micronutrients. 
Interactions between iron, P-carotene and zinc, as well as effectiveness of 
supplementation on improving micronutrient status were analysed. Special attention 
was given to iron and vitamin A as these micronutrients are included in many nutrition 
intervention programmes, but usually only given as single micronutrients. 
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SUBJECTS AND METHODS 
Study design, subjects and procedures. 
The study was a randomised, double-blind, placebo-controlled supplementation 
trial in infants aged 4 months at recruitment. The study was carried out in a rural area 
of Bogor District, West Java, Indonesia. Supplementation was given 5 days/week for 6 
months by trained village health volunteers. Six groups of infants were supplemented 
with a sweet, strawberry flavoured, clear syrup (2 mL/day) and neutral tasting, brightly 
orange coloured corn oil (0.5 mL/day). Four syrup preparations contained ferrous 
sulphate, zinc sulphate, ferrous sulphate + zinc sulphate, or neither ferrous sulphate nor 
zinc sulphate. The oil contained either P-carotene or annato (both from Quest 
International, Naarden, The Netherlands), a permitted food additive with no provitamin 
A activity, but the same colour as P-carotene. The iron and zinc supplements were 
produced by a local pharmaceutical company (Kenrose Ltd., Jakarta, Indonesia) in 
cooperation with UNICEF-Jakarta. The infants received either iron (10 mg Fe/day), or 
zinc (10 mg Zn/day), or iron+zinc (10 mg of each/day), or zinc+ p-carotene (10 
mg/day and 2.4 mg/day respectively), or p-carotene (2.4 mg/day) or placebo. 
Eligible infants were identified by the village health volunteers, and the 
mothers invited to participate in the study. Mothers were informed of the procedures 
and purpose of the study. After written informed consent was given by the mother, 
infants were assessed anthropometrically, and a short history was taken. Infants were 
assigned to one of the six groups on basis of individual randomization, using a block 
randomised group allocation list, which was computer generated before the study was 
commenced. 
Supplementation was double-blind, and the supplements were coded with a 
letter at production. The allocation code was kept safe at the Wageningen University 
until the study was finished. 
At recruitment, each subject was allocated a personal bottle with a dosing 
syringe, labeled with the subject's name, subject number, and date. The bottles were 
kept safe by the health volunteer to prevent accidental overdosing. Bottles were 
weighed before allocation, replaced every month with a new bottle, and weighed again 
after return to estimate the dose given to the infant as a measure of compliance. 
At each monthly follow-up, the infant was assessed anthropometrically, and a short 
history concerning health, diet, lactation and possible adverse effects of the 
supplements was taken. After 6 months of supplementation, a blood sample was taken 
from the infants for biochemical assessment of nutritional status. Five hours prior to 
the blood sampling, the infants received a dose of 3,4-didehydroretinol in corn oil (1.5 
mg in 700 uL oil) for the modified relative dose response (MRDR) test. The MRDR 
test uses the ratio of 3,4-didehydroretinol to retinol as an indicator of liver stores of 
vitamin A (13). When vitamin A liver stores are low, more 3,4-didehydroretinol 
appears in the blood relative to retinol concentrations. A ratio of > 0.06 of the 
concentrations in plasma is considered indicative of insufficient stores of vitamin A in 
the liver (13). All infants with a haemoglobin concentration of <110 g/L were given 
iron supplementation treatment upon completion of the trial. The protocol was 
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approved by the ethical committee of the National Health Research and Development 
Institute of Indonesia and by the ethical committee of the Royal Netherlands Academy 
of Arts and Sciences. 
Measurements and analysis. 
A non-fasting venous blood sample (5 mL) was taken from the infants into 
heparinized vacuum tubes (Becton and Dickinson. Leiden, The Netherlands). Blood 
samples were immediately stored at 4°C to prevent microhaemolysis and separated 
within 5 hours. Plasma samples were aliquoted and stored at -30 °C until analysis. 
Haemoglobin concentrations were measured the same day by a standard 
cyanoblue method (Humalyzer, Germany). Plasma zinc concentrations were analysed 
with flame atomic absorption spectrophotometry (Varian, Clayton South, Vic, 
Australia) using trace-element free procedures. The CV (10% duplicate analysis and 
pooled control samples) for zinc analyses was <5%. Plasma retinol, carotenoids and 
3,4-didehydroxyretinol concentrations were measured by HPLC (MilliporeWaters, 
Harrow, Middlesex, UK) (14). 3,4-Didehydroxyretinol and retinol were measured in 
the same extract as carotenoids but using a different mobil phase (methanol: water 
90:10 v/v). The CV (10% duplicate analysis and pooled control samples) for the retinol 
and carotenoid analysis was <10%. Ferritin concentrations were measured using 
commercial ELIS A-kits (IBL-Hamburg, Germany) according to the guidelines of the 
manufacturer. C-reactive protein (CRP) and ai-acid glycoprotein (AGP) were 
measured using immunoturbidimetric techniques (Cobas Fara analyzer, Roche 
Products, Welwyn, UK). The CV for the ferritin, CRP and AGP assays was <10%. 
Plasma CRP and AGP concentrations were analysed to assess the acute-phase reaction, 
which lowers plasma concentrations of zinc and retinol, and raises plasma 
concentrations of ferritin (15). Plasma CRP concentrations rise early in the acute phase 
response, but normalise generally within two weeks. Plasma AGP concentrations rise 
more slowly than those of CRP, but stay elevated for up to two months after the initial 
acute phase response (16). 
Statistical analysis. 
Data were checked for normal distribution using the Kolmogorov-Smirnov test 
of normality. Plasma concentrations of ferritin and zinc were transformed to logarithms 
before statistical analysis. Differences in prevalence were tested with Pearson's chi-
square test, differences between infants who dropped-out and infants who completed 
the study were tested with Student's t-test. Difference in compliance and plasma (3-
carotene concentrations was tested using the non-parametric Kruskal-Wallis test. 
Differences for age, biochemical indicators and anthropometry were analysed using 
analysis of variance (ANOVA) or analysis of covariance (ANCOVA). Plasma CRP 
and AGP concentrations were used as covariates in the analysis of plasma 
concentrations of retinol, ferritin, and zinc, to control for the effects of the acute phase 
response. When the overall F-test was significant, differences between the groups were 
further explored with post-hoc multiple comparisons for ANOVA, and in a general 
linear model for ANCOVA. In the general linear models, plasma retinol concentrations 
were transformed to logarithms as a variance stabilising measure. 
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Statistical analysis was carried out with the SPSS 7.5.2 (SPSS Inc, Chicago, IL) 
software package, and anthropometrical Z-scores were calculated with EPI-Info, 
version 6.04b (CDC, Atlanta, GA). 
RESULTS 
Between November 1997 and July 1998, 387 infants were recruited from six 
adjacent villages in Bogor District. Of these, 271 infants completed the 
supplementation trial and of 256 infants, a complete blood sample was collected 
(Figure 1). Of the recruited infants, 27 (7%) never came back for follow-up and were 
considered non-sincere recruits. A further 89 infants (23%) dropped-out during the 
study for various reasons (non-cooperation 18%, moving house 3% and mortality 5 
cases (1%)). The infants who dropped out did not differ from the infants who 
completed the trial for any of the characteristics at recruitment. The drop-out among 
the groups ranged from 20% in groups receiving iron or zinc to 39% in the group 
receiving the combination of iron and zinc (chi-square, p=0.06). At recruitment, the 
mean age of the infants was 4.2 months [SD + 0.4], and the male:female ratio was 
206:181. Anthropometry was expressed as Z-scores, and the mean weight-for-age was 
-0.02 [SD + 0.85]; the mean height-for-age was -0.88 [SD + 0.77]; the mean weight-
for-height was +0.82 [SD + 0.82]. There were no differences among the groups for any 
of the baseline characteristics. The median overall compliance was 91% [IQR 76%-
98%] of the total intended dose, and did not differ between the groups. 
After six months of supplementation micronutrient status was assessed (Table 
1). The mean age of the infants was 10.2 months [SD + 0.5]. Infants receiving iron or 
iron+zinc had significantly lower plasma retinol concentrations than infants receiving 
placebo (p<0.05 and p<0.001 respectively). Haemoglobin concentrations were 
significantly increased in the infants receiving iron (p<0.01) but the increase just failed 
to reach significance for infants receiving iron+zinc (p=0.052). Plasma ferritin 
concentrations were highest in the group receiving iron, and also significantly higher in 
the iron+zinc supplemented group as compared to all other group (p<0.001 for both, 
ANCOVA controlling for CRP). Plasma zinc concentrations were significantly higher 
in the groups receiving zinc and zinc+ P-carotene (p<0.001, ANCOVA, controlling for 
CRP), and also higher but to a lesser extent in the group receiving iron+zinc (p<0.05). 
P-Carotene supplementation, either alone or in combination with zinc, significantly 
raised plasma P-carotene concentrations (p<0.001, Kruskal-Wallis), but failed to 
increase plasma retinol concentrations. 
The effect of the three micronutrients supplemented on plasma retinol 
concentrations was further investigated using a general linear model, with CRP 
included as covariate. Supplementation with iron was associated with lower plasma 
retinol concentrations of 0.15 umol/L (p<0.01). Neither zinc nor p-carotene 
supplementation significantly affected plasma retinol concentrations. 
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In the placebo group, the prevalence of micronutrient deficiencies was high 
(Figure 2): 54% had vitamin A deficiency (plasma retinol concentration <0.70 
(j.mol/L), 49% were anaemic (haemoglobin concentration <110 g/L), 26% had iron 
deficiency anaemia (anaemia and plasma ferritin concentration <12 |ig/L), and 14% 
had zinc deficiency (plasma zinc concentration <10.7 umol/L). However, the 
prevalence of vitamin A deficiency was significantly higher in the infants receiving 
iron or iron+zinc supplementation (p<0.01), 20% and 26% higher respectively 
compared to the placebo group. In contrast, the prevalence of insufficient vitamin A 
liver stores, as indicated by a MRDR >0.06, was lowest in the iron and iron+zinc 
groups (p<0.01; 30% and 32% respectively) than in the placebo group. Furthermore, 
the prevalence of anaemia and iron deficiency anaemia were lowest in the groups 
receiving iron and iron+zinc (p<0.01). Neither the reduction in the prevalence of 
vitamin A deficiency in the groups receiving fj-carotene or zinc+P-carotene nor the 
reduction in the prevalence of zinc deficiency in the groups receiving zinc, iron+zinc 
and zinc+ P-carotene were large enough to be statistically significant. 
The effect of iron supplementation on vitamin A status is clearly illustrated by 
the relationship between plasma retinol concentration and MRDR (figure 3). There is a 
strong linear relationship between plasma retinol concentrations and the MRDR for the 
groups not receiving iron (r= -0.69, p<0.001, Pearson correlation), with the infants with 
a low plasma retinol concentration having a high MRDR (indicative of depleted 
vitamin A liver stores). However, the groups receiving iron and iron+zinc supplements 
clearly form a separate subgroup, placed outside this relationship (r=0.08, p>0.1). In 
these subjects, in contrast to the infants not receiving iron or iron+zinc, a low plasma 
retinol concentration is accompanied by a low MRDR (p<0.001, chi-square). 
06 
v.j-
0.2-
0.1-
n n 
U.LM 0 0 
• 
• 
o 
D D A • 
A • 
• a v 
«a v 
O SD 
A • <M 
\Z£VO A 
D4ESA I 
o o a x i i 
D + ££M 
O 4DCX 
• o a n DAZXS • OJKZ 
A 
• at r. 
• D 
• « * • m A A * « A 
• « * J » « • 
A A AM. 
D 
. A 
D V A 
> A 47 
D ZS7 
\B3 A A3 
EDO QA 
f A V A> 
ZBIV r~A 
A Iron 
• Iron+zinc 
• Placebo 
A Zinc+6-car. 
v B-Carotene 
o Zinc 
O 
A D 
ysAA^A m v 
• GZU7 AO • • 
>A W 
• 
• 
• 
0.4 0.8 
D A 
1.2 1. 6 
Plasma retinol concentration (|xmol/L) 
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concentrations in infants supplemented with various combinations of micronutrients. 
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DISCUSSION 
We find that a daily supplement of 10 mg of iron, which is not very different 
from the RDA, markedly reduces plasma retinol concentrations and increases the 
prevalence of vitamin A deficiency in infants. The lower MRDR in the iron 
supplemented infants, indicating increased hepatic stores of vitamin A, would suggest 
that iron supplementation redistributes vitamin A from plasma to liver. Such findings 
have not been reported previously. For example, our group reported that iron 
supplementation had no effect on plasma retinol concentrations in pregnant women (9). 
However, only 10% of the pregnant women were vitamin A deficient, and they were 
supplemented for only 8 weeks. No effect of either iron or zinc supplementation on 
plasma retinol concentrations was found in children in Mexico although plasma retinol 
concentrations were found to be increased six months after supplementation had 
stopped (17). 
It is cause for concern that iron supplementation leads to plasma retinol 
concentrations below cut-off levels for vitamin A deficiency as low plasma retinol 
concentrations are directly related to the consequences of vitamin A deficiency (18). 
Although in the present study retinol liver concentrations were increased after iron 
supplementation, a reduced mobilisation of retinol from the liver to the plasma will 
induce a state of vitamin A deficiency. Thus iron supplementation, by inducing vitamin 
A deficiency, could increase the risk of morbidity and mortality from infectious 
diseases in infants. This would be especially important in populations where vitamin A 
status is already marginal. 
An alternative explanation for the reduction of plasma retinol concentrations as 
a result of iron supplementation may be that vitamin A requirements are increased 
because of accelerated erythropoiesis. However, such an explanation would not be 
consistent with the reduced MRDR, signifying increased retinol liver stores. Whether 
redistribution of retinol after iron supplementation only occurs in populations with a 
high prevalence of both iron deficiency and vitamin A deficiency remains to be 
investigated. However, this is of great importance because these are precisely the 
populations targeted by micronutrient supplementation programmes. 
Observations of the interaction between vitamin A and iron metabolism can be 
obscured by the acute phase response, which leads to increased plasma ferritin 
concentrations and to decreased plasma retinol concentrations. In the present study, 
CRP was included in the analyses to control for these effects. The proportion of infants 
with plasma CRP concentrations >10 mg/L was not different among the 
supplementation groups. Furthermore, excluding the 32 infants with CRP levels >10 
mg/L did not change the findings. Using a different acute-phase protein (AGP) as 
covariate, or as exclusion criterion (plasma AGP levels >1.2 g/L; excluded n=56) also 
gave identical results. Hence, the decrease in plasma retinol concentrations in the iron 
supplemented groups cannot be attributed to differences in the acute phase response. 
How should we interpret the increase in vitamin A liver stores after iron 
supplementation? On the basis of the MRDR measurements, we surmise that there is a 
redistribution of retinol after iron supplementation. The MRDR method may have 
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certain limitations. Because the measurement is derived from the ratio of the 
concentration of 3,4-dihydroxyretinol to that of retinol, precision is less than that of the 
measurement of plasma retinol alone. However, since the effect of iron 
supplementation on the MRDR was highly significant, this limitation is not of concern 
here. Furthermore, the MRDR may be affected by factors other than the concentration 
of vitamin A in liver. In children with protein-energy malnutrition, the MRDR is less 
sensitive because the concentration of many plasma proteins is low. Thus the low 
concentration of retinol-binding protein in protein-energy malnutrition distorts the 
competitive binding between 3,4-dihydroxyretinol and retinol (19). As the infants in 
the present study were not malnourished, it may be assumed that the MRDR 
adequately reflects retinol liver stores. 
Most studies, including those using animal models, on the interrelation between 
iron and vitamin A metabolism have focussed on the influence of vitamin A on iron 
metabolism (20), but not vice versa. This is because earlier studies in humans have 
shown that supplementation with vitamin A in addition to iron has been shown to 
reduce the prevalence of anemia more than the provision of iron supplements alone9. 
However, Rosales et al. showed that retinol distribution over various body 
compartments is dependent on iron status, with lower concentrations of vitamin A in 
the liver of iron deficient rats than in food-restricted control rats (21). On the other 
hand, Jang et al. showed that iron deficiency inhibits the mobilisation of vitamin A 
stores in rats, and may impair the absorption and utilisation of vitamin A (22). Under 
normal conditions, the hepatic stellate cells contain over 90% of the liver stores of 
vitamin A, mainly as retinyl esters. Secretion of retinol from the liver stores to the 
circulation is thought to be directly from the stellate cells or indirectly via the 
hepatocytes (23). Interference in this complicated intrahepatic balance between cellular 
uptake and mobilisation could underlie the effect of iron supplementation on retinol 
distribution. 
Deficiencies of both vitamin A and iron are very prevalent worldwide, and 
moreover often occur together. However, most efforts to combat these deficiencies are 
directed towards just one of these micronutrients. In view of the adverse effect of iron 
supplementation on vitamin A status found in this study, supplementation with iron 
alone in infants may compromise vitamin A status. This effect would be exacerbated in 
infants, and perhaps others, with low vitamin A status. 
ACKNOWLEDGEMENTS 
We would like to thank all the mothers and the infants, and the health 
volunteers who participated in this study, and we are grateful for the enthusiastic 
support we received from Dr.Hendra, Dr. Anni and their staff. Furthermore we would 
like to thank the field team of Puslitbang Gizi, and the staff from the Bogor laboratory 
for their untiring efforts. Also we would like to thank Jen-Shiu Chiang-Chiau, C. 
Northrop-Clewes and J. Coulter from NICHE, University of Ulster for their help with 
the analysis of retinol, 3,4-didehydroretinol, carotenoids, CRP and AGP, S. 
Tanumihardjo from the Department of Nutrition Sciences, University of Wisconsin for 
providing the 3,4-didehydroretinol and sharing her experience with MRDR testing, and 
M. Van der Heuvel for commenting on earlier drafts of the manuscript. Financial 
support for this study was received from the Netherlands Foundation for the 
96 
Iron Supplementation and Vitamin A Status 
Advancement of Tropical Research (WOTRO), Ter Meulen Fund (Royal Netherlands 
Academy of Arts and Sciences), and UNICEF Jakarta. 
REFERENCES 
1. Hurtado EK, Claussen AH, Scott KG. Early childhood anemia and mild or 
moderate mental retardation. Am J Clin Nutr 1999; 69: 115-119. 
2. Bates CJ. Vitamin A. Lancet 1995; 345: 31-35. 
3. Brown KH, Peerson JM, Allen LH. Effect of zinc supplementation on children's 
growth: a meta-analysis of intervention trials. Bibl NutrDieta 1998; 76-83. 
4. Umeta M, West CE, Haidar J, Deurenberg P, Hautvast JG. Zinc supplementation 
and stunted infants in Ethiopia: a randomised controlled trial. Lancet 2000; 335: 
2021-2026. 
5. Bhutta ZA, Bird SM, Black RE, et al. Therapeutic effects of oral zinc in acute and 
persistent diarrhea in children in developing countries: pooled analysis of 
randomized controlled trials. Am J Clin Nutr 2000; 72: 1516-1522. 
6. UNICEF-WHO Joint Committee on Health Policy. World summit for children: 
Strategic approach to operationalizing selected end-decade goals; Reduction of iron 
deficiency anaemia. Thirtieth Session. 1994. 
7. Dijkhuizen MA, Wieringa FT, West CE, Muherdiyantiningsih, Muhilal. 
Concurrent micronutrient deficiencies in lactating mothers and their infants in 
Indonesia. Am J Clin Nutr 2001; 73:78:786-91 
8. Whittaker P. Iron and zinc interactions in humans. Am J Clin Nutr 1998; 68(suppl): 
442S-446S. 
9. Suharno D, West CE, Muhilal, Karyadi D, Hautvast JG. Supplementation with 
vitamin A and iron for nutritional anaemia in pregnant women in West Java, 
Indonesia. Lancet 1993; 342: 1325-1328. 
10. De Pee S, West CE, Muhilal, Karyadi D, Hautvast JG. Lack of improvement in 
vitamin A status with increased consumption of dark-green leafy vegetables. 
Lancet 1995; 346: 75-81. 
11. Christian P, West KP, Jr. Interactions between zinc and vitamin A: an update. Am J 
Clin Nutr 1998; 68(suppl): 435S-441S. 
12. Udomkesmalee E, Dhanamitta S, Sirisinha S, et al. Effect of vitamin A and zinc 
supplementation on the nutriture of children in Northeast Thailand. Am J Clin Nutr 
1992; 56: 50-57. 
13. Tanumihardjo SA, Cheng JC, Permaesih D, et al. Refinement of the modified-
relative-dose-response test as a method for assessing vitamin A status in a field 
setting: experience with Indonesian children. Am J Clin Nutr 1996; 64: 966-971. 
14. Thurnham DI, Smith E, Flora PS. Concurrent liquid-chromatographic assay of 
retinol, alpha-tocopherol, beta-carotene, alpha-carotene, lycopene, and beta-
cryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 
1988; 34: 377-381. 
15. Filteau SM, Tomkins AM. Micronutrients and tropical infections. Trans R Soc 
TropMedHyg 1994; 88: 1-3. 
16. Paracha PI, Jamil A, Northrop-Clewes CA, Thurnham DI. Interpretation of vitamin 
A status in apparently healthy Pakistani children by using markers of subclinical 
infection. Am J Clin Nutr 2000; 72: 1170-1178. 
97 
Chapter 5 
17. Munoz EC, Rosado JL, Lopez P, Furr HC, Allen LH. Iron and zinc 
supplementation improves indicators of vitamin A status of Mexican preschoolers. 
Am J Clin Nutr 2000; 71: 789-794. 
18. Underwood BA, Arthur P. The contribution of vitamin A to public health. FASEB J 
1996; 10: 1040-1048. 
19. Wahed MA, Alvarez JO, Khaled MA, Mahalanabis D, Rahman MM, Habte D. 
Comparison of the modified relative dose response (MRDR) and the relative dose 
response (RDR) in the assessment of vitamin A status in malnourished children. 
Am J Clin Nutr 1995; 61: 1253-1256. 
20. Roodenburg AJC, West CE, Hovenier R, Beynen AC. Supplemental vitamin A 
enhances the recovery from iron deficiency in rats with chronic vitamin A 
deficiency. Br J Nutr 1996; 75: 623-636. 
21. Rosales FJ, Jang JT, Pinero DJ, Erikson KM, Beard JL, Ross AC. Iron deficiency 
in young rats alters the distribution of vitamin A between plasma and liver and 
between hepatic retinol and retinyl esters. J Nutr 1999; 129: 1223-1228. 
22. Jang JT, Green JB, Beard JL, Green MH. Kinetic analysis shows that iron 
deficiency decreases liver vitamin A mobilization in rats. Journal of Nutrition 
2000; 130: 1291-1296. 
23. Blomhoff R. Transport and metabolism of vitamin A. Nutr Rev 1994; 52(suppl): 
S13-S23. 
98 
Iron Supplementation and Vitamin A Status 
99 
Marginalia 
Iron in the Oceans. 
Not unlike the discussion in human nutrition concerning growth-limiting nutrients, is 
the debate in oceanography about which nutrients limit phytoplankton growth. Many 
nutrients important for optimal growth in humans, such as iron, nitrogen and 
phosphorus, are also essential for growth of phytoplankton. Phytoplankton play a 
crucial role in the conversion of CO2 to new organic matter. By removing CO2 from 
the atmosphere, phytoplankton can influence the process of climate change. It is 
unlikely that all nutrients are equally limiting at the same time. Residence times of 
nutrients in the ocean vary considerably, from around 50,000 years for phosphate to 
only 30 years for iron. Mostly, interest has centred on the fast exchange nutrients such 
as NOs~ and Fe. Some groups argue that iron is the limiting factor in at least 30% of 
the world's oceans. Phytoplankton use iron for both photosynthesis and respiratory 
electron transfer. The role of iron in oceans is poorly understood however. Dissolved 
iron is present in very low concentrations (10'w - 10' moles/kg), mostly bound to 
ligands. Free iron would precipitate as oxyhydroxides, or be absorbed on sinking 
particles. Organic ligands like porphyrin and siderophores help to retain iron where it 
is most needed: near the sea surface where there is sufficient light for photosynthesis. 
Indeed, phytoplankton biomass can be dramatically increased by addition of Fe or 
N03~. Recently however, Tyrell argued that these effects are relatively short lived, as 
the balance between nitrogen fixation and denitrification is ultimately set by influx of 
phosphate. When more phosphate comes into the oceans, more nitrogen is fixed. The 
nitrogen cycle is more adaptable than the phosphate cycle and adjusts to the input 
and loss of phosphate. This is not unlike the concept of type-1 and type-2 nutrients in 
human nutrition. Thus it is possible to find low concentrations of phosphate in surface 
sea water, while all available nitrogen has been consumed, even though phosphate is 
the limiting nutrient. 
Toggweiler JR. An ultimate limiting nutrient. Nature. 1999;400:511-2. Tyrrell T. The 
relative influences of nitrogen and phosphorous on oceanic primary production. 
Nature. 1999;400:525-31. Geider RJ. Complex lessons or iron uptake. Nature. 1999; 
400;815-6. Hutchins DA, Witter AE, Butler A, Luther GW. Competition among marine 
phytoplankton for different chelated iron species. Nature. 1999;400: 858-61 
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Modulation of Interf eron-y, Neopterin and 
Interleukin-6 by Iron, Zinc and p-Carotene 
Supplementation. 
Marjoleine A. Dijkhuizen, Frank T. Wieringa, Clive E. West, Johanna van 
der Ven-Jongekrijg, Muhilal, Jos W.M. van der Meer. 
Submitted for publication. 
101 
Chapter 6 
ABSTRACT 
Micronutrients can have profound effects on cellular and humoral immunity. 
Micronutrient deficiency is associated with increased risk of morbidity and mortality. 
Supplementation with various micronutrients has been shown to improve 
immunocompetence. In the present study, the effects of iron, P-carotene and zinc 
supplementation on ex-vivo cytokine production and macrophage activation were 
investigated in infants with high prevalence of micronutrient deficiencies. 
In a double-blind, placebo controlled intervention trial, 387 infants, aged 4 
months, were supplemented for 6 months with iron and/or zinc and/or P-carotene or 
placebo. Micronutrient status and immune function were assessed at the end of 
supplementation. 
Anemic and iron deficient infants had lower, and zinc deficient infants higher 
inferon-y production than non-deficient infants. Plasma neopterin concentrations were 
lower in iron deficient, and higher in zinc and vitamin A deficient infants. Interferon-y 
production was higher in iron, and lower in zinc and P-carotene supplemented infants. 
Interleukin-6 production exhibited the opposite pattern to interferon-y production. In 
concordance with the production of interferon-y, plasma neopterin concentrations were 
higher in iron and lower in zinc supplemented infants. 
Concluding, iron deficiency depressed, whilst iron supplementation enhanced 
the type-1 immune response, whereas zinc and P-carotene had opposite 
immunomodulatory effects to iron supplementation. Thus, micronutrient deficiency as 
well as supplementation has an important effect on cytokine responses and immune 
reactivity. 
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INTRODUCTION 
_Modulation of Immune Response by Supplementation 
Deficiency of micronutrients can have profound effects on cellular and humoral 
immunity in humans and experimental animals. Such deficiencies are associated with 
high morbidity and mortality, especially in infants. Supplementation is commonly used 
to combat micronutrient deficiencies and to improve health in infants: both vitamin A 
and zinc supplementation have been shown to reduce morbidity and mortality from 
infectious diseases (1,2). Iron supplementation is more controversial: positive as well 
as negative effects have been reported (3,4). 
Anemia and iron deficiency are associated with depressed cell-mediated 
immunity (5). Studies in animals suggest that inadequate supply of iron impairs T-
lymphocyte proliferation, whereas humoral immunity is probably less affected. Iron 
also has a critical role in cytotoxic activity of macrophages as it is required for the 
production of hydroxyl radicals, although it is unclear to what extent macrophages or 
other cytotoxic cells are affected by iron deficiency (6). Supplementation with iron has 
given conflicting results ranging from increased immunocompetence to increased 
incidence and severity of infections (3). 
Zinc deficiency leads to a decrease of both B- and T-lymphocyte numbers, and 
also reduces antibody response and numbers of cytotoxic cells. Zinc supplementation 
has been reported to improve the incidence, severity and outcome of infections, 
especially of diarrheal and respiratory tract infections, but also of malaria (2,4,7). 
Severe vitamin A deficiency leads to xerophthalmia and blindness. However, 
morbidity and mortality are markedly increased in populations with only marginal 
vitamin A deficiency (8). Decreased cell-mediated immune function, reduced cytotoxic 
cell activity and reduced antibody titers have all been reported in vitamin A deficiency. 
However, the exact underlying immune defects are not yet clear (9).Vitamin A 
supplementation has been shown to reduce infant mortality by about 25% (1). 
Furthermore, vitamin A supplementation has been shown to reduce the severity of 
malaria (4). 
Status with respect to various micronutrients is a major determinant of optimal 
host defense. However, not only are the underlying mechanisms by which 
micronutrients modulate immune function not fully understood, also the exact effects 
of different micronutrients on immune function are not yet clear. One major problem in 
the interpretation of host defense defects in micronutrient deficiencies is that often 
status with respect to more than one micronutrient is suboptimal. Concomitant 
micronutrient deficiencies can have immunomodulatory effects that counteract or 
enhance each other, confounding the overall effect. 
In this study, the effects of supplementation with iron, zinc and |}-carotene on 
cytokine response and macrophage activation was investigated in infants with a high 
prevalence of iron, zinc and vitamin A deficiency. We measured ex-vivo cytokine 
production after stimulation in whole blood cultures, as well as plasma neopterin 
concentrations and micronutrient status. 
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SUBJECTS AND METHODS 
Study design, subjects and procedures. 
The study was a randomized, double-blind, placebo-controlled supplementation 
trial in infants aged 4 months at recruitment. Six groups of infants were supplemented 
with iron (10 mg/day), zinc (10 mg/day), iron+zinc (10 mg each/day), p-carotene (2.4 
mg/day), zinc+|3-carotene (10 mg/day and 2.4 mg/day respectively) or placebo. The 
study was carried out in a rural area of Bogor District, West Java, Indonesia. Infants 
were supplemented 5 days/week for 6 months by trained village health volunteers. 
Mothers were informed of the purpose and procedures of the study. After 
written informed consent was given by the mother, infants were assessed 
anthropometrically, and a short history was taken. After 6 months of supplementation, 
a blood sample was taken of the infant for biochemical assessment of nutritional status 
and immune function. All infants with a hemoglobin concentration of <110 g/L were 
given iron supplementation treatment after completion of the trial. The protocol was 
approved by the ethical committees of the National Health Research and Development 
Institute of Indonesia and the Royal Netherlands Academy of Arts and Sciences. 
Measurements and analysis. 
Non-fasting 5 mL venous blood samples (heparinized vacuum tubes from 
Becton and Dickinson. Leiden, The Netherlands) were taken from the infants. Blood 
samples were immediately stored at 4°C to prevent microhemolysis and separated 
within 5 h. Plasma samples were aliquoted and stored at -30 °C until analysis. 
Cytokine production was measured using an ex-vivo whole blood cytokine production 
after stimulation assay as described by Van Crevel et al (10). Within 15 minutes of 
collection of the blood sample, 200 1 of whole blood, diluted 1:1 with RPMI (RPMI 
1640, Dutch Modification, Costar, Badhoevedorp, The Netherlands, with pyruvate, 
glutamin and garamycine 1% w/v each), was incubated with either phyto-
haemagglutinin (PHA-P, Sigma, Zwijndrecht, The Netherlands) in a final 
concentration of 30 mg/L, lipopolysaccharide (LPS, E. coli serotype 055:b5; Sigma) in 
a final concentration of 10 ug/L, or PBS as blank control, and then incubated at 37°C 
for 10 h. After incubation, the supernatant was collected for determination of cytokine 
concentrations. The concentrations of PHA and LPS used, as well as the incubation 
time, were chosen to give an optimal response in this system. 
Hemoglobin concentrations were measured by a standard cyanoblue method 
(Humalyzer, Germany). Plasma zinc concentrations were analysed with flame atomic 
absorption spectrophotometry (Varian, Clayton South, Vic, Australia) using trace 
element-free procedures (11). The CV (10% duplo analysis and pooled control 
samples) for zinc analyses was <5%. Plasma retinol concentrations were measured by 
HPLC (MilliporeWaters, Harrow, Middlesex, UK) (12). The CV (10% duplo analysis 
and pooled control samples) for the retinol and carotenoid analysis was <10%. Ferritin 
and neopterin concentrations were measured using commercial ELISA kits (IBL-
Hamburg, Germany) according to the guidelines of the manufacturer. The cytokines 
interferon-y (IFN-y) and interleukin-6 (IL-6) were also measured with ELISA 
(Pelikine, CLB, Amsterdam, The Netherlands, calibrated with the standards of the 
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National Institute of Biological Standards and Controls, Potters Bar, UK) and 
according to the manufacturer's guidelines. The CV for all ELISA assays was <10%. 
a 1-Acid glycoprotein (AGP) concentrations were measured using immuno-
turbidimetric techniques (Cobas Fara analyzer, Roche Products, Welwyn, UK). The 
CV for the AGP assays was <10%. Plasma AGP concentrations were analyzed to 
assess the acute phase reaction, which will lower plasma concentrations of zinc and 
retinol, and raise plasma concentrations of ferritin (13). Also, plasma neopterin 
concentrations will be affected by infection. Plasma AGP concentrations rise within 24 
hours of infection, and stay elevated for up to several weeks after the initial acute 
phase response (14). 
Statistical analysis. 
Data were checked for normal distribution using the Kolmogorov-Smirnov test 
of normality. Plasma concentrations of ferritin, zinc, interleukin-6 and neopterin were 
transformed to logarithm, and interferon-y concentrations were transformed to square 
root before statistical analysis to achieve normality. Differences in cytokine production 
and plasma neopterin concentrations between the different supplementation groups 
were tested with analysis of variance (ANOVA). The effect of each supplemented 
micronutrient on cytokine production and plasma neopterin concentrations was 
explored with multiple linear regression (MLR), taking sex or AGP concentrations into 
account as indicated. Differences in cytokine production and neopterin concentration 
between infants with deficiency of a specific micronutrient and non-deficient infants 
was tested with the non-parametric Mann-Whitney U test. Statistical analysis was 
carried out SPSS 7.5.2 (SPSS Inc, Chicago, IL) software package. 
RESULTS 
Subjects. 
Between November 1997 and July 1998, 387 infants from six adjacent villages 
in rural West Java, Indonesia were enrolled in a supplementation trial with iron, zinc, 
iron+zinc, p-carotene, zinc+ P-carotene or placebo. After six months of 
supplementation, at a mean age of 10.2 months [SD + 0.5], an end-point blood sample 
was taken to assess biochemical indicators of micronutrient status and immune 
function. In total 256 infants (66%) completed the trial including an end-point 
bloodsample. Ex-vivo whole blood cytokine production was assessed in 184 of these 
infants. Results of 13 incubations were excluded from statistical analyses as high 
blanks indicated possible breach of sterility during incubation, and 8 samples were lost 
for IFN-y determination during incubation or analysis. Circulating plasma neopterin 
concentrations were only measured in the infants who had received iron, zinc, P-
carotene or placebo (n=174). 
Effect of micronutrient status on ex-vivo cytokine production. 
The effect of the micronutrient status of the infants, irrespective of 
supplementation, on ex-vivo production of IFN-y and IL-6 was investigated. As 
micronutrient status indicators are not reliable in the presence of the acute phase 
response, all infants with plasma AGP concentrations >1.2 g/L were excluded from the 
analysis (n=39). IFN-y production correlated negatively with plasma zinc 
105 
Chapter 6_ 
4000-, 4000n B O 
*-» 
2 E 3000-
B -r> © tJ 
>- §"2000-
a w 
2 
g 1000-
C 
^^  
._ 
P < 0.05 
IT • • 
Anemic Non-anemic 
(n=54) (n=70) 
a © 
R 
"H 0» 3000-
>. g>2000-
e "-' 
£ 
ft 
c 
1000-
(H 
P<0.1 
1 1 
Iron 
deficient 
(n= =33) 
_ ^ 
Not iron 
deficient 
(n= =91) 
s 
o 
•3 
2 
4000-1 
3000 s 
© H 
£. 3*2000-
I 1000-
P < 0.05 
line 
deficient 
(n=13) 
Not zinc 
deficient 
(n=lll) 
s 
o 
40001 
3000-s 
v 
3 
o 
Z- §"20004, 
I 
s 
E 
•B 
1 
1000-
=1= 
Vitamin A Not vitamin A 
deficient deficient 
(n=66) (n=S8) 
Figure 1. Ex-vivo interferon-y production after stimulation with PHA in infants 
with anemia or deficiency of iron, vitamin A or zinc, compared to non-anemic 
or non-deficient infants. Infants (n=39) with an acute phase response (plasma 
AGP>1.2 g/L) were excluded. Anemia was defined as hemoglobin <110 g/L, 
iron deficiency as anemia and plasma ferritin <12 (J.g/L, zinc deficiency as 
plasma zinc < 10.7 |xmol/L, and vitamin A deficiency as plasma retinol < 0.70 
\imo\fL. Differences between the groups were tested with the Mann-Whitney U 
test. Boxes extend from the 25-th to the 75-th percentile, with the median 
indicated by the horizontal line. Whiskers show the range of the data. 
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Figure 2. Ex-vivo interleukin-6 production after stimulation with LPS in infants 
with anemia or deficiency of iron, vitamin A or zinc, compared to non-anemic 
or non-deficient infants. Infants (n=39) with an acute phase response (plasma 
AGP>1.2 g/L) were excluded. Anemia was defined as hemoglobin <110 g/L, 
iron deficiency as anemia and plasma ferritin <12 |Xg/L, zinc deficiency as 
plasma zinc < 10.7 (xmol/L, and vitamin A deficiency as plasma retinol < 0.70 
|0.mol/L. Boxes extend from the 25-th to the 75-th percentile, with the median 
indicated by the horizontal line. Whiskers show the range of the data. 
concentrations (p = -0.29, P<0.01, Spearman's rank), but not with other micronutrient 
status indicators. Ex-vivo production of IL-6 weakly correlated with plasma retinol 
concentrations (r=0.15, P =0.08, Pearson's correlation) and with plasma (3-carotene 
concentrations (p =0.21, P<0.05, Spearman's rank). Next, the effect of deficiency of 
various micronutrients on production of IFN-y and IL-6 was investigated (figure 1 and 
figure 2). Anemic infants (hemoglobin concentrations < 110 g/L) had significantly 
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lower IFN-y production (P<0.05, Mann Whitney U) than non-anaemic infants. Iron 
deficient infants (anemia and plasma ferritin concentration < 12 |Ag/L) also tended 
towards decreased IFN-y production but the difference failed to reach significance 
(P=0.08, Mann Whitney U). In contrast, zinc deficient infants (plasma zinc 
concentration < 10.7 umol/L) had higher IFN-y production (P<0.05, Mann Whitney U) 
than infants not zinc deficient. The differences in IL-6 production between deficient 
and non-deficient infants were much smaller, and not significant. Also, cytokine 
production in vitamin A deficient infants was not different from that in replete infants. 
Effect of supplementation on ex-vivo cytokine production. 
The ex-vivo production of IFN-y was highest in the infants receiving iron, 
whilst IFN-y production was lowest in the infants who had received zinc+p-carotene 
(Kruskal Wallis, P<0.05, Figure 3). In contrast, IL-6 production was lowest in the 
infants who received iron and highest in the infants who had received zinc+P-carotene, 
however because of the large interindividual variation the difference failed to reach 
significance (Figure 4). 
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Figure 3. Ex-vivo production of interferon-y after stimulation with PHA in 
infants supplemented with iron, zinc, and/or p-carotene. Boxes extend from the 
25-th to the 75-th percentile, with the median indicated by the horizontal line. 
Whiskers show the range of the data. Groups are significantly different from 
each other (P<0.05, Kruskal-Wallis). 
The effect of each supplemented micronutrient on ex-vivo cytokine production 
was investigated in a multiple linear regression model. Supplementation with iron was 
positively related to IFN-y production (r=0.21, P<0.01), whereas supplementation with 
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zinc was negatively related to IFN-y production (r= -0.20, P<0.05). Also (3-carotene 
supplementation was negatively related to TFN-y production (r = -0.18, P<0.05). 
However when all 3 supplemented micronutrient were entered into the model 
simultaneously, (3-carotene no longer contributed significantly to the model. Ex-vivo 
IL-6 production was negatively related to iron supplementation (r= -0.14, P=0.07), and 
postively related to (i-carotene supplementation (r= 0.14, P=0.06), but these 
relationships just failed to reach statistical significance. There was no relationship 
between IL-6 production and zinc supplementation . Sex and plasma AGP 
concentrations were initially included as possible confounders, but as they did not 
contribute to the models, they were not included in the final analyses. 
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Figure 4. Ex-vivo production of interleukin-6 after stimulation with LPS in 
infants supplemented with iron, zinc, and/or p-carotene. Boxes extend from the 
25-th to the 75-th percentile, with the median indicated by the horizontal line. 
Whiskers show the range of the data. 
The effect of micronutrient status on plasma neopterin concentrations. 
The relationship between plasma neopterin concentrations and micronutrient 
status was investigated in a multiple linear regression model, again including plasma 
AGP concentrations as confounder and irrespectively of supplementation (Table 1). 
Plasma ferritin concentrations were positively related to plasma neopterin 
concentrations (R=0.21, P<0.01), whereas plasma zinc concentrations were negatively 
related to plasma neopterin concentrations (R= -0.20, P<0.01). Plasma retinol 
concentrations were also negatively related to plasma neopterin concentrations (R= -
0.16, P<0.05). Hemoglobin concentrations were not significantly related to plasma 
neopterin concentrations. 
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Table 1. Relationship between micronutrient status and plasman neopterin concentration. 
Micronutrient status Plasma neopterin concentration 
indicator I* P 
Hemoglobin concentration 0.05 NS 
Plasma ferritin concentration 0.21 <0.01 
Plasma zinc concentration - 0.20 <0.01 
Plasma retinol concentration -0.16 0.04 
. Partial correlation coefficient between indicator of micronutrient status and plasma neopterin 
concentration, taking plasma concentrations of o -^acid glycoprotein concentrations as indicator 
for the acute phase response into account as possible confounder. 
Micronutrient deficiency was also associated with altered plasma neopterin 
concentrations (Figure 5). Infants (n=39) with a plasma AGP concentration of >1.2 
g/L were excluded from statistical analyses to prevent confounding by the acute phase 
response. Anemic infants had similar plasma neopterin concentrations to non-anemic 
infants, but infants with iron deficiency anemia had significantly lower plasma 
neopterin concentrations than infants without iron deficiency (P<0.01, Student's T 
test). In contrast to iron deficiency, infants with zinc deficiency or with vitamin A 
deficiency had higher plasma neopterin concentrations than non-deficient infants 
(P<0.05, Student's T test). 
Effect of supplementation on plasma neopterin concentrations. 
Circulating plasma neopterin concentrations were measured in the four groups 
receiving single micronutrient supplements or placebo. Plasma neopterin 
concentrations were highest in the iron group, and lowest in the zinc supplementation 
group (Figure 6). Iron supplemented infants had significantly higher plasma neopterin 
concentrations than zinc supplemented infants (P<0.05, ANOVA). The possible 
confounding effects of the presence of inflammation on circulating plasma neopterin 
concentrations were taken into account by including plasma AGP concentrations in a 
multiple linear regression model. Iron supplementation was significantly positively 
related to plasma neopterin concentrations (R=0.20, P<0.01, MLR controlling for 
AGP). Zinc supplemention was negatively related to plasma neopterin concentration, 
but only weakly (R= -0.12, P=0.1, MLR controlling for AGP). p-Carotene 
supplementation was not significantly related to plasma neopterin concentrations. 
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Figure 5. Plasma neopterin concentrations in infants with anemia or deficiency 
of iron, vitamin A or zinc, compared to non-anemic or non-deficient infants. 
Infants (n=39) with an acute phase response (plasma AGP>1.2 g/L) were 
excluded. Anemia was defined as hemoglobin <110 g/L, iron deficiency as 
anemia and plasma ferritin <12 \igfL, zinc deficiency as plasma zinc < 10.7 
|amol/L, and vitamin A deficiency as plasma retinol < 0.70 |Xmol/L. Differences 
between the groups were tested with Student's t-test, neopterin concentrations 
were transformed to logarithms before statistical analyses. Boxes extend from 
the 25-th to the 75-th percentile, with the median indicated by the horizontal 
line. Whiskers show the range of the data. 
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Figure 6. Plasma neopterin concentrations in infants supplemented with iron, 
zinc, and/or p-carotene. Boxes extend from the 25-th to the 75-th percentile, 
with the median indicated by the horizontal line. Whiskers show the range of 
the data. The iron group is significantly higher than the zinc group (P < 0.05, 
ANOVA). Neopterin concentrations were transformed to logarithms before 
statistical analyses. 
DISCUSSION. 
This study demonstrates that supplementation of infants with iron increases 
IFN-y production while supplementation with zinc or (3-carotene reduces IFN-y 
production. The effect of supplementation with iron, zinc or J3-carotene on plasma 
neopterin concentrations mirrors the effects on ex-vivo IFN-y production. This is 
consistent with neopterin being a downstream product of the IFN-y pathway. 
Supplementation affected ex-vivo production of the type-2 cytokine IL-6 in the 
opposite way to that of IFN-y production, with iron supplementation resulting in lower, 
and p-carotene supplementation in higher IL-6 production. 
IFN-y is important in the initiation of the cellular immune response and the 
increased production in iron supplemented infants could reflect increased cellular 
immune reactivity. The effect of iron status in modulating the cellular immune 
response is further supported by the lower production of IFN-y in the anemic and iron 
deficient infants compared to non-anemic or replete infants. Interestingly, IL-6 
production was lower in the iron supplemented infants, whereas anemia or iron 
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deficiency did not affect IL-6 production. IL-6, as a type-2 cytokine, is important for 
the humoral immune response. The decreased IL-6 production in iron supplemented 
infants may be due, at least in part, to the increased IFN-y production in these infants, 
as IFN-y downregulates the type-2 cytokine response. This may imply that iron 
supplementation shifts the cytokine balance towards a type-1 response. At first glance, 
this would conceptually be contradictory to the known effects of iron supplementation 
with respect to increasing susceptibility to, and severity of infection. However, part of 
the explanation could be that the infectious agent also utilises the supplemented iron 
(15,16). Furthermore, high dose iron supplementation as used in some of the earlier 
studies could well have different effects on immune function than lower doses of iron 
such as given in the present study (4). On the other hand, impaired host defense in iron 
deficiency and improved immunocompetence after iron supplementation have been 
reported (17-20). 
The effects of zinc and P-carotene supplementation on the ex-vivo production 
of IFN-y and IL-6 were less pronounced than those of iron supplementation, and 
showed an opposite pattern. Plasma zinc concentrations were negatively correlated to 
IFN-y production, and infants with zinc deficiency had higher production of IFN-y. 
Thus it would appear that the availability of zinc can dampen type-1 cytokine 
production. Alternatively, zinc deficiency could upregulate the cell-mediated immune 
response. These findings are rather unexpected, since the addition of zinc to cell 
cultures has been found to enhance cytokine production, with a marked increase in 
IFN-y production after stimulation with some but not all antigens (21,22). However, 
results obtained in in-vitro experiments may not reflect the conditions of zinc 
deficiency in-vivo or zinc supplementation. In humans, the effect of zinc deficiency or 
supplementation on immune function is not clear (4,23,24). Results from earlier studies 
may have been confounded by intercurrent infection which affects both assessment of 
micronutrient status as well as immune function. Therefore, we excluded subjects with 
infection as indicated by an acute phase response, from statistical analysis. 
The effect of supplementation with micronutrients on cytokine response can be 
confounded by concurrent deficiency of various micronutrients on immune function. 
This interrelationship is made even more complex by the fact that micronutrient 
supplementation can affect the status of not only the micronutrient supplemented but 
also of other micronutrients. Vice versa, when investigating the effects of micro-
nutrient deficiencies on immune response, the independent effects of micronutrient 
supplementation on immune function may also play a role. In situations where 
micronutrient deficiencies are prevalent and supplementation is contemplated however, 
the same confounding interactions will be present, and will determine the overall effect 
of supplementation on immune function. 
Neopterin is produced by macrophages activated by IFN-y. Hence, circulating 
plasma neopterin concentrations can be used as an indicator for in-vivo macrophage 
activity (25). Interestingly, neopterin concentrations were highest in iron supplemented 
and lowest in zinc supplemented infants, consistent with the effects of supplementation 
on the ex-vivo cytokine production. The high neopterin concentrations in the iron 
supplemented infants indicates higher activity of the cell-mediated immune system, 
also resulting in higher IFN-y production after stimulation. However, higher neopterin 
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concentrations will also be found during infection. After controlling for infection, 
neopterin concentrations were still positively related to iron supplementation, and 
negatively to zinc supplementation. 
Furthermore, plasma neopterin concentrations were related to plasma 
concentrations of ferritin, zinc and retinol, and these relationships were further 
confirmed by the marked effect of micronutrient deficiencies on plasma neopterin 
concentrations. Infants with iron deficiency had lower plasma neopterin concen-
trations, whereas infants with either zinc deficiency or vitamin A deficiency had higher 
plasma neopterin concentrations. This may reflect higher cell-mediated activity fitting 
with a type-1 dominance in vitamin A deficiency as described in animal models (26). 
Only few studies have investigated neopterin in relation to micronutrients, but a 
study in South African children did not find an effect of vitamin A status on urinary 
neopterin concentrations (27). A study in HIV infected adults reported higher serum 
neopterin concentration in zinc deficiency, similar to the findings in the present study 
(28). As neopterin production is induced by IFN-y, these results also support the effects 
of zinc deficiency on ex-vivo IFN-y production as reported here (29). 
The results of this study show that micronutrient supplementation alters 
cytokine response and immune reactivity. Iron supplementation enhanced, whilst iron 
deficiency depressed the type-1 immune response. Zinc and (3-carotene 
supplementation had opposite immunomodulatory effects to iron supplementation. 
However, coexisting deficiencies of other micronutrients can counteract potential 
benificial effects of supplementation. Supplementation with more than one 
micronutrient can be expected to be more effective in improving immunocompetence 
because this strategy will address not only concurrent micronutrient deficiencies, but 
may also prevent unbalanced immunomodulatory effects of single micronutrients on 
host defense. 
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Marginalia 
Indonesian Puppets. 
The Indonesian tradition of Wayang puppets is ancient, with references dating as far 
back as the 9th century AD. Wayang is found on Java and Bali, and probably derives 
from Indian influences. Wayang performances are always based on the mythical 
stories from the epic poems Mahabharata and Ramayana. Although the epics have 
Sanskrit origins they have evolved considerably and are uniquely Indonesian. There 
are essentially three kinds of Wayang. The shadow theater using elaborately cut-out 
figures of leather is called Wayang Kulit. Wayang Golek features three-dimensional 
wooden puppets, exquisitely carved and painted. The least common is Wayang Wong, 
featuring human dancers. A Wayang performance usually lasts all night, and is 
accompanied by traditional gamalan music. Although based on the classical epics, 
personal interpretation, commentary on current affairs and politics, and other themes 
are all incorporated. For instance in the seventies family planning was propagated 
through Wayang Kulit performances in the villages. Wayang is a true folk art, and has 
contemporary value as such. The puppeteer, called dayang, is central to Wayang Kulit 
and Golek performances, as he composes the story, performs it, chooses the 
accompanying music, and improvises to keep his audience captivated. He also has a 
deep knowledge of mythology and Javanese philosophy, and plays an important role in 
traditional Javanese society as mediator, healer, and adviser. The most intriguing and 
also most popular Wayang figure is Semar. Superficially a clown, a clumsy servant to 
the heroes, he is fat, round, and ageless, with a facial expression that is in between 
laughing and crying. On closer observation however, his comments are wise and 
cryptic, his role is more of a father than of a servant, and he has an odd impartiality 
that shakes the very distinction between good and evil. He simultaneously represents 
the ordinary clumsy human among the mythical heroes of the story, and is a divine and 
moral presence, commenting on and intervening in the play. Perhaps the ambiguous 
role of the fool in a Shakespeare play, being simultaneously the lowest character in the 
story, and the aloof commentator not only on the happenings in the play, but also on 
the human condition in general, most closely approaches the character of Semar. 
Fisher J. The Folk Art of Java. The Oxford University Press, Kuala Lumpur 1994. 
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Effects of the Acute Phase Response on Indicators of 
Micronutrient Status. 
Frank T. Wieringa, Marjoleine A. Dijkhuizen, Clive E. West, Christine A. 
Northrop-Clewes, Muhilal. 
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ABSTRACT 
Background. The plasma concentrations of many micronutrient status 
indicators change during infection because of the acute phase response, leading to 
unreliable measurement of micronutrient status and deficiency. 
Objective. In this study, the sensitivity of several micronutrient status 
indicators to the acute phase response was investigated. Three acute phase proteins, C-
reactive protein (CRP), ai-antichymotrypsin (ACT), and oq-acid glycoprotein (AGP) 
were used to quantify the acute phase response and related to plasma concentrations of 
micronutrient status indicators. 
Design. The end-point blood samples of all 418 infants who completed a 6 mo 
randomized, double-blind, placebo-controlled, supplementation trial with iron, zinc 
and/or P~carotene were used to analyze relationships between acute phase proteins and 
micronutrient status indicators in a cross-sectional observational way. 
Results. The acute phase response significantly affected indicators of iron, 
vitamin A and zinc status. Plasma ferritin concentrations were higher, whereas plasma 
concentrations of retinol and zinc were lower. Hemoglobin concentrations and the 
MRDR were less affected. Consequently, iron deficiency anemia was underestimated 
(4.5%), and vitamin A deficiency (4.6%) and zinc deficiency (1.9%) were 
overestimated in the whole population as compared to infants with no infection. 
Plasma retinol concentrations were most closely related to plasma concentrations of 
ACT, whereas plasma concentrations of ferritin and zinc were most closely related to 
plasma AGP concentrations. 
Conclusions. Using micronutrient status indicators without taking the effects of 
the acute phase response into account will result in a distorted measurement of the 
micronutrient status, with the extent of the distortion depending on the prevalence of 
infection in the population. 
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INTRODUCTION 
Micronutrient status defines the amount of a micronutrient available for 
metabolic functions, with body stores being the most important determinant of 
micronutrient supply for most micronutrients. Plasma concentrations of micronutrients 
are often measured as surrogates for total body stores and thus micronutrient status, 
assuming that the distribution between the different compartments is constant. 
However during the acute phase response, plasma concentrations of many 
micronutrients change (1). It is unclear as yet whether these changes solely reflect a 
redistribution or also changed body stores. Moreover, during infection, micronutrient 
losses and requirements are higher so eventually body stores will also be affected by 
the infection. Regardless of the underlying mechanisms, many commonly used 
indicators of micronutrient status are affected by the acute phase response, and may not 
adequately reflect micronutrient status during infection. 
The extent to which indicators of micronutrient status are affected by the acute 
phase response depends not only on the specific indicator, but also on the severity of 
infection, the time phase of the acute phase response, and the nutritional status of the 
individual (2). Much effort has been put into finding micronutrient status indicators 
that are not affected by the acute phase response, but with limited success. Another 
approach however, is to measure the acute phase response and quantify the effects on 
different micronutrient status indicators, so as to be able to take changes into account. 
Several studies have looked at vitamin A status in both clinically ill subjects and in 
apparently healthy subjects in relation to the acute phase response. Plasma retinol 
concentrations were found to decrease during illness and rise again during recovery, 
and in healthy children were related to acute phase proteins (3-6). However, the overall 
effects of the acute phase response on indicators of vitamin A status or other 
micronutrients are not yet well established enough to be able to predict changes, 
especially at the population level. 
The acute phase response is a generalized reaction of the body to inflammation 
(7). The proteins most directly involved are referred to as acute phase proteins, but 
reaction time and magnitude of change after the onset of inflammation, and also their 
sensitivity to stimuli can differ. C-reactive protein (CRP) is very sensitive, especially 
to bacterial infections. Plasma concentrations increase within 10 hr of the onset of 
acute inflammation, and normalize rapidly, usually in a week. oci-Antichymotrypsin 
(ACT) is also rises early, but remains elevated for longer than CRP. oci-Acid 
glycoprotein (AGP) starts to rise more than 24 hr after the onset of inflammation, but 
remains elevated well into convalescence, thus can be detected for weeks after the 
infection, and is also elevated in low grade chronic inflammation (7,8). 
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In this study the sensitivity of several frequently used indicators of 
micronutrient status to the acute phase response, and the magnitude of changes through 
the consecutive stages of infection was investigated. The acute phase response was 
quantified using the concentrations of three different acute phase proteins. For each 
indicator of micronutrient status studied, the relationship with each acute phase protein 
was investigated and the most informative acute phase protein for each indicator of 
micronutrient status was identified. 
SUBJECTS AND METHODS 
Study design and location. 
Infants were recruited at 4 mo of age for a randomized, double-blind, placebo-
controlled supplementation trial with iron (10 mg/day), zinc (10 mg/day), P-carotene 
(2.4 mg/day), iron plus zinc (10 mg each/day), zinc plus p-carotene (10 mg and 2.4 mg 
respectively/day) or placebo. Eligible infants were identified by the village health 
volunteers, and the mothers invited to participate in the study. Mothers were informed 
of the procedures and purpose of the study, and written informed consent was given by 
the mother or warden. The study was carried out in a rural area of Bogor District, West 
Java, Indonesia between October 1997 and March 1999. After 6 mo of 
supplementation, a blood sample was taken from the infants to assess micronutrient 
status and acute phase proteins. A blood sample was only collected from infants who 
were deemed healthy after clinical examination. All infants with a hemoglobin 
concentration of <110 g/L were given iron supplementation treatment upon completion 
of the trial. In this study only the relationship between acute phase proteins and 
indicators of micronutrient status is investigated. The effects of supplementation are 
reported elsewhere. 
A non-fasting 5 mL venous blood sample was taken from the infants. A closed-
tube heparinized vacuum system was used to avoid zinc contamination (Becton and 
Dickinson. Leiden, The Netherlands). Blood samples were immediately stored at 4°C 
to prevent microhemolysis and separated within 5 h. Plasma samples were aliquoted 
and stored at -30 °C until analysis. 
Five hours prior to the blood sampling, the infants received a small dose of 3,4-
didehydroretinol in oil (1.5 mg in 700 ul) for the modified relative dose response 
(MRDR) test. The MRDR test uses the ratio of 3,4-didehydroretinol to retinol as an 
indicator of retinol liver stores (9). When retinol liver stores are low, more 3,4-
didehydroretinol appears in plasma relative to retinol concentrations. A ratio of > 0.06 
is considered indicative of insufficient retinol liver stores (9). 
Hemoglobin concentration was measured by the standard cyanoblue method 
(Humalyzer, Germany). Plasma zinc concentrations were analysed with flame atomic 
absorption spectrophotometry (Varian, Clayton South, Australia) using trace-element 
free procedures, as described in an earlier paper (10). The CV (10% duplo analysis and 
pooled control samples) for zinc analyses was <5%. Plasma retinol and 3,4-
didehydroxyretinol concentrations were measured by HPLC (Millipore Waters, 
Harrow, Middlesex, UK). 3,4-Didehydroxyretinol was measured in the same run as 
plasma retinol (11). The CV (10% duplo analysis and pooled control samples) for the 
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retinol analysis was <10%. Ferritin was measured using a commercial ELISA-kit (IBL-
Hamburg, Germany) according to the guidelines of the manufacturer. C-reactive 
protein (CRP), ai-antichymotrypsin (ACT) and cci-acid glycoprotein (AGP) were 
measured using immunoturbidimetric techniques (Dako, Ely, UK) using a Cobas Fara 
analyzer (Roche Products, Welwyn, UK). The CV for the ferritin, CRP, ACT and AGP 
assays was <10%. 
Ethical approval. 
The protocol was approved by the Ethical Committees of the National Health 
Research and Development Institute of Indonesia and of the Royal Netherlands 
Academy of Arts and Sciences. 
Statistical analysis. 
Data was checked for normal distribution using the Kolmogorov-Smirnov test 
of normality. Plasma concentrations of CRP, ACT, AGP, ferritin and zinc were 
transformed to logarithms before statistical analysis. Correlations between the plasma 
concentrations of the acute phase proteins were analyzed using Pearson's correlation, 
and differences in prevalence were tested with Pearson's chi-square test. 
Differences in indicators of micronutrient status between groups of consecutive 
stages of infection were analysed using analysis of variance (ANOVA). When the 
overall F test was significant, differences between the groups were further explored 
with post-hoc multiple comparisons. 
The effect of each acute phase protein on each indicator of micronutrient status 
was further investigated with a multiple linear regression (MLR) model, with the three 
supplemented micronutrients included as independent factors to correct for possible 
effects of the supplementation on the relationship between micronutrient status and the 
acute phase response. The acute phase proteins were analyzed in separate models 
because of the strong interrelations between them. Sex and age were initially included 
as possible confounders, but only sex was included in the final analysis of ferritin as in 
all other cases they did not contribute to the model. 
Statistical analysis was carried out with SPSS 7.5.2 (SPSS Inc, Chicago, IL) 
software package. 
RESULTS 
Biochemical data on iron and zinc status was available of 418 infants. Acute 
phase proteins were measured in all 418 infants. Plasma retinol concentrations were 
measured in 256 of these infants, with a complete MRDR test available for 238 infants. 
The infants had participated in a supplementation trial in the 6 mo prior to the 
collection of the blood sample. Of the infants, 90 had received iron supplements, 94 
had received zinc supplements, 38 had received (3-carotene supplements, 74 had 
received iron plus zinc supplements, 39 had received zinc plus (i-carotene supplements, 
and 83 infants had received a placebo supplement. The infants had a mean age (+ SD) 
of 10.1 (+ 0.6) mo at the time of blood sampling. 
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The effects of the acute phase response on indicators of micronutrient status 
were further investigated using multiple linear regression (Table 5). The relationship 
of each acute phase protein with each indicator of micronutrient status was analyzed. 
The supplemented micronutrients the infants received prior to the blood sampling were 
included in the model as independent factors, to correct for possible effects of 
supplementation on the relationship between micronutrient status and the acute phase 
response. Sex was included in the analysis of plasma ferritin concentrations as 
confounder. 
Plasma ferritin concentrations were significantly positively related to all three 
acute phase proteins, but most strongly to plasma concentrations of AGP (R= 0.27 for 
CRP; R=0.32 for ACT; R=0.35 for AGP, /><0.001 for all). Plasma retinol 
concentrations were significantly negatively related to plasma concentrations of CRP 
(R= -0.23, p<0.001), AGP (R=-0.28, F<0.001) and most closely to plasma 
concentrations of ACT (R= -0.32, P<0.001). Plasma zinc concentrations were 
significantly negatively related to plasma CRP concentrations (R= -0.13, P<0.01) and 
plasma AGP concentrations (R= -0.15, P<0.01), but not to plasma ACT 
concentrations. The MRDR and hemoglobin concentrations were related to only a 
single acute phase protein. Hemoglobin concentrations were related to plasma 
concentrations of AGP (R= -0.12, P<0.05), perhaps reflecting a depression of 
erythropoiesis in later stages of infection. The MRDR was related to plasma CRP 
concentrations (R= -0.14, P<0.05), which might be related to the decreased 
mobilisation of retinol during the acute phase response. 
DISCUSSION 
This study shows that the acute phase response distorts the measurement of 
micronutrient status, by affecting the plasma concentration of commonly used 
indicators. These effects can in part be considered transient, and directly related to the 
acute phase response, as the consecutive phases of infection affect the plasma 
concentrations of the indicators differently. However, the effects of the acute phase 
response continue well into the convalescence phase of infection. These findings have 
important consequences for the estimation of micronutrient deficiencies in populations. 
In the present study, the perceived prevalences of vitamin A deficiency and zinc 
deficiency were significantly higher, whereas the perceived prevalence of iron 
deficiency anemia was significantly lower in the presence of an acute phase reaction. 
Some frequently used indicators of micronutrient status, such as plasma 
concentrations of ferritin, retinol and zinc are definitely sensitive to the acute phase 
response. Other indicators such as hemoglobin concentrations and the MRDR are 
much less affected by the acute phase response. As these indicators represent nutrient 
balance over a longer time period, changes in for instance infection state are not 
immediately reflected. At the population level, the effect of the acute phase response 
on sensitive indicators of micronutrient status is significant but small. During infection, 
micronutrient indicators are not related to micronutrient status in the same way as in 
the absence of infection. Hence, including a measure of the acute phase response in the 
determination of micronutrient status will enable either correction for the effects of the 
acute phase response, or exclusion of subjects with an infection. This is especially 
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important when comparing populations, as the overall effect of the acute phase 
response on the measurement of micronutrient status is dependent on the prevalence of 
infection in the population. Infection patterns and prevalence can vary enormously 
between populations and subgroups. Furthermore, several studies have shown that 
clinical examination does not rule out the presence of an acute phase response (6,10). 
Hence, the micronutrient status of populations cannot be confidently compared without 
taking the acute phase response into account. 
The effect of the acute phase response on the plasma concentrations of 
micronutrient status indicators can be the result of two different mechanisms. During 
an infection, the requirements and/or losses of a micronutrient are increased, 
sometimes in combination with impaired absorption, resulting in a real change in body 
stores (13). Alternatively there can be a redistribution of the indicator of micronutrient 
status, without a real change in the total body content of the micronutrient, resulting in 
a distorted measurement of the micronutrient status (14). 
To clarify the relative importance of both mechanisms, the pattern of change in 
plasma concentrations throughout the consecutive phases of the acute phase response 
can be examined. CRP rises within 10 hr of an infection, whereas AGP only after 24 
hr. The most substantial decrease in plasma concentrations of retinol and zinc occurs 
during the acute infection phase, before the AGP concentrations have risen. During the 
convalescence phase the plasma concentrations rise again. Plasma zinc concentrations 
recover almost to the no-infection level, while plasma retinol concentrations rise also, 
but not quite to the no-infection level. The rapid decrease and the subsequent (partial) 
recovery of plasma concentrations during the consecutive phases of the acute phase 
response implies that the first and most substantial effect of the acute phase response is 
the result of redistribution, rather than changes in body stores. The remaining deficit in 
plasma retinol concentrations during the convalescence phase may reflect the real 
change in body stores incurred during the infection. 
The importance of the redistribution effect is further supported when the 
indicators that appear to be less sensitive for the acute phase response are considered. 
Hemoglobin concentrations and anemia prevalence are hardly affected by infection. 
Also, the MRDR does not really change during the consecutive phase of infection 
indicating that retinol liver stores, and thus vitamin A status, is hardly affected, despite 
the substantial changes in plasma retinol concentrations. Changes in plasma ferritin 
concentrations during the acute phase response are different from the changes of 
plasma retinol and zinc concentrations as ferritin itself can be considered an acute 
phase reactant. In view of this double role, plasma ferritin concentrations cannot 
reliably reflect iron status unless the presence of infection is excluded. 
Are low plasma concentrations of micronutrients during infection a sign of 
deficiency, and is there an increased risk of clinical symptoms of deficiency? When the 
low plasma concentrations are caused by a redistribution, they do not necessarily 
reflect lower tissue concentrations (15). For instance, there is evidence of increased 
concentrations of zinc and iron in specific tissues such as the liver and the reticulo-
endothelial system. Also, the lower plasma concentrations during the acute phase 
response will rebound when infection has resolved, at least partially. As to yet, it is 
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unclear whether the lowering of plasma concentrations of micronutrients carries a 
physiological benefit, except for iron where the redistribution has clear advantages. 
However, on the other hand there is evidence that the lower plasma retinol 
concentrations during infection can imperil the retinol supply to the eye, and induce 
acute clinical ocular signs of deficiency (16). Also, in some instances in may well be 
that supplementation during infection can have beneficial effects even when there is no 
deficiency. Such is the case for measles infection and vitamin A supplementation (17). 
Furthermore, this study shows that the effect of the acute phase response varies 
among the different indicators of micronutrient status and with the stage of infection. 
Each acute phase protein rises at a different stage of the acute phase response. To be 
able to quantify the effects of the acute phase response on the different indicators of 
micronutrient status, it is important to know which acute phase protein is the most 
informative for each indicator of micronutrient status. In this study, plasma retinol 
concentrations were most strongly correlated with plasma ACT concentrations, 
whereas plasma zinc and ferritin concentrations were most strongly correlated with 
plasma AGP concentrations. Although plasma CRP concentrations appear to be the 
least correlated of the three acute phase proteins with the indicators of micronutrient 
status, CRP might in practise be more useful than ACT as the cut-off values for CRP 
are more established than for ACT. Also, ACT used with the present cut-off value of 
0.6 g/L identified only a small number of subjects as having an acute phase response, 
and thus might lack sensitivity. The fact that AGP is strongly correlated to indicators of 
micronutrient status shows that the effects of infection on these indicators continue 
well into the convalescence phase, which might be weeks after the initial infection. 
The results of this study show that the acute phase response significantly affects 
the plasma concentrations of commonly used indicators of micronutrient status. 
Prevalences of vitamin A deficiency and zinc deficiency can be overestimated, 
whereas the prevalence of iron deficiency anemia can be underestimated if the effect of 
the acute phase response on the plasma concentration of indicators of micronutrient 
status is not taken into account. The different indicators of micronutrient status are not 
affected in the same way or to the same extent through different stages of infection, 
and thus different acute phase proteins are required to optimally quantify the effect of 
the acute phase response on specific indicators of micronutrient status. Based on the 
results of this study, AGP is the most useful indicator of the acute phase response when 
determining zinc and iron status, whereas ACT is most informative concerning vitamin 
A status. At population level, using micronutrient status indicators without taking the 
effects of the acute phase response into account, will result in a distorted measurement 
of the micronutrient status, with the extent of the distortion depending on the 
prevalence of infection in that population. 
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King of the Sea. 
The coelacanths (Latimera chalumnae) are the only surviving species of a prehistoric 
lineage of fishes, known only from fossil finds until the discovery of a live specimen off 
the coast of South Africa in 1938. The coelacanth is not just a "living fossil", but the 
species is related to the ancestors of the land-living vertebrates, and its unique 
anatomical structures, and physiological and neurological functioning could be 
precursory to the development of terrestrial life. The coelacanth was thought to have 
quietly survived as an isolated population of around 500 fish near the Comoro Islands, 
an evolutionary remnant on its way to extinction. They have gone unnoticed for so long 
because they are deep-sea fish, living in caves at around 180 meters depth. In 1998 
Erdmann et al report the existence of a living population of coelacanths off the 
northeast coast of Sulawesi. In fact it was Mr Erdmann's wife who first saw a 
coelacanth on a fish-market in Manado a year earlier, but could not persuade the 
buyer of the fish to part with it. Interviews revealed that fishermen know the fish and 
even have a specific name for it (Raja Laut: king of the sea). It is amazing that a huge 
fish (coelacanths are up to 1.6 meters in length) can be newly discovered, in an era 
where every square centimeter of the earth has been mapped. Concern is warranted 
however, as population pressure and industrialisation are rapidly destroying the 
environment, also in Indonesia, and the little known, incompletely explored world 
which lies underwater is extremely vulnerable. The ecosystems of reefs and seas are 
complex and easily damaged. In this context it is sad to note that the coelacanth's 
conservation status is "insufficiently known to justify conservation action". Some 
efforts at marine conservation and increasing awareness of the marine environment 
are being made however. The Wallacea project is describing the flora and fauna of the 
marine parks in Indonesia systematically, and the Aseanarean initiative is linking the 
marine ecosystems of the whole South-east Asian region, and the regulations and 
conservation efforts affecting them. However more research, funds, time and effort are 
definitely needed! 
Erdmann MV, Caldwell RL, KasimMoosa M. Indonesian 'King of the Sea' discovered. 
Nature. 1998;395:335. Forey P. A Home from Home for Coelacanths. Nature. 
1998:395:319. 
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Supplementing Indonesian Pregnant Women with (3-
Carotene and Zinc in Addition to Iron and Folic Acid 
Affects Birth Weight and Incidence of Pregnancy 
Complications. 
Frank T. Wieringa, Marjoleine A. Dijkhuizen, Dewi Permeasih, Clive E. 
West, Muhilal. 
Submitted for publication. 
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ABSTRACT 
Background. Micronutrient deficiencies are prevalent in pregnant women, and 
adversely affect pregnancy outcome, including maternal and neonatal complications 
and birth weight. Pregnant women are often supplemented with iron and folic acid, but 
deficiencies of other micronutrients such as zinc and vitamin A are prevalent also. 
Objective. To investigate whether supplementing pregnant women with (i-
carotene and zinc in addition to iron and folic acid can reduce pregnancy complication 
rate and increase birth weight. 
Design. In a randomized double-blind trial, 229 women 10-20 weeks pregnant, 
were supplemented until delivery with iron and folic acid, in combination with zinc 
and/or P-carotene or neither. Maternal and neonatal complications and birth weight 
were monitored as well as micronutrient status during pregnancy 
Results. Supplementation of pregnant women with P-carotene and zinc in 
addition to iron and folic acid increased birth weight in boys. However, women 
supplemented with only zinc added to iron and folic acid had more complications 
during delivery. Micronutrient status indicators during pregnancy were significantly 
affected by progressive hemodilution, but not discernably by supplementation. 
Conclusions. As pregnant women are likely to be at risk of more than one 
micronutrient deficiency, supplementation of more micronutrients than only iron and 
folic acid during pregnancy can not only improve pregnancy outcome, but also 
enhance effectiveness of supplementation and prevent possible antagonistic 
interactions between micronutrients. Only supplementation of pregnant women with 
the combination of P-carotene and zinc but not with either zinc or P-carotene alone, in 
addition to iron and folic acid, improved pregnancy outcome in this study. 
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Pregnant women are very vulnerable with respect to micronutrient deficiencies, 
because of increased requirements and grave consequences of deficiency during 
pregnancy. Micronutrient deficiencies in pregnant women are associated with 
increased maternal mortality, increased incidence of complications during pregnancy 
and labor, lower birth weight, and increased incidence of neonatal complications (1). 
Iron deficiency is the most prevalent micronutrient deficiency, affecting over 35% of 
the women worldwide (2). Supplementation of pregnant women with iron and folic 
acid is standard practice in many countries. However, a number of other micronutrient 
deficiencies are also prevalent, especially in developing countries. 
There are indications that zinc deficiency may be common in pregnant women, 
especially when they are iron deficiency, as the same dietary risk factors are involved. 
Zinc deficiency has been implicated in pregnancy complications, and supplementation 
has been shown to improve birth weight (3,4). An additional reason for concern is that 
iron and folic acid supplementation reduces zinc absorption, and can impair zinc status 
(5-7). Although clear evidence is lacking, zinc is thought to be implicated in vitamin A 
metabolism, and zinc deficient animals have lower plasma retinol concentrations (8). 
Vitamin A is another micronutrient which is commonly deficient in many 
developing countries, and associated with increased morbidity and mortality. 
Furthermore, vitamin A has been shown to have synergistic effects on iron 
metabolism, and supplementation of pregnant women with vitamin A in addition to 
iron reduced the prevalence of anemia more than did iron supplementation alone (9). 
Supplementation with vitamin A and also with p-carotene reduced maternal mortality 
in Nepal, although the underlying mechanisms are not completely clear (10). However, 
vitamin A also has teratogenic effects especially during the first trimester, and only 
low doses of vitamin A (< 10,000 IU per day or <25,000 IU per week) are considered 
safe during pregnancy. P-Carotene is a precursor to retinol, and is considered safe 
during pregnancy (11). 
In Indonesia, maternal mortality is still high, 65 per 10,000 live births (12), 
despite major improvements in health care quality and access. Poor health and 
nutritional status of pregnant women are major risk factors, also leading to a high 
prevalence of low birth weight. Low birth weights are directly associated with high 
neonatal morbidity and mortality, and the detrimental effects continue well into 
infancy. 
The aim of this study was to investigate whether supplementing pregnant 
women with p-carotene and zinc in addition to iron and folic acid can reduce the 
incidence of complications during pregnancy and delivery. In addition, birth weight 
and health of the neonate was also examined. 
137 
Chapter 8 
SUBJECTS AND METHODS 
Study design and location. 
The study was designed as a four cell, randomized, controlled, double-blind 
supplementation trial. The control group received standard supplementation with iron 
and folic acid. Pregnant women were recruited from 13 adjacent villages in a rural area 
in Bogor District, West Java, Indonesia. Women were assigned to one of the four 
groups on basis of individual randomization. All women received iron and folic acid 
(30 mg/day and 0.4 mg/day respectively) supplementation. In addition, one group 
received P-carotene (4.5 mg/day), one group zinc (30 mg/day), and one group p-
carotene+zinc (4.5 mg/day and 30 mg/day respectively). The iron was given as ferrous 
fumerate, the zinc as zinc sulphate and the p-carotene as a granulate preparation. 
Supplements were prepared by the pharmacy of the Gelderse Vallei Hospital 
(Bennekom, The Netherlands), given as capsules, and taken daily until delivery. 
Subjects and procedures. 
Pregnant women with a gestational age of <20 weeks were identified by village 
health volunteers or by local midwifes and invited to participate in the study. Women 
were informed of the procedures and purpose of the study. After written informed 
consent was given, pregnancy duration was estimated using a detailed amenorrhea 
history and physical examination, and an expected date of delivery was calculated. 
Women were anthropometrically assessed, a history concerning socio-economic status, 
previous pregnancies, dietary habits, and health was taken, and a 3 mL blood sample 
was collected. Exclusion before recruitment was on grounds of a gestational age of <10 
or >20 weeks, chronic disease, or previous pregnancies with complications. 
At recruitment, every subject received a personal bottle, labeled with the 
subject's name, subject number, and date, containing 40 capsules. Bottles were 
replaced every month with a new bottle containing 40 capsules,. The number of 
capsules remaining each month were counted to estimate the number of capsules taken 
by the subject as a measure of compliance. 
At the monthly follow-up during pregnancy, the women were 
anthropometrically assessed, and a short history concerning health and diet was taken. 
Minor complaints were addressed. When women had a gestational age of 
approximately 8 mo, a 3 mL blood sample was collected for biochemical assessment of 
micronutrient status, and women were screened for hypertension, albuminurea and 
anemia. Minor complaints were addressed, women with severe anemia (hemoglobin 
<80 g/L) were advised to deliver in the local health center, and major complaints or 
symptoms were referred to appropriate medical care. All women received a card to 
record the details of delivery, the newborn and the birth weight. The cards used 
pictograms to score delivery complications and neonatal condition. Cards had to be 
filled in and signed by the birth attendant, midwife, or local health volunteer, 
preferably on the day of delivery, but not later than 3 days after birth. To facilitate 
accurate weighing of the newborn, verified scales were supplied, and the health 
volunteers and midwifes were trained. 
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Methods. 
Anthropometry included measurement of weight, height and mid-upper-arm 
circumference by trained anthropometrists using standard methods. Non-fasting, 
morning blood samples were collected using a closed-tube heparanized vacuum system 
to avoid zinc contamination (Becton and Dickinson. Leiden, The Netherlands). Blood 
samples were immediately stored at 4°C to prevent microhemolysis and separated 
within 5 h. Plasma samples were aliquoted and stored at -30°C until analysis. 
Hemoglobin concentrations were measured by the standard cyanoblue method 
(Humalyzer, Germany). Plasma zinc concentrations were analysed with flame atomic 
absorption spectrophotometry (Varian, Clayton South, Vic, Australia) using trace-
element free procedures, as described in an earlier paper (13). The CV (10% duplo 
analysis and pooled control samples) for zinc analyses was <5%. Plasma retinol and (3-
carotene concentrations were measured by HPLC, in two separate runs as described by 
Ehrhardt et al.(14). The CV for retinol and carotenoid analyses (10% duplo analysis 
and pooled control samples) was <5%. Ferritin was measured using a commercial 
ELISA-kit (IBL-Hamburg, Germany) according to the guidelines of the manufacturer. 
C-reactive protein (CRP) and ccl-acid glycoprotein (AGP) were measured using 
immunoturbidimetric techniques at the Northern Ireland Centre for Diet and Health, 
University of Ulster, Northern Ireland (Cobas Fara analyzer, Roche Products, Welwyn, 
UK). The CV for the ferritin, CRP and AGP assays was <10%. 
Ethical approval. 
The protocol was approved by the ethical committees of the National Health 
Research and Development Institute of Indonesia and the Royal Netherlands Academy 
of Arts and Sciences. 
Statistical analysis. 
Data was checked for normal distribution using the Kolmogorov-Smirnov test 
of normality. Differences in prevalence were tested with Pearson's chi-square test, or 
when numbers were small (e.g. delivery complications) with Fischer's exact test. 
Differences among groups were tested with analysis of variance (ANOVA), or Kruskal 
Wallis for non-parametric data. Differences in biochemical indicators among 
supplementation groups were analysed using ANOVA, and differences in birth weight 
with analysis of covariance (ANCOVA), with sex as covariate. Plasma concentrations 
of ferritin and (3-carotene were transformed to logarithms before statistical analysis. 
Differences between recruitment and 8 mo of pregnancy were tested per group using 
paired T-test, or Wilcoxon rank test for non-parametric data. Differences among the 
supplementation groups in changes in biochemical indicators between recruitment and 
8 mo of pregnancy were analysed with repeated measurements multivariate ANOVA 
statistics. When the overall F-test was significant, differences among the groups were 
further investigated with post-hoc multiple comparisons for ANOVA. Statistical 
analysis was carried out with SPSS 7.5.2 (SPSS Inc, Chicago, IL) software package. 
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RESULTS 
Between July 1998 and January 1999, 229 pregnant women with a gestational 
age between 10 and 20 weeks were recruited from 13 adjacent villages in Bogor 
District, Indonesia. A blood sample was collected at recruitment (all women) and of 
164 women at approximately 8 mo of pregnancy (Figure 1). Information on delivery 
and birth outcome was obtained from 179 pregnancies. Twenty-two of these women 
missed the 8 mo blood sample collection. Forty-three women dropped out before, and 
7 women after, the collection of the 8 mo blood sample for various reasons (Figure 1). 
Spontaneous abortions (n= 7) occurred in all supplementation groups. 
229 pregnant women recruited 
(pregnancy duration between 10 - 20 weeks) 
1 ' i 
57 women: 
Iron+folic acid 
3 moved 
10 withdrew 
2 spont abort. 
i 
34 blood samples 
at 8 mo gestation 
0 moved 
0 withdrew 
« -
i 
r 
r 
' 
56 women: 
Iron+folic acid and 
P-carotene+zinc 
1 moved 
6 withdrew 
1 spont. abort. 
i 
43 blood samples 
at 8 mo gestation 
0 moved 
4 withdrew 
i 
r 
v 
58 women: 
Iron+folic acid and 
P-carotene 
4 moved 
6 withdrew 
1 spont. abort. 
^ 
42 blood samples 
at 8 mo gestation 
1 moved 
1 withdrew 
1 
r 
i' 
58 women: 
Iron+folic acid and 
zinc 
3 moved 
3 withdrew 
3 spont. abort. 
• 
45 blood samples 
at 8 mo gestation 
1 moved 
0 withdrew 
ir 
42 deliveries 44 deliveries J45 deliveries I 48 deliveries 
Figure 1. Trial Profile 
The age of the pregnant women at recruitment ranged from 15 to 40 y, with a 
median parity of 2 (Table 1). Thirty-two percent of the women were primigravida. As 
the women were already pregnant when height and weight were measured at 
recruitment, the midupper arm circumference is preferred as indicator for 
anthroprometrical status. Mean values were just above the cut-off for undernutrition 
(<23.3 cm) as used in Indonesia. Hemoglobin concentrations did not differ among the 
groups at recruitment, and mean values were below the cut-off for anemia (< 120 g/L). 
However, hemodilution already starts early in pregnancy so hemoglobin concentrations 
at recruitment may already have been subject to dilution effects, making interpretation 
more difficult. 
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TABLE 1 
General characteristics of the pregnant women at recruitment. 
Supplementation groups 
Control p-Carotene (J-Carotene Zinc 
n 
Age (yr)2 
range 
Parity2 
range 
Primigravida (%) 
MUAC (cm)2 
Hemoglobin (g/L) 
57 
23.8 (±5.6) 
15-40 
2 (1-3) 
1-7 
40 
23.6 (+2.1) 
117 (±15) 
56 
25.5 (±5.2) 
16-40 
2 (1-4) 
1-8 
36 
24.1 (±2.3) 
115 (±12) 
58 
26.2 (±6.2) 
15-40 
2 (1-4) 
1-12 
28 
24.2 (±2.3) 
117 (±12) 
58 
24.9 (±5.3) 
17-37 
2 (1-4) 
1-11 
32 
24.2 (±2.3) 
115 (±10) 
No differences between the groups for any of the baseline characteristics. 
1
 Mean (± SD) or median (IQR) 
When the women were approximately 8 mo pregnant, after 4 mo or more of 
supplementation, micronutrient status was assessed (Table 2). As a result of 
progressive hemodilution and other physiological changes during pregnancy, 
concentrations of hemoglobin, plasma retinol and plasma zinc decreased significantly 
between recruitment and 8 mo of pregnancy in all groups (P <0.01, paired T-test). 
Plasma concentrations of ferritin decreased in all groups, but to a lesser extent in the (}-
carotene+zinc group (P =0.055 for the p-carotene+zinc group, P <0.01 all other 
groups, paired T-test). At 8 mo of pregnancy, there was no difference among the 
groups in the plasma concentrations of retinol, ferritin, zinc and the hemoglobin 
concentration (ANOVA). However, at 8 mo of pregnancy plasma concentrations of P-
carotene were higher in the women receiving either P-carotene or P-carotene and zinc 
(P <0.05, ANOVA). The decrease in plasma p-carotene concentrations between 
recruitment and 8 mo of pregnancy was only significant in the zinc group (P <0.01, 
Wilcoxon signed rank test). 
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TABLE 2 
Indicators of the micronutrient status of the pregnant women at recruitment and at 8 mo of pregnancy. 
n 
Concentrations' 
Hemoglobin (g/L) 
Recruitment 
8 months pregnant 
Plasma ferritin (Hg/L)1 
Recruitment 
8 months pregnant 
Plasma retinol (nmol/L) 
Recruitment 
8 months pregnant 
Supplementation 
Control 
34 
118 (±14) 
109 (+ 12)2 
24 (8.7-39.6) 
14 (7.8-22.8)3 
1.1 (±0.26) 
0.8 (± 0.29)2 
Plasma p-carotene (ixmol/L)1 
Recruitment 
8 months pregnant 
Plasma zinc (iimol/L) 
Recruitment 
8 months pregnant 
0.2 (0.13-0.30) 
0.2 (0.10-0.23) 
11 (± 3.5) 
9.1 (+3.0)2 
groups 
p-Carotene 
+zinc 
43 
116 (±12) 
109 (±11)2 
21 (10.1-43.2) 
16 (8.8-25.3)4 
1 (±0.27) 
0.8 (+0.31)2 
0.3 (0.15-0.38) 
0.2 (0.14-0.32)5 
11 (±4.3) 
9.2(+4.1)2 
P-Carotene 
42 
118 (±12) 
107 (+ 12)2 
25.0 (16.4-39.6) 
16.2 (8.5-24.4)3 
1 (± 0.20) 
0.8 (+0.31)2 
0.21 (0.15-0.29) 
0.22 (0.14-0.34)5 
12 (±3.9) 
8.2 (± 3.1)2 
Zinc 
45 
114 (±11) 
106 (± 14)2 
28 (14.2-46.7) 
14 (7.0-22.3)3 
1 (±0.25) 
0.9 (± 0.24)2 
0.3 (0.16-0.34) 
0.2 (0.08-0.29)3 
12 (±4.1) 
9.1 (±2.9)2 
Mean (± SD) or median (IQR); Ferritin and p-carotene concentrations were transformed to logarithm 
before statistical analysis when necessary. 
Significant decrease from recruitment (P<0.01, Paired T test). 
Significant decrease from recruitment (P<0.01, Wilcoxon rank test). 
Decrease from recruitment (P=0.055, Wilcoxon rank test). 
Significantly higher than plasma P-carotene concentration at 8 mo in the zinc group (P<0.05, ANOVA) 
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TABLE 3 
Pregnancy outcome and delivery complications per supplementation group. 
Supplementation groups 
Control p-Carotene fi-Carotene Zinc 
n (deliveries) 
Sex ratio (M:F) 
Delivery statistics 
Primigravida (n) 
Preterm (n)1 
Stillborn / neonatal death (n) 
Deliveries with complications 
Prolonged labor 
Retention of placenta 
Postpartum hemorrhage 
Meconium in amniotic fluid 
Breech presentation 
Cesarean section 
Puerperal fever 
Deliveries with neonatal complications 
Preterm delivery 
Twins 
Blue / floppy (neonatal hypoxia) 
Neonatal jaundice 
Fever / not drinking 
Umbilical infection 
Congenital abnormalities 
Stillborn / neonatal death 
42 
27:16 
14 
4 
0 
3 
1 
0 
2 
0 
0 
0 
0 
6 
4 
1 
1 
1 
1 
0 
1 
0 
44 
29:16 
15 
2 
1 
4 
1 
2 
2 
0 
1 
0 
0 
6 
2 
1 
0 
2 
1 
1 
0 
1 
45 
23:23 
9 
2 
1 
5 
1 
1 
3 
1 
1 
1 
0 
6 
2 
1 
0 
2 
1 
0 
1 
1 
48 
27:21 
12 
3 
4 
12 2 
4 3 
5 3 
1 
2 
3 
1 
1 
12 
3 
0 
6 4 
1 
0 
1 
2 
4 
Definitions of complications. Preterm delivery: hosptial diagnosis or birth weight 
< 2.5 kg with pregnancy duration < 37 weeks. Prolonged labor: >12 h. Retention of 
placenta: >30 min. Postpartum hemorrhage: blood loss >1 L. 
P< 0.05 (chi-square). P< 0.05 (Fisher's exact test). 
1
 P< 0.05 (Fisher's exact test, prolonged labor and retention of placenta were combined). 
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In total, information on 179 deliveries was available (Table 3). Eleven women 
delivered preterm (defined as a hospital diagnosis of preterm delivery or a delivery 
before 37 weeks of estimated gestational age combined with a birth weight below 2.5 
kg). All women (3) with twin pregnancies delivered preterm. Six pregnancies ended in 
stillbirth or neonatal death. One full term infant was stillborn, with no certain cause 
diagnosed. One preterm neonate died within one day of birth. Three neonates had 
congenital abnormalities incompatible with life, and one normal, term neonate died 
within 7 days of birth with suspected umbilical infection. One full term infant was born 
with a pes equinus of the left foot, but was otherwise healthy. Birth weight, and 
complications of the delivery and the neonate were recorded preferably on the day of 
birth, but always within 3 days, by the birth attendant, midwife, or health volunteer. 
Deliveries with complications were significantly more frequent in the zinc group 
compared to all other groups (P <0.05, chi-square). The frequency of most specific 
complications was not high enough to allow meaningful statistical testing, except for 
the combination of prolonged labour and/or retentio placenta, both indicative of uterine 
contractile dysfunction, which was significantly higher in the zinc group as compared 
to all other groups (P <0.05, Fischer exact test). Although the overall frequency of 
neonatal complications was not significantly different among the groups, there is a 
disturbingly higher frequency of neonatal complications in the zinc group. Dividing the 
complications into specific categories shows that there were significantly more 
neonates with signs of hypoxia in the zinc supplementation group as compared to the 
P-carotene or P-carotene+zinc groups (P <0.05, Fischer exact test). 
TABLE 4 
Birth weights per supplementation group. 
Normal, term delivery (n)1 
Sex ratio (M:F) 
Birth weight (kg) 
Birth weight boys (kg) 
Birth weight girls (kg) 
boys <3.0 kg 
boys <2.5 kg 
girls <3.0 kg 
girls <2.5 kg 
Supplementation 
Control 
38 
26:12 
3.2 (±0.4) 
3.2 (± 0.4) 
3.1 (±0.5) 
10 
2 
6 
2 
groups 
P-Carotene 
+zinc 
42 
27:15 
3.3 (±0.5) 
3.4 (+0.3)2 
3.0 (±0.6) 
4 3 
0 
9 
3 
p-Carotene 
42 
22:20 
3.1 (±0.4) 
3.1 (+0.4) 
3.1 (±0.5) 
13 
3 
11 
2 
Zinc 
42 
23:19 
3.1 (±0.5) 
3.0 (±0.6) 
3.1 (±0.4) 
12 
4 
9 
3 
Excluding twins, preterm, stillborn and fatal congenital abnormalities. 
' Different from the p-carotene and the zinc group, P< 0.05 (ANOVA) 
' Different from all other groups, P< 0.01 (chi-square) 
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Prior to comparing birth weight among the groups, all twins, preterm infants, 
stillbirth and fatal congenital abnormalities were excluded from these analysis as these 
conditions can affect birth weight. Although there was no significant difference in 
mean birth weights among the groups, the birth weights of the boy infants was 
significantly different among the groups (F <0.05, ANOVA), with the P-carotene+zinc 
group being significantly higher (P <0.05) than the zinc group and almost significantly 
higher (P= 0.054) than the P-carotene group (Table 4). This is also apparent in the 
frequency distributions of the birth weights of the boy infants (Figure 2). Furthermore, 
there were significantly less boys with a birth weight of 3.0 kg or less in the P-
carotene+zinc group as compared to all other groups (P <0.01, chi-square). Birth 
weight of girl infants was lower, but not significantly so, than that of boys, and did not 
differ among the groups (Figure 3). 
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Figure 2. Birth weight frequency distribution curves (smoothed) of boy infants 
born of mothers supplemented during pregnancy with different micronutrients 
added to iron and folic acid supplementation. Control group received only iron 
and folic acid 
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Figure 3. Birth weight frequency distribution curves (smoothed) of girl infants 
born of mothers supplemented during pregnancy with different micronutrients 
added to iron and folic acid supplementation. Control group received only iron 
and folic acid. 
DISCUSSION 
In this study, supplementation of pregnant women with not only iron and folic 
acid, but also p-carotene and zinc, increased birth weight, but only of boys. However, 
supplementation of pregnant women with the addition of only zinc to iron and folic 
acid increased the incidence of complications during delivery. There was no clear 
difference in micronutrient status indicators at 8 mo of pregnancy among the different 
supplementation groups although the decrease in plasma ferritin concentrations was 
lowest in the women receiving P-carotene and zinc combined, and P-carotene 
supplementation increased plasma concentrations of p-carotene concentrations but not 
of retinol. The progressive hemodilution during pregnancy complicates the 
interpretation of plasma concentrations of micronutrient status indicators however, and 
may have obscured effects of supplementation on biochemical indicators. 
Micronutrient deficiencies are likely to occur concurrently, as dietary risk 
factors for deficiency are the same for many micronutrients. Earlier, we have shown 
that iron, vitamin A and zinc deficiency are prevalent in lactating mothers and infants 
in this area, and that vitamin A deficient mothers and infants have an increased risk of 
also being deficient for iron and/or zinc (13). In this perspective, the addition of only 
zinc or only P-carotene to the standard iron and folic acid supplementation might not 
address all the needs of pregnant women. This is supported by the finding in the 
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present study that only the combination of P-carotene and zinc but not of the single 
addition of either zinc or |3-carotene had beneficial effects on birth weight. 
Why this effect is only apparent in boys is not clear. However other studies 
have also reported that zinc supplementation improves growth more in boys than in 
girls (15, 16), and some animal studies have shown a greater sensitivity of males to 
zinc deficiency than females (17). These findings may be related to the higher growth 
rate of males, or to differences in body composition between males and females. 
Besides direct effects of the supplemented micronutrients, interactions between 
micronutrients may also play an important role. Alleviation of one micronutrient 
deficiency might concomitantly increase the requirements for other micronutrients. In 
the present study, women receiving only zinc had the largest decrease during 
pregnancy in plasma P-carotene concentrations, pointing perhaps to an active role of 
zinc in vitamin A metabolism, and a greater utilisation of p-carotene with better zinc 
status (8, 18). The decrease in plasma ferritin concentrations was the least in the 
women receiving (3-carotene and zinc, possibly reflecting the interactions between 
vitamin A, iron and zinc metabolism (19). Although the exact mechanisms are not 
known yet, the findings of the present study clearly indicate that multimicronutrient 
supplementation not only has additive but also synergistic effects. 
The higher delivery complication rate, and the possibly increased incidence of 
neonatal complications in the zinc group, may be due to inadvertent interactions 
between micronutrients. Supplementation with zinc can impair iron absorption, and 
may compromise iron status (7). In this respect, it is important to note that hemoglobin 
and plasma ferritin concentrations at 8 mo of pregancy were lowest in the zinc group, 
and plasma ferritin concentrations during pregnancy decreased most in this group, 
although the differences failed to reach statistical significance. Although the exact 
mechanisms underlying the higher complication rates in the women who were 
supplemented with zinc cannot be elucidated here, and other factors may also play a 
role, the findings of this study certainly warrant concern. 
The nutritional status of pregnant women is a major factor determining 
pregnancy outcome, including birth weight, pregnancy complications, and health and 
nutritional status of the newborn. Supplementation of iron and folic acid during 
pregnancy is standard practice in many countries. However, in developing countries 
deficiencies of other micronutrients are also prevalent. Supplementation of a wider 
range of micronutrients than only iron and folic acid during pregnancy not only ensures 
an adequate supply of lacking or scarce micronutrients, but also facilitates optimal 
utilization of supplemented micronutrients. By supplementing pregnant women with a 
balanced and complete array of micronutrients, effectiveness of supplementation can 
be enhanced by synergistic interactions, whereas possible antagonistic or inhibitory 
interactions can be compensated for. This study shows that the addition of p-carotene 
and zinc combined can augment the standard iron and folic acid supplementation of 
pregnant women, and improve pregnancy outcome. 
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Zinc in Plants. 
Metals can have profound effects on plants. Lack of zinc in the soil for example, will 
greatly reduce plant growth. Zinc deficiency is the most widely occurring 
micronutrient disorder affecting crops. Moreover, high level of phosphate fertilisers 
used with modern high yielding cereal varieties can exacerbate or induce zinc 
deficiency in crops. High levels of soil zinc also inhibit plant growth however, although 
certain plants grow only on soils very rich in certain metals. Indeed, in early times, the 
aspect of vegetation was an important tool in the search for metal ore. In 1809, 
Lejeune proposed that a subtype of pansy found only on zinc-rich meadows be named 
Viola zinci. In 1911, Heimans observed that this pansy occurred in The Netherlands 
only near the river Geul, and only where silt is deposited during winter. He also noted 
that this was probably due to the high concentration of zinc in the silt originating from 
the zinc mines upstream in Belgium. ("Het heet, dat de Geul van boven uit Belgie 
inderdaad zink in zijn water meevoert; dat blijft bij overstromingen op de oevers 
achter. Ge vindt in Nederland geen enkel geel zink-viooltje, dat niet aan de Geul 
staat"). Plants that grow on soils rich in heavy metals have been named "heavy-metal 
tolerating plants ". As these plants also grow on normal soil but significantly less well 
than non-tolerant plants, it is likely that the greater competition on normal soils 
inhibits their wider distribution. 
Imtiaz M, Alloway BJ. Zinc deficiency in cereals. Congress on Zinc and Human 
Health, Stockholm, June 2000. abstract. Heimans E. Uit ons Krijtland. W. Versluys, 
Amsterdam, 1911. Kakes P. Genecological investigations on zinc plants. Ph.D. thesis 
University of Amsterdam, 1980. 
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(3-Carotene Supplementation Only Improves Vitamin 
A Status when Given in Combination with Zinc. 
Marjoleine A. Dijkhuizen, Frank T. Wieringa, Clive E. West, Muhilal. 
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ABSTRACT 
Background. Deficiencies of vitamin A, iron and zinc are prevalent in 
pregnant and lactating women and their infants in developing countries. Combined 
supplementation of several micronutrients during pregnancy could benefit both mother 
and infant. The effectiveness of adding P-carotene and zinc to the standard iron and 
folic acid supplementation during pregnancy in improving vitamin A status of mothers 
and infants 6 months post-partum was investigated. 
Methods. After supplementation during pregnancy with P-carotene and zinc in 
a randomised, double-blind controlled trial, 170 mothers with their newborn infants 
were enrolled for follow-up 6 months post-partum. 
Findings. Supplementation during pregnancy with P-carotene and zinc 
increased plasma retinol concentrations of both mothers and infants 6 months post-
partum, and reduced the prevalence of vitamin A deficiency of infants at 6 months of 
age by more than 30%. Breast milk retinol concentrations were significantly higher in 
the P-carotene+zinc group at 6 months post-partum. p-Carotene supplementation 
during pregnancy without zinc did not improve vitamin A status in mothers or infants. 
Interpretation. P-Carotene improved vitamin A status of mother and infant 
only when given in combination with zinc. This points to a specific role of zinc in the 
conversion of P-carotene to retinol. Impaired bioconversion of provitamin A 
carotenoids in zinc deficiency could explain in part the high prevalence of vitamin A 
deficiency in the presence of abundant dietary carotenoids as encountered in many 
developing countries. The addition of p-carotene and zinc to standard iron supplements 
could be an effective way to improve health of mothers and infants. 
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INTRODUCTION 
Micronutrient deficiency during infancy can lead not only to poor growth 
performance, but also to increased risk of morbidity and mortality from infectious 
diseases, and delayed psychomotor development (1-4). Maternal nutritional status is 
the one of the most important factors determining the nutritional status of infants (5). 
The nutritional status of women during pregnancy determines to a large extent the 
nutritional stores with which infants are born, and the nutrition status of women post-
partum also determines breast milk micronutrient content. In many developing 
countries, deficiencies of various micronutrients are prevalent in pregnant and lactating 
women, and also in their infants. Micronutrient supplementation during pregnancy has 
the advantage of addressing the needs of both mothers and infants simultaneously. 
Vitamin A deficiency is still a major health problem worldwide. Vitamin A 
supplementation has been shown to reduce mortality in children under the age of 5 
years by an estimated 23-34% (6). Several approaches to reduce vitamin A deficiency 
have been implemented, including intermittent high dose vitamin A supplementation of 
infants and children, and single high dose vitamin A supplementation of the mother 
directly post-partum. However, because of the teratogenicity of vitamin A, only small 
doses (< 10,000 IU/day or <25,000 IU/week) can be given safely during pregnancy. In 
addition, only small doses of vitamin A can be safely given to young infants (7). P-
Carotene is a precursor of vitamin A, and is not teratogenic. Therefore it is considered 
a useful alternative to retinol for supplementation during pregnancy. P-Carotene is also 
the main dietary source of vitamin A in developing countries, but both the uptake and 
the conversion of dietary P-carotene to retinol are less efficient than previously thought 
(8). 
Iron deficiency is the most prevalent micronutrient deficiency, and over 50% of 
the pregnant women in developing countries are estimated to be iron deficient (9). 
Supplementation of iron, in combination with folic acid, during pregnancy has been 
implemented as a standard program in many countries. The same dietary factors 
leading to iron deficiency also lead to zinc deficiency, suggesting that zinc deficiency 
is very prevalent also. 
If more than one micronutrient is deficient, supplementation of only one 
micronutrient will not adequately address all needs. Moreover, utilisation of the 
supplemented micronutrient can be compromised by the presence of deficiency of 
other micronutrients, reducing the effectiveness of supplementation. For example, the 
prevalence of anaemia can be reduced even more by supplementation with vitamin A 
in addition to iron (10). 
This study investigates whether supplementing women during pregnancy with 
P-carotene and zinc, in addition to iron and folic acid, can improve vitamin A status of 
mothers and newborns 6 months post-partum. 
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SUBJECTS AND METHODS 
Study design and location. 
The study was designed as a randomised, double-blind, controlled 
supplementation trial with pregnant women. Pregnant women (229) with a gestational 
age <20 weeks had been recruited from 13 adjacent villages in a rural area in Bogor 
District, West Java, Indonesia. All women were supplemented with iron and folic acid 
(30 mg of iron as ferrous fumarate and 0.4 mg of folic acid per day). In addition, one 
group of women received P-carotene (4.5 mg per day), one group zinc (30 mg of zinc 
as sulphate per day), and one group P-carotene plus zinc (4.5 mg and 30 mg per day, 
respectively). Supplements were prepared by the pharmacy of the Gelderse Vallei 
Hospital (Bennekom, The Netherlands), given as capsules, and taken daily until 
delivery. The effects of supplementation on pregnancy outcome will be reported 
elsewhere. 
Subjects and procedures. 
All women supplemented during pregnancy were eligible after delivery for 
follow-up of infant and mother until 6 months post-partum. The women had been 
informed at the beginning of supplementation and written informed consent was given. 
Exclusion criteria at enrolment were twin pregnancy because of a different growth 
pattern in twin infants, and congenital abnormalities interfering with growth, 
development or metabolism. Mothers and infants were assessed anthropometrically 
each month. Two breast milk samples were collected from each mother; one in the first 
and one in the sixth month post-partum. Furthermore, a blood sample (5 mL) was 
collected at the end of the study of both the mother and the infant for assessment of 
micronutrient status. 
Methods. 
Anthropometry included measurement of weight and length by trained 
anthropometrists using standard methods. Non-fasting, morning blood samples were 
collected using a closed-tube vacuum system to avoid zinc contamination (Becton and 
Dickinson. Leiden, The Netherlands). Blood samples were immediately stored at 4°C 
to prevent microhaemolysis and separated within 5 h. Plasma and serum samples were 
aliquoted and stored at -30°C until analysis. 
Haemoglobin concentrations were measured by a standard cyanoblue method 
(Humalyzer, Germany). Serum zinc concentrations were analysed with flame atomic 
absorption spectrophotometry (Varian, Clayton South, Vic, Australia) using trace-
element free procedures, as described in an earlier paper (5). The CV (10% duplicate 
analysis and pooled control samples) for zinc analyses was <5%. Plasma retinol and P-
carotene concentrations were measured by HPLC, with two separate extractions and 
separations as described by Ehrhardt et al. (11) The CV for retinol and carotenoid 
analyses (10% duplicate analysis and pooled control samples) was <5%. Breast milk 
retinol and carotenoid concentrations were measured as described by Jackson et al. 
(12). In short, 200 L of breast milk was mixed with KOH-ethanol (12.5% w/v, 250 
L), and internal standard (9 mol/L echinenone in ethyl alcohol, 100nL) was added. 
The mixture was saponificated at 45°C for 2 h. Retinol and carotenoids were doubly 
extracted with hexane, dried under nitrogen and reconstituted in solvent for HPLC 
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analysis. Creamatocrit was measured to estimate breast milk fat content using a method 
analogous to haematocrit measurement, and breast milk fat content was calculated 
according to Lucas et al. (13). The CV for the measurement of breast milk fat content 
and concentrations of retinol and P-carotene was <10%. Ferritin was measured using a 
commercial ELISA kit (IBL-Hamburg, Germany) according to the guidelines of the 
manufacturer. al-Acid glycoprotein (AGP) was measured using immunoturbidimetric 
techniques at the Northern Ireland Centre for Diet and Health, University of Ulster, 
Northern Ireland (Cobas Fara analyzer, Roche Products, Welwyn, UK). The CV for the 
ferritin and AGP assays was <10%. 
Ethical approval. 
The protocol was approved by the Ethical Committees of the National Health 
Research and Development Institute of Indonesia and of the Royal Netherlands 
Academy of Arts and Sciences. 
Statistical analysis. 
Data was checked for normal distribution using the Kolmogorov-Smirnov test 
of normality. Plasma ferritin concentrations and breast milk concentrations of retinol, p 
-carotene and zinc were transformed to logarithms before statistical analyses. 
Differences in prevalence were tested with Pearson's chi-square test. Differences 
among groups were tested with analysis of variance (ANOVA), with sex as between-
subject factor when necessary, or Kruskal Wallis for non-parametric data. Differences 
in biochemical indicators among supplementation groups were analysed using 
ANOVA or analysis of covariance (ANCOVA), with AGP as covariate. Correlations 
between micronutrient status of mothers and infants were investigated with multiple 
linear regression, controlling for age, sex and AGP when necessary, or Spearman's 
rank test for non-parametric data. Decreases in breast milk concentrations between 1 
months and 6 months of lactation were tested with paired t test and repeated 
measurements multivariate ANOVA. When the overall F test was significant, 
differences among the groups were further investigated with post-hoc multiple 
comparisons for ANOVA, and in a general linear model for ANCOVA. Frequency 
distribution curves were smoothed using a moving average, taking the two previous 
and two following values into account. Anthropometrical Z scores were calculated 
with EPI-Info, Version 6.04b (CDC, Atlanta GA, USA), and statistical analysis was 
carried out with the SPSS 7.5.2 (SPSS Inc, Chicago, IL, USA) software package. 
RESULTS 
Of the 179 women who were supplemented during pregnancy, 170 were 
enrolled after delivery with their newborn infants for follow-up for 6 months. The 
infants of nine mothers were not enrolled for follow-up because of twin pregnancy 
(3x), still birth (lx) or neonatal death (5x). The mothers had been supplemented during 
pregnancy with iron and folic acid (control group), iron and folic acid combined with p 
-carotene (p-carotene group), iron and folic acid combined with zinc (zinc group), or 
iron and folic acid combined with both p-carotene and zinc (P-carotene+zinc group). 
Infants were born between November 1998 and July 1999. During follow-up, 34 
mother-infant pairs dropped out for various reasons (Figure 1): 2 moved house, 29 
withdrew from the study, 1 infant died, 1 mother was too ill with tuberculosis to attend 
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follow-up, and 1 infant developed protein-energy malnutrition and was withdrawn 
from the study for treatment. 
170 newborns eliglible for follow-up 
(mothers were supplemented during pregnancy only) 
1 r 
41 newborns. 
During pregnancy 
mother received 
iron+folate 
* 1 moved 
* 6 withdrew 
* 1 died 
i 
33 completed 
follow-up at 
6 mo of age 
IT 
42 newborns 
During pregnancy 
mother received 
iron+folate and 
p-carotene+zinc 
* 1 moved 
* 8 withdrew 
*1PEM 
i 
32 completed 
follow-up at 
6 mo of age 
^ ' 
43 newborns 
During pregnancy 
mother received 
iron+folate and 
p-carotene 
* 0 moved 
* 5 withdrew 
* 1 mother ill 
i 
37 completed 
follow-up at 
6 mo of age 
ir 
44 newborns 
During pregnancy 
mother received 
iron+folate and 
zinc 
* 0 moved 
*10 withdrew 
i ' 
34 completed 
follow-up at 
6 mo of age 
Figure 1. Trial Profile 
Newborn infants were evenly born into the 4 groups (Table 1). There were 101 
boys and only 69 girls, but both sexes were equally distributed over the groups. Seven 
infants were born preterm (Table 1). There was no significant difference in birth 
weight among the groups when taking both sexes together, but the birth weight of boys 
in the p-carotene+zinc group was significantly higher than in the p-carotene group and 
the zinc group (p<0.05, ANOVA). 
At the age of 6 months, there were no significant differences in anthropometric 
parameters (expressed as Z scores) among the groups (Table 2). There was however a 
strong positive correlation between birth weight and Z scores at 6 months of age for 
both weight for age (R=0.28, P< 0.01, multiple linear regression controlling for sex) 
and height for age (R=0.28, P<0.001, multiple linear regression controlling for sex), 
but not for weight for height. 
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Supplementation groups1 
Control P-Carotene 
+zinc 
P-Carotene Zinc 
41 42 43 44 
Sex ratio (M:F) 27:14 27:15 23:20 24:20 
Preterm 3 1 1 2 
Birth weight (kg)2 3.1 (±0.5) 3.2 (+0.5) 3.0 (+0.4) 3.0 (±0.5) 
No differences between the groups for any of the baseline characteristics, except for the 
birth weight of boys in the P-carotene + zinc group which was significantly higher than the 
P-carotene group and the zinc group (P<0.05, ANOVA) 
2
 Mean (+ SD) 
Table 1. General characteristics of the newborn infants at birth. 
n . 
Sex ratio (M:F)' 
Age (mo) 
Supplementation 
Control 
33 
21:12 
6.0 (±0.6) 
Anthropometry (Z-scores) 
Weight for age 
Height for age 
Weight for height 
-0.06 (±0.76) 
-0.81 (±0.73) 
0.68 (+ 0.73) 
groups 
p-Carotene 
+zinc 
32 
22:10 
6.1 (±0.8) 
-0.06 (±0.74) 
-0.80 (±0.71) 
0.66 (± 0.83) 
P-Carotene 
37 
20:17 
6.0 (± 0.6) 
-0.28 (±0.92) 
-0.78 (±0.64) 
0.36 (±0.64) 
Zinc 
34 
19:15 
6.3 (±0.7) 
-0.28 (+0.88) 
-0.70 (±0.76) 
0.28 (±0.95) 
No significant differences between the groups (chi-square) (ANOVA). 
Table 2. Anthropometry of the infants at 6 months of age. 
In the women supplemented during pregnancy with P-carotene and zinc, 
plasma retinol concentrations were significantly higher than in all other groups 
(P<0.05, ANCOVA controlling for AGP, Table 3). Also, the infants of these mothers 
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had plasma retinol concentrations significantly higher than the infants from the other 
groups (P<0.01, ANCOVA controlling for AGP). Plasma P-carotene concentrations 
were also significantly higher in the women who were supplemented with P-carotene 
and zinc during pregnancy as compared to the other groups (P<0.01, Kruskal Wallis). 
At 6 months post-partum, plasma concentrations of retinol and P-carotene of the 
mothers were significantly correlated with those of their infants (P<0.01, R=0.23 
multiple linear regression controlling for AGP concentrations of mothers and infants, 
and P<0.01, p=0.28, Spearman's rank respectively, Table 3). The haemoglobin 
concentrations and the plasma ferritin and zinc concentrations did not differ among the 
groups. 
n 
Concentrations1 
Haemoglobin (g/L) 
Mothers 
Infants 
Plasma ferritin (ng/L) 
Mothers 
Infants 
Supplementation 
Control 
33 
122 (±11) 
109 (± 15) 
21.6 (6.7-39.1) 
23.1 (11.4-41.6) 
Plasma retinol (nmol/L) 
Mothers2 
Infants 
0.90 (±0.31) 
0.62 (±0.18) 
Plasma P-carotene (ixmol/L) 
Mothers 
Infants 
Plasma zinc (jtmol/L) 
Mothers 
Infants 
0.14(0.11-0.19) 
0.03 (0.00-0.07) 
11.7 (±1.3) 
12.4 (±2.1) 
groups 
P-Carotene 
+zinc 
32 
123 (+11) 
111 (±10) 
19.0 (9.7-38.4) 
38.2(11.7-61.3) 
1.12(+0.34)4 
0.77 (+0.18)5 
0.26 (0.18-0.36)6 
0.04 (0.00-0.08) 
11.5 (±1.8) 
12.9 (± 2.0) 
p-Carotene 
37 
120 (± 13) 
108 (± 10) 
16.8 (8.7-26.5) 
24.7 (8.2-48.0) 
0.89 (±0.27) 
0.60 (±0.16) 
0.15 (0.10-0.29) 
0.03 (0.00-0.08) 
11.4 (±1.4) 
12.3 (±2.1) 
Zinc 
34 
120 (±9) 
111 (±10) 
20.7 (10.2-29.7) 
24.1 (9.4-61.8) 
0.93 (+0.39) 
0.62 (+0.16) 
0.17 (0.07-0.27) 
0.03 (0.00-0.05) 
11.4 (+1.4) 
12.4 (+2.5) 
Mean (± SD) or median (IQR); Ferritin concentrations were transformed to logarithm before statistical analy: 
Correlation between mother and infant:2 p<0.01, R=0.23 (multiple linear regression controlling AGP); 
p<0.01, p=0.48 (Spearman's rank test). 
Significantly different from other groups:4 p<0.05 and5 p<0.01 (ANCOVA controlling for AGP); p<0.01 
(Kruskal Wallis). 
Table 3. Indicators of micronutrient status of mothers and their infants, 6 months post-partum. 
158 
Zinc Enhances fi-Carotene Supplementation 
The effect of supplementation during pregnancy on plasma retinol 
concentrations of mothers and infants 6 months post-partum is clearly illustrated in the 
frequency distributions (Figure 2 and 3). The distribution curve of plasma retinol 
concentrations 6 months post-partum of the mothers in the (3-carotene+zinc group is 
shifted to higher concentrations, as compared to all other groups (Figure 2). The 
distribution curve of women who received P-carotene is also shifted to the right, but to 
a much lesser extent than the (3-carotene+zinc group. The distribution curve of plasma 
retinol concentrations of the infants born from mothers receiving (3-carotene+zinc 
during pregnancy is also clearly shifted towards higher retinol concentrations, whereas 
the distribution curve of the infants in the P-carotene group is in between the control 
and (i-carotene+zinc groups (Figure 3). 
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Figure 2. Frequency distribution curve (smoothed) of plasma retinol 
concentrations 6 months post-partum in mothers, supplemented during 
pregnancy with p-carotene and zinc in addition to iron and folic acid. The 
control group received only iron and folic acid. 
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Figure 3. Frequency distribution curve (smoothed) of plasma retinol 
concentrations 6 months post-partum in infants, born of mothers supplemented 
during pregnancy with (J-carotene and zinc in addition to iron and folic acid. 
The control group received only iron and folic acid during pregnancy. 
Supplementation of pregnant women with p-carotene and zinc during 
pregnancy decreased the prevalence of vitamin A deficiency in the newborns 6 months 
post-partum by more than 30% (41% in the p-carotene+zinc group vs. 73-74% in the 
other groups, P<0.01, chi-square). In mothers, the prevalence of vitamin A deficiency 
was lower, hence the effect of supplementation was less pronounced, and the 
difference among the groups was not statistically significant. Still, in the mothers who 
received P-carotene and zinc, the prevalence of vitamin A deficiency 6 months post-
partum was 9%, whereas in the other groups the prevalence of vitamin A deficiency 
ranged from 21% (control group) to 32% (zinc group). 
In the first month of lactation, the micronutrient concentrations and fat content 
of breast milk were not different among the groups (Table 4). Breast milk 
concentrations of retinol and zinc decreased significantly between the first and sixth 
months of lactation in all groups (P<0.001, paired t test). At 6 months post-partum 
retinol concentrations in breast milk were significantly higher in the women 
supplemented during pregnancy with P-carotene and zinc than the women in the 
control group (P<0.05, ANOVA). Breast milk p-carotene concentrations 6 months 
post-partum were significantly higher in both the women who were supplemented 
during pregnancy with P-carotene and zinc as well as with P-carotene alone as 
compared to the control group (P<0.01, ANOVA). 
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Supplementation groups 
Control 
n 33 
Breast milk concentrations 
Fat(g/L) 
1 mo 30.6 (± 12.1) 
6 mo 33.8 (+ 14.0) 
Retinol (nmol/g fat)2 
1 mo 25.3 (21.2-44.3) 
6 mo 13.9(9.5-18.3) 
P-Carotene (nmol/g fat) 
1 mo 0.29 (0.16-0.58) 
6 mo 0.28(0.17-0.36) 
Zinc (|±mol/L)2 
1 mo 40.2 (29.0-49.8) 
6 mo 17.0(12.0-26.1) 
p-Carotene 
+zinc 
32 
31.6 (±9.2) 
28.8 (±11.0) 
27.6 (15.8-53.6) 
19.7 (12.5-29.0)3 
0.30 (0.20-0.69) 
0.41 (0.32-0.69)4 
47.7 (37.0-64.1) 
18.4 (13.2-29.4) 
3-Carotene 
37 
34.8 (± 12.0) 
31.8 (±16.0) 
26.3 (17.8-36.5) 
14.9 (9.7-23.2) 
0.36 (0.20-0.57) 
0.43 (0.26-0.67)4 
45.6 (34.8-59.8) 
18.4 (11.9-29.0) 
Zinc 
34 
32.3 (+ 15.3) 
34.2 (± 16.5) 
26.4 (21.9-41.7) 
15.2 (9.9-24.0) 
0.26 (0.15-0.67) 
0.37 (0.24-0.45) 
49.9 (31.5-63.9) 
18.5 (11.9-29.8) 
Means (± SD) or median (IQR). Concentrations of retinol, (3-carotene and zinc were transformed to 
logarithms before statistical analysis. 2 Significant decrease from 1 mo to 6 mo (P< 0.01, paired t test). 
Significantly different from control group: 3 p<0.05 and 4 p<0.01 (ANOVA) 
Table 4. Micronutrient concentrations in breast milk samples at 1 month and 6 months post-partum 
DISCUSSION 
This study shows that p-carotene supplementation is only effective in 
improving vitamin A status when given in combination with zinc. This effect of zinc 
on the conversion of P-carotene to retinol has not been reported previously. In the 
present study, supplementation of pregnant women during pregnancy with p-carotene 
and zinc increased plasma retinol concentrations of both mothers and infants at 6 
months post-partum, and reduced the prevalence of vitamin A deficiency of the infants 
by more than 30%. Intriguingly, p-carotene supplementation alone, without zinc, did 
not significantly increase plasma retinol concentrations neither in the mothers nor in 
the infants. Analogous to plasma, retinol concentrations in breast milk at 6 months 
post-partum were significantly higher in the women supplemented during pregnancy 
with p-carotene and zinc, but not in the women who received only p-carotene. 
The findings of this study point to a specific role of zinc in the conversion of p-
carotene to retinol, distinct from the role of zinc in the mobilisation of vitamin A as 
reported by other studies, which have shown that zinc deficiency can reduce plasma 
retinol-binding-protein concentrations (14,15). All women who received P-carotene 
had higher breast milk concentrations of P-carotene 6 months post-partum than the 
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control group. The increased breast milk concentrations of P-carotene 6 months after P 
-carotene supplementation is most likely a direct result of higher concentrations of P-
carotene in the fat tissue of the breast, as P-carotene is primarily stored in fat tissue. 
However, only the women who also received zinc in addition to p-carotene had 
increased concentrations of retinol in plasma and in breast milk. Thus, the p-carotene 
supplement would appear to be utilised for conversion to retinol only when zinc is also 
given. The conversion of p-carotene to retinol is mainly via central enzymatic cleavage 
by 15-15'-dioxygenase, with a likely role of metals in its activity (16). Main sites of 
cleavage are thought to be the gut and the liver, but the enzyme is expressed in most 
tissues (17). Interestingly, plasma concentrations of P-carotene 6 months post-partum 
were increased in the women who received zinc in addition to p-carotene, but not in 
the women who received only P-carotene. Apparently, zinc is also important for the 
mobilisation of P-carotene from tissue storage to plasma, but not to breast milk. 
There are several possible explanations for the improved vitamin A status in 
those infants born from mothers who received zinc in addition to P-carotene during 
pregnancy. Increased neonatal vitamin A stores at birth could have made an important 
contribution. Foetal vitamin A stores are accumulated during the last trimester of 
pregnancy, but depend on maternal plasma retinol concentrations (18). Although 
colostrum and early milk always contain high concentrations of retinol, after a few 
weeks of lactation the concentrations fall, and the high requirements of rapidly 
growing infants may no longer be met. In the present study the breast milk of women 
supplemented during pregnancy with P-carotene and zinc contained significantly more 
retinol and p-carotene after 6 months of lactation. The contribution of the higher breast 
milk retinol concentrations towards maintaining vitamin A nutriture in these infants 
can be estimated. If we assume an average daily milk intake of 600 ml, and an average 
fat content of breast milk of 31 g/L, it then follows that the median daily retinol intake 
from breast milk of the infants in the p-carotene+zinc group was 105 IU [IQR 66-154], 
whereas the median daily intake of the infants in the control group was only 75 RE 
[IQR 50-97]. For comparison, the UK lower reference nutrient intake (LRNI) for 
retinol in this age group is 150 RE (19). 
The contribution of breast milk P-carotene to the vitamin A status of the infants 
is probably small. Following the same calculation as for retinol, the median daily 
intake of P-carotene from breast milk of the infants in the P-carotene group was only 7 
RE [IQR 4-11], assuming a conversion factor of 1:6. Furthermore, the infants in the p-
carotene group do not have significantly increased plasma retinol concentrations, 
although breast milk P-carotene concentrations were also high. Thus it is not very 
likely that an increase in breast milk p-carotene concentrations alone can contribute 
substantially to improving vitamin A status in the infants. 
In the body, P-carotene can be converted into retinol, and when provided in oil 
approximately 2.4 |ig of P-carotene can yield 1 ng of retinol (20). However, the 
bioavailability of p-carotene from fruits and vegetables is much lower, and estimates of 
the extent of conversion of p-carotene to retinol have varied widely among studies 
(21,22). On the basis of the available data, the US Institute of Medicine recently 
revised the factor for calculating the amount of P-carotene in a mixed diet required to 
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supply 1 u.g of retinol. This amount is now estimated to be 12 |ig of P-carotene, 
whereas formerly it was only 6 \ig (23). Differences in zinc status may in part explain 
the wide range of estimates of the extent of conversion. In developing countries, most 
vitamin A is derived from provitamin A carotenoids, especially p-carotene. Impaired 
bioconversion of pro-vitamin A carotenoids to retinol due to zinc deficiency could 
partly explain the high prevalence of vitamin A deficiency in the presence of 
apparently abundant dietary carotenoids. In Nepal, supplementation with either vitamin 
A or P-carotene during pregnancy was shown to increase plasma retinol concentrations 
in infants at the age of 3 months, but supplementation with p-carotene was much less 
effective than with vitamin A (24). Concurrent zinc deficiency could well have reduced 
the effectiveness of the p-carotene supplementation. 
In Bangladesh, supplementation of women directly post-partum with a single 
high dose of vitamin A (200.000 IU) or daily supplementation with P-carotene during 
lactation did not increase serum retinol concentrations of the mothers nor the infants at 
6 months post-partum (25). In the present study, retinol concentrations were increased 
in the plasma of both the mother and infants, as well as in breast milk at 6 months post-
partum, after supplementation of p-carotene and zinc during pregnancy. Hence, 
supplementation during pregnancy appears to be more effective and has more benefits 
for both mother and infant than supplementation of the mother post-partum. 
The findings of this study clearly show that P-carotene can only improve 
vitamin A status when zinc is also available. Supplementation during pregnancy with p 
-carotene and zinc, but not with p-carotene alone, is effective in improving the vitamin 
A status of both the mother and the infant at 6 months post-partum. Increased breast 
milk vitamin A content is an important contributor to this effect. In view of the high 
prevalence of vitamin A deficiency in infants and lactating mothers in developing 
countries, and the direct relationship between vitamin A deficiency and increased 
morbidity and mortality, supplementing pregnant women with P-carotene and zinc is 
clearly indicated. Moreover, as iron supplementation of pregnant women is widely 
implemented, the addition of p-carotene and zinc to these supplements could be a very 
efficient and cost-effective measure to improve health of both infants and lactating 
mothers. 
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Publication Nightmares. 
Even though today the writing of a scientific publication is still a major task, this bears 
no comparison to the amount of work and frustration that earlier scientists had to face. 
Georg Rumphius for instance was a German medical doctor and botanist who worked 
on Ambon, from 1653 until his death in 1702. He went to Indonesia in the service of 
the VOC, but was eventually relieved of his work as a merchant because of the 
scientific importance of his voluntary botanical work. He became known as 'Plinius 
Indicus' as he systematically studied and described the unique flora and fauna of the 
Maluccu Islands. His work is still of relevance today. He became blind during the 
writing of his six-volume work on the botany of the Maluccu Islands, "Amboinsch 
Kruid-boek" or "Herbarium Amboinense". He continued working on the manuscript 
however with the aid of hired artists. When almost finished, at least half the 
illustrations were destroyed in a fire. When the manuscript was completed at last, it 
was sent to The Netherlands for publishing, but the manuscript was lost in a battle at 
sea, when the ship was attacked and sunk by the French in 1692. However, Rumphius 
succeeded in submitting a second version, 5 years later, based on copies. For unknown 
reasons, his work was only published in 1750, 48 years after his death. Another great 
biologist working in Indonesia, whose work is also still of relevance today, was Pieter 
Bleeker, a Dutch army doctor interested in fish. He arrived in Batavia in 1842, and in 
the following 30 years wrote the nine volumes of the "Atlas Ichthyologique". It took 18 
years before the first volume was published. During his life he sent more than 12,000 
fish specimen from Indonesia to The Netherlands. Due to his death in 1878, volume 9 
remains unfinished. 
Rumphius GE. Het Amboinsch Kruid-boek, and Amboinsche Rariteiten-kamer. 
Meinarduytwerf, Amsterdam 1750. Bleeker P. Atlas Ichthyologique des Indes 
Orientates Neerlandaises. Muller, Amsterdam 1862-1878. 
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INTRODUCTION 
The main objective of the research described in this thesis was to investigate 
the effects of supplementation with p-carotene, iron and zinc on micronutrient status, 
growth and immune function. First the prevalence of vitamin A, iron and zinc 
deficiency was assessed, as well as the interrelationship of these deficiencies with each 
other and with growth impairment and immune function. Special attention was given to 
the relationship between the nutritional status of the mother and her infant (Chapters 2 
and 3). Subsequently, the effects of supplementation of infants with P-carotene, iron 
and zinc on micronutrient status and deficiency were investigated. Furthermore, the 
effects of supplementation on growth and immune function were studied (Chapters 4-
6). In addition, the extent of changes in plasma concentrations of commonly used 
indicators of micronutrient status in the presence of inflammation, and implications for 
the assessment of micronutrient status were explored (Chapter 7). In a separate study, 
effects of supplementation of pregnant women with P-carotene and zinc in addition to 
iron and folic acid on pregnancy outcome were investigated. Mothers and newborns 
were followed for 6 months post-partum to study the effects of supplementation during 
pregnancy on micronutrient status of mothers and newborns post-partum, and growth 
of the new born during the first 6 months (Chapters 8 and 9). 
METHODOLOGY AND DESIGN OF THE STUDIES 
The first study was a cross-sectional survey in infants and their lactating 
mothers. This design is well suited to assess the prevalence of deficiencies of various 
micronutrients. Relationships, eg. between the micronutrient status of mothers and 
infants, can be established but cause and effect cannot, as only one point in time is 
studied, and there is no intervention. The same limitations apply to anthropometry, as 
growth is a continuos process, and a single anthropometrical assessment measures only 
the end-point of the preceding process of growth. The cross-sectional survey was 
carried out in the same area and the same age group as the two supplementation 
studies, so that baseline information on micronutrient status and growth was available 
for the two intervention studies. 
The supplementation trial in infants was designed as a randomised, double-
blind, placebo-controlled intervention study. It was initially designed as a 2x2 trial 
with p-carotene and zinc supplementation. However, at the request of UNICEF-Jakarta 
two groups were added to investigate the effects of iron and zinc supplementation also. 
The final design was a 6 cell trial centering upon the zinc and placebo groups; with one 
arm being a 2x2 trial with iron and zinc supplementation, and one arm being a 2x2 trial 
with P-carotene and zinc supplementation. Theoretically a 2x2x2 trial would have been 
preferable, but resources did not allow such an option. Growth and morbidity were 
monitored monthly. Blood samples however were only taken at the end of the 
supplementation study for three reasons. The first consideration is ethical; when a 
baseline blood sample is taken, there is an ethical obligation to treat anaemia, iron 
deficiency and/or vitamin A deficiency immediately, given the established and 
considerable health risks of these deficiencies. Infants with a known deficiency cannot 
be allocated at random to supplementation of possibly placebo. For zinc deficiency, 
this is at the moment less clear. However, treating deficiencies found at baseline would 
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mean exclusion of these infants from the study, and lead to not only a considerable 
drop out at recruitment, but also create a bias in the recruited infants, as only infants 
with no prior deficiency would be selected. Secondly, there was concern that taking a 
baseline blood sample would lead to considerable drop out prior to the second blood 
sample. Finally, during infancy biochemical indicators of micronutrient status and 
immune function change considerably. Hence, the informative value of a blood sample 
taken at 4 months of age is limited, and not strictly comparable with the end point 
blood sample taken at 10 months of age. However, with only an end point blood 
sample, there was some restriction in the possibilities of statistical analyses, e.g. 
subgroups and stratification, and in the interpretation of causality of some 
relationships. Morbidity has not yet been thoroughly addressed due to the difficulties 
of deriving quantitative parameters from the available data. However, these analyses 
will be carried out at a later stage. 
The supplementation trial with pregnant women was designed as a randomised, 
double-blind intervention trial. Because the benefits of iron and folic acid 
supplementation during pregnancy have been well established, and iron and folic acid 
supplementation during pregnancy is national policy in Indonesia, a placebo group was 
considered unethical. Therefore, all women, including the control group, received the 
standard iron and folic acid supplementation. The design was a 2x2 trial in which [}-
carotene and/or zinc were supplemented in addition to iron and folic acid. Women 
were recruited at a gestational age of between 10 and 20 weeks, because a gestational 
age of less than 10 weeks was considered too early to be able to diagnose pregnancy 
with enough certainty, and later than 20 weeks of gestational age would diminish the 
duration of supplementation. Because effects of prenatal supplementation were studied, 
supplementation was until delivery only. The women were seen monthly for 
anthropometry and health assessment. Blood samples were taken from the women at 
recruitment and at 8 months of pregnancy. Delivery complications of the mother and 
the neonate and birth weight were recorded within 3 days of birth, using a card with 
pictograms, to be filled in and signed by the birth attendant or health volunteer. 
Newborns and their mothers were seen monthly, until 6 months post-partum. Growth 
and morbidity of the newborn was assessed monthly, and a blood sample was taken 
from the newborn and the mother 6 months post-partum. Furthermore, two breast milk 
samples were collected, 1 and 6 months post-partum respectively. Although 3 blood 
samples were taken from the women, the comparison of biochemical indicators over 
these three time points was hampered by the substantial physiological changes that 
occur during pregnancy. A major drawback of recruiting women when already 
pregnant is that not only the baseline biochemical, but also the anthropometrical 
measurements are already affected by the state of pregnancy. However, a study design 
covering all women in the fertile age in order to start recruitment and supplementation 
before conception, although much preferable, would require a huge number of 
subjects, not compatible with the available resources. From the newborns, only an 
endpoint blood sample was taken, for the same reasons and with the same limitations 
as for the supplementation trial in infants. 
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MAIN FINDINGS AND INTERPRETATION 
Micronutrient status and deficiency. 
The studies described in this thesis show that anaemia, iron deficiency, vitamin 
A deficiency and zinc deficiency are all prevalent in both pregnant and lactating 
women as well as in infants in Bogor district (Chapters 2, 4, 5, 8 and 9). Earlier studies 
in this area showed that anaemia, iron deficiency and vitamin A deficiency are 
prevalent in pregnant women and in children (1-3). In the present studies, we show that 
zinc deficiency is prevalent also. Furthermore, the studies described in this thesis show 
that vitamin A, anaemia, iron deficiency and zinc deficiency occur concomitantly, are 
correlated with each other, and that there is a significantly increased risk in vitamin A 
deficient subjects of being also deficient for iron and/or zinc. Deficiencies of various 
micronutrients during infancy and childhood increase the risk of morbidity and 
mortality of infectious diseases, can impair growth, and may result in delayed psycho-
motor development and impaired learning (4-8). In this context, the high prevalence of 
deficiencies of various micronutrients as found in the present studies in a population 
that is not extremely poor or disadvantaged, has access to primary health care facilities, 
and is apparently healthy, certainly warrants concern. Micronutrient deficiency may be 
a major factor underlying the prevailing high infant mortality (60 per 1000 infants) in 
Indonesia (9). 
The high prevalence of deficiencies of various micronutrients in pregnant and 
lactating women is an important finding. Many studies have shown adverse 
consequences of micronutrient deficiency during pregnancy on pregnancy outcome 
including maternal and neonatal mortality, premature birth, and birth weight (10-13). 
Maternal mortality is still high in Indonesia (65 per 10,000 pregnancies), and could be 
associated with the high prevalence of deficiency of various micronutrients in pregnant 
women (9). However, the present studies were not designed to measure effects on 
mortality, either maternal or infant, as much larger numbers of subjects are needed for 
this. 
Effects of supplementation on micronutrient status and deficiency. 
In the studies described in this thesis, supplementation with iron was effective 
in reducing anaemia and iron deficiency in infants (Chapter 4). Supplementation with 
iron combined with zinc reduced the efficacy of the iron supplementation. However, 
the combined supplementation of iron and zinc was still effective in reducing the 
prevalence of anaemia and iron deficiency, whilst also reducing the prevalence of zinc 
deficiency. Supplementation with iron alone does not impair zinc status, but 
supplementation with zinc alone appears to have a slight negative effect on iron status. 
There has been major concern that supplementation with either iron or zinc alone could 
inhibit the uptake of the other micronutrient (14). However, it seems that the negative 
effects of supplementation with the single micronutrients are small, and that substantial 
inhibition is only seen when iron and zinc are given together in relatively high 
concentrations such as in a combined supplement. In pregnant women, 
supplementation with micronutrients did not alter the plasma concentrations of any of 
the micronutrient status indicators during pregnancy, probably because changes were 
obscured by the much larger effects of haemodilution (Chapter 8). 
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Zinc is thought to play a role in vitamin A metabolism (15,16). 
Supplementation of infants with P-carotene, with or without zinc, did not significantly 
improve plasma retinol concentrations, although the prevalence of vitamin A 
deficiency was somewhat reduced (Chapter 5). However, plasma P-carotene 
concentrations in infants increased substantially after supplementation with P-carotene. 
In pregnant women, supplementation with P-carotene combined with zinc during 
pregnancy improved vitamin A status of both mother and newborn 6 months post-
partum, whereas supplementation with P-carotene alone had no effect (Chapter 9). This 
indicates that zinc plays an important role in the conversion of P-carotene to retinol. 
This is also illustrated by the finding that women who received only p-carotene 
supplementation, had increased breast milk concentrations of P-carotene but not of 
retinol. Also, these women had neither increased plasma retinol nor P-carotene 
concentrations, pointing to an impaired utilisation of the supplemented P-carotene in 
the absence of zinc. In this context, it is important to note the high prevalence of low 
plasma zinc concentrations in the lactating women (25% or more < 10.7 mol/L). The 
fact that the synergistic effect of zinc on P-carotene supplementation is not apparent in 
the infants can have several reasons. First of all, metabolic functions are often not yet 
fully developed in infants, so that the capacity of many enzymatic processes is less. 
This might reduce the potential contribution of p-carotene to vitamin A status. Also, 
infants have very little adipose tissue, hence infants have less capacity to store the 
supplemented P-carotene. 
Supplementation with vitamin A and iron has been shown to be more effective 
in reducing the prevalence of anaemia than supplementation with iron alone (17). 
Although exact mechanism are still unknown, it is thought that vitamin A improves the 
utilisation of iron (18). In the present studies, supplementation of infants with p-
carotene reduced the prevalence of anaemia (Chapter 5). However the effects were not 
very large, perhaps because the infants were supplemented with P-carotene and not 
with retinol. In the pregnant women, there was no beneficial effect of P-carotene 
supplementation on anaemia prevalence, neither during pregnancy nor 6 months post-
partum (Chapters 8 and 9). 
Although an effect of iron supplementation on vitamin A metabolism has not 
been described before in humans, there are some indications in animal models that iron 
status affects mobilisation and utilisation of retinol (19,20). In the present studies, 
infants receiving iron supplementation, either alone or combined with zinc, had 
markedly reduced plasma retinol concentrations, and a much higher prevalence of 
vitamin A deficiency (Chapter 5). At the same time, these infants had higher hepatic 
stores of vitamin A, as shown by the decreased MRDR. This suggests that iron 
supplementation causes a redistribution of vitamin A from plasma to the liver. As iron 
supplementation can cause plasma retinol concentrations to fall below the cut-off 
concentration for vitamin A deficiency, iron supplementation in infants should not be 
given without measures to improve vitamin A status also. This is especially important 
in populations were vitamin A status is already marginal. To fully elucidate the 
underlying mechanisms of the observed redistribution of retinol, animal models are 
more suitable. 
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Micronutrients during pregnancy and lactation. 
Micronutrient deficiency during pregnancy is associated with increased 
maternal mortality, increased incidence of complications during pregnancy and labour, 
lower birth weight, and increased incidence of neonatal complications (10). In this 
thesis (Chapter 8) we show that supplementation of pregnant women with p-carotene 
and zinc, in addition to the standard supplementation regime of iron and folic acid, 
increases birth weight, although only in boys. Other studies have found beneficial 
effects of supplementation during pregnancy with only retinol or P-carotene in 
reducing maternal mortality (11), and with only zinc on pregnancy complications and 
birth weight (12). However, there is reason for caution, as in the studies described in 
this thesis supplementation during pregnancy with only zinc in addition to iron and 
folic acid, increased the prevalence of complications during delivery. In view of the 
concurrent occurrence of deficiency of several micronutrients, supplementation of only 
zinc or only p-carotene in addition to iron and folic acid might not address all the 
micronutrient requirements during pregnancy. 
Micronutrient supplementation during pregnancy benefits not only the mother 
but also the infant. The studies described in this thesis show that maternal 
micronutrient status is a major determinant of the micronutrient status of the infant. A 
key connection factor between the nutritional status of mothers and infants is of course 
breast milk. The micronutrient content of breast milk is affected by the micronutrient 
status of the mother. In Chapters 2 and 9, it is shown that especially retinol and p-
carotene content of the breast milk is affected by the vitamin A status of the mother. 
Moreover, there is a significant relation between the vitamin A content of breast milk, 
and the vitamin A status of the infant. As already mentioned above, P-carotene 
supplementation during pregnancy had to be combined with zinc to be able to increase 
plasma and breast milk retinol concentrations 6 months post-partum. It is encouraging 
that supplementation during pregnancy is able to significantly improve vitamin A 
status even 6 months after the end of supplementation, not only in the mothers but also 
in their infants. In other studies, supplementation of lactating mothers with either a 
single high dose of retinol directly post-partum or daily with p-carotene did not 
improve vitamin A status of the infants at 6 months of age (21). In Nepal, pregnant 
women were supplemented during pregnancy with either retinol or p-carotene. At 3 
months of age, plasma retinol concentrations were increased in the newborns, but the 
effect of retinol supplementation was greater than that of P-carotene (22). In the studies 
described in this thesis, the effect of P-carotene supplementation during pregnancy was 
greatly enhanced by the addition of zinc. 
Micronutrients and growth. 
Micronutrient deficiency has been implicated in the growth impairment during 
infancy that is seen in many developing countries (6). Especially zinc deficiency has 
recently been the focus of much interest. Zinc supplementation has been shown to 
improve growth performance in several studies (23,24). In the studies described in this 
thesis, zinc deficiency was not related to growth impairment (Chapter 2). Interestingly, 
there was an association between vitamin A status and growth impairment (Chapter 2). 
Moreover, zinc supplementation did not improve growth performance (Chapter 4). 
This is surprising as the prevalence of iron and zinc deficiency are high in these 
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infants, and iron and zinc supplementation were very effective in decreasing these 
deficiencies. Apparently, additional factors are involved in the growth impairment in 
these infants. A recent meta-analysis showed that the effects of supplementation with 
zinc on growth are small, and most pronounced in stunted infants (25). The studies 
described in this thesis aimed at preventing stunting during infancy, and not to improve 
growth in already stunted infants. Therefore, supplementation was started at an age 
before stunting is prevalent. 
Supplementation with micronutrients during pregnancy was not effective in 
preventing growth impairment in newborn infants during the first 6 months of life, 
even though birth weight of boys was increased after supplementation during 
pregnancy with P-carotene and zinc (Chapter 8 and 9). Birth weight however, remained 
the most important predictor of height-for-age and weight-for-age Z scores at 6 months 
of age. 
Micronutrients and immune function. 
Micronutrients are essential for optimal functioning of the immune system. 
Moreover, micronutrients can modulate the immune response (26). In the studies 
described in this thesis, micronutrient status distinctly affected immune function in 
infants. Vitamin A deficiency markedly decreased the ability to produce the type-1 
cytokine interferon-7 in whole blood after stimulation (Chapter 3). Intriguingly, 
circulating neopterin concentrations were higher in vitamin A deficient infants, 
suggesting increased in vivo macrophage activity, which in turn signifies increased 
stimulation by interferon-7. Zinc deficiency was accompanied by significantly reduced 
white blood cell numbers, as well as significantly reduced ex vivo production of the 
type-2 cytokine interleukin-6 (Chapter 3). 
Supplementation with iron resulted in higher ex vivo interferon-7 production, 
and lower ex vivo interleukin-6 production (Chapter 7). The higher circulating 
neopterin concentrations found in the infants who received iron supplementation are 
consistent with the ex vivo findings. Supplementation with either p-carotene or zinc 
seemed to have an opposite effect on immune function (Chapter 7). Overall, these 
studies show that iron, vitamin A and zinc have marked albeit divergent effects on the 
immune function of infants. The implications for immunocompetence are less clear. 
Deficiencies of vitamin A and zinc are known to increase the risk of morbidity and 
mortality (27,28). An impaired ability to produce pro-inflammatory cytokines in 
response to infection in infants with deficiency of various micronutrients, as found in 
the studies described in this thesis, might underlie the increased risk of morbidity and 
mortality from infectious diseases (29-32). Supplementation with vitamin A has been 
shown to reduce mortality and morbidity in children (4), and zinc supplementation has 
been shown to reduce the prevalence and severity of infections, especially in diarrheal 
disease, respiratory infections and malaria (23,33,34). Iron supplementation is more 
controversial in this context, and positive as well as negative effects of iron 
supplementation on immune function are reported (35). 
It is important to realise that supplementation of different micronutrients can 
have opposite immunomodulatory effects. Effects of single micronutrient 
supplementation can be counteracted by the immunomodulatory effects of deficiency 
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other micronutrients. Furthermore, single micronutrient supplementation can also lead 
to unbalanced enhancement or depression of immune response. Therefore, 
supplementation of more than one micronutrient seems preferable to optimally 
improve immune function. 
CONCLUSIONS AND IMPLICATIONS 
From the studies described in this thesis, several conclusions can be drawn with 
implications for programmes and policy. One conclusion that is recurrent in all the 
studies described in this thesis, and that warrants to be highlighted, is that concurrent 
deficiency of several micronutrients are the norm rather than the exception, and that 
supplementation with more than one micronutrient is preferable and more effective. In 
populations where micronutrient supplementation is considered, often nutriture of 
more than one micronutrient is inadequate. The effectiveness of supplementation with 
only one micronutrient, when multiple deficiencies exist, is considerably reduced as 
utilisation will not be optimal, and health benefits will fall short of expectations as the 
other deficiencies are not addressed. Furthermore, single micronutrient 
supplementation can inadvertently impair absorption, utilisation or metabolism of other 
micronutrients, especially when nutriture of these micronutrients is already marginal. 
Until recently, research efforts were primarily focussed on single 
micronutrients. Furthermore, the current strategy of most nutrition intervention 
programmes is to target only one micronutrient deficiency at the time. Iron 
supplementation for pregnant women, and vitamin A capsule distribution programmes 
for children are clear examples. When the effort is made to implement a 
supplementation programme, it would take little extra cost or effort to supply a more 
complete mixture of micronutrients. The effectiveness of supplementation will be 
increased in an additive as well as in a synergistic way, and overall health benefits will 
be much greater. 
From the results of the studies described in this thesis, we conclude that 
supplementation of pregnant women, not only with iron and folic acid, but also with p-
carotene and zinc, seems clearly more beneficial than supplementation with iron and 
folic acid alone, and this would be the easiest change to implement. Furthermore, when 
considering large scale supplementation in infants, single supplementation of iron 
would not address concurrent zinc or vitamin A deficiencies, so that a combined 
supplementation approach is required. However, a significant improvement of growth 
performance might not be achieved with the combined supplementation of these three 
micronutrients, as other factors seem to be involved in the growth impairment in these 
infants also. 
774 
General Discussion 
RECOMMENDATIONS FOR FUTURE RESEARCH 
Interactions between micronutrients are very important, not only in the etiology 
of micronutrient deficiency, but also during supplementation and in utilisation in 
metabolic processes. Although many interactions between micronutrients have been 
described, exact mechanisms are often not yet elucidated. Most often animal models 
are needed to study metabolic interactions in detail. However, careful and in depth 
study of deficiencies of micronutrients and the effects of supplementation in human 
subjects can also give insight in underlying mechanisms and the relative importance of 
interactions between micronutrients. More research is needed to identify the factors 
involved in the growth impairment during infancy that is seen in many developing 
countries. Optimal growth in infants and children is an important health goal, as 
impaired growth is associated with poor health, increased risk of morbidity and 
mortality and delayed psycho-motor development. 
The important role of the effects of micronutrients in immune function is only 
recently being recognized. However, immunology is a fast developing field, and many 
aspects of immune function are still not completely understood, making it even more 
difficult to investigate exact mechanisms by which micronutrients affect immune 
function. Elucidating the immunomodulatory effects of micronutrients is very 
important when considering supplementation of micronutrients, to achieve optimal 
immunocompetence, and thus optimal reduction of morbidity and mortality. 
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SUMMARY 
The research described in this thesis was concerned with vitamin A, iron and 
zinc deficiency in pregnant and lactating women and in infants. The effects of 
supplementation with P-carotene, iron and zinc on micronutrient status, growth, 
pregnancy outcome and immune function, and interactions between micronutrients 
were investigated. 
Deficiencies of vitamin A, iron and zinc are prevalent worldwide. Vitamin A 
deficiency leads to increased risk of morbidity and mortality, and vitamin A 
supplementation can reduce child mortality by 20-30%, regardless of the prevalence of 
xerophthalmia in the population. In developing countries, pro-vitamin A carotenoids, 
especially P-carotene, from plant foods is the most important source of vitamin A, but 
bioavailability and conversion are highly variable, and less than often assumed. Iron 
deficiency is the most common micronutrient deficiency globally, affecting over 50% 
of the women in developing countries. Iron deficiency leads to anaemia, but in children 
also to delayed psychomotor development and impaired learning, and possibly affects 
immunocompetence. Diets rich in phytate and low in animal products result in a low 
availability of iron, and predisposes to iron deficiency. 
Zinc availability is impaired by the same factors as iron, and hence zinc deficiency is 
presumed to be very widespread also. Zinc status however, is difficult to assess due to 
homeostasis, and the absence of real body stores. Zinc deficiency causes especially 
growth impairment and decreased immunocompetence, although probably many 
metabolic functions are affected. 
In Indonesia, both vitamin A deficiency and iron deficiency are major health 
problems, affecting especially pregnant and lactating women, and infants. Zinc 
deficiency is also thought to be important, and has been implicated in the growth 
impairment commonly seen in infants in Indonesia. Also, maternal and infant mortality 
remain high, despite significant improvements in vaccination coverage and access to 
primary health care. There are several programmes in Indonesia to combat vitamin A 
and iron deficiency. For example, there is a national iron and folic acid 
supplementation programme for pregnant women, and there is a programme for 
intermittent high dose vitamin A supplementation with capsules for children. The 
vitamin A supplementation programme has successfully decreased the prevalence of 
xerophthalmia, but marginal vitamin A deficiency remains a problem. Also, because of 
possible toxicity, young infants and pregnant women are not included in the vitamin A 
supplementation programme. 
The research described in this thesis comprises three studies. The objective of 
the first study was to assess the prevalence of deficiency of vitamin A, iron and zinc in 
lactating mothers and their infants as well as the interrelationships of these deficiencies 
with each other, and with growth impairment and immune function. In the second 
study, the effects of supplementation of infants with P-carotene, iron and zinc on 
micronutrient status and deficiency, and on growth and immune function were 
investigated. In the third study, the effects of supplementation of pregnant women with 
p-carotene and zinc in addition to iron and folic acid on pregnancy outcome, 
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micronutrient status of mothers and newborns, and growth of the newborn during the 
first 6 months were investigated. 
The main findings of the research described in this thesis are summarized in 
relation to several topics important for mother and child health. An important finding 
in all three studies is not only that deficiency of vitamin A, iron and zinc are prevalent 
in infants and mothers, but also that these deficiencies are likely to occur 
concomitantly. Furthermore, micronutrient status of the mother is strongly related to 
that of her infant, and breast milk is a key connecting factor between mother and infant 
for vitamin A status. 
Supplementation of infants with iron and zinc was effective in reducing the 
prevalence of anaemia and deficiencies of iron and zinc. Although supplementation of 
iron combined with zinc reduced the efficacy of iron supplementation, the combined 
supplement still effectively reduced the prevalence of anaemia and iron deficiency, and 
in addition reduced zinc deficiency. This shows that although zinc partially inhibits 
iron uptake, zinc is still a valuable addition to iron supplementation. Supplementation 
of women during pregnancy with p-carotene combined with zinc improved vitamin A 
status of both mother and newborn 6 months post-partum, whereas supplementation 
with P-carotene alone had no effect. This indicates that zinc plays an important role in 
the conversion of p-carotene to retinol. Therefore zinc is necessary to improve vitamin 
A status with P-carotene supplementation in pregnant women. The synergistic effect of 
zinc on P-carotene supplementation is not apparent in infants, but infants may have a 
reduced capacity to metabolise or store p-carotene. In contrast, iron supplementation 
was found to have an antagonistic effect on vitamin A status of infants, resulting in 
lower plasma retinol concentrations, and higher prevalence of vitamin A deficiency in 
the iron supplemented infants. Concomitantly hepatic stores of vitamin A were 
increased, suggesting that iron supplementation causes a redistribution of vitamin A 
from the plasma to the liver. Hence, iron supplementation in infants should not be 
given without measures to improve vitamin A status also. 
Supplementation of pregnant women with p-carotene and zinc improved birth 
weight, but only in boys. However, supplementation with only zinc in addition to iron 
and folic acid, increased the prevalence of complications during delivery. In view of 
the concurrent occurrence of deficiency of various micronutrients, supplementation of 
only zinc or only P-carotene, in addition to iron and folic acid, may not address all 
micronutrient requirements during pregnancy. 
Although zinc deficiency has been implicated in the growth impairment 
commonly seen in infants in developing countries, supplementation of infants with 
zinc did not improve growth performance. Also, supplementation of women during 
pregnancy with zinc did not improve growth of the infant during the first 6 months of 
life. Apparently, additional factors are involved in the growth impairment of these 
infants. 
Various micronutrients have profound, albeit different effects on immune 
function. Infants with vitamin A deficiency had lower ex vivo type-1 cytokine 
response, but higher in vivo macrophage activity. Zinc deficiency was accompanied by 
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reduced white blood cell numbers, as well as lower ex vivo type-2 cytokine production. 
Supplementation with iron resulted in higher type-1, and lower type-2 cytokine 
production, whilst supplementation with (3-carotene and zinc seem to have opposite 
effects on immune function. Deficiency of various micronutrients can impair the 
ability to produce pro-inflammatory cytokines in response to infection. 
Supplementation of different micronutrients can have opposing immunomodulatory 
effects, but implications for immunocompetence are less clear. 
Concluding, the studies described in this thesis clearly and repeatedly show that 
concomitant deficiencies of various micronutrients are the norm rather than the 
exception. Supplementation with single micronutrients is not optimal. The expected 
effectiveness of supplementation with one micronutrient will not be achieved if the 
utilisation of the micronutrient is impaired by deficiency of another micronutrient. 
Health benefits of supplementation will also fall short of expectations as long as 
deficiencies of other micronutrients are not addressed. Therefore supplementation with 
more than one micronutrient is recommended, not only for infants but also for pregnant 
women. 
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SAMENVATTING 
Het onderzoek dat in dit proefschrift beschreven wordt, was gericht op het 
voorkomen en de effecten van voedingstekorten van vitamine A, ijzer en zink in 
zwangere en lacterende vrouwen en in jonge kinderen. Ook werd het effect van het 
suppleren met P-caroteen, ijzer en zink op micronutrientenstatus, groei, 
zwangerschapsuitkomst en immuunfunctie onderzocht, alsmede interacties tussen de 
verschillende micronutrienten. 
Wereldwijd komen deficienties van vitamine A, ijzer en zink vaak voor. Een 
tekort aan vitamine A verhoogt het morbiditeits- en mortaliteitsrisico, en suppletie van 
kinderen met vitamine A kan de kindersterfte verminderen met 20 tot 30%, ongeacht 
de prevalentie van xerophthalmie in de bevolking. In ontwikkelingslanden is p-
caroteen, een provitamine A die zich met name in plantaardig voedsel bevindt, de 
belangrijkste bron van vitamine A. De opname en omzetting van P-caroteen zijn echter 
hoogst variabel, en lager dan tot voor kort werd aangenomen. Wereldwijd is een 
ijzerdeficientie het meest prevalente voedingstekort, en meer dan 50% van de vrouwen 
in ontwikkelingslanden heeft een ijzertekort. Een tekort aan ijzer leidt tot 
bloedarmoede, maar in kinderen kan het ook leiden tot een vertraging van de psycho-
motore ontwikkeling, een verminderd leervermogen en tot een verminderde afweer 
tegen infekties. De opname van ijzer uit een dieet dat rijk is aan fytaten, en weinig 
dierlijke produkten bevat, is laag. Zo'n dieet is gebruikelijk in ontwikkelingslanden: 
hierdoor wordt de kans op een tekort aan ijzer verhoogt. De opname van zink wordt 
door dezelfde factoren vermindert als de opname van ijzer. Het is dus waarschijnlijk 
dat een tekort aan zink ook erg algemeen is. Het meten van de zinkstatus is echter 
moeilijk door de strikte homeostase en door de afwezigheid van echte 
lichaamsvoorraden. Duidelijke gevolgen van een zinktekort zijn een verminderde groei 
en een verminderde afweer tegen infekties, maar waarschijnlijk zijn vele metabole 
funkties aangedaan. 
In Indonesie' is een tekort aan zowel vitamine A als ijzer een belangrijk 
gezondheidsprobleem, met name voor zwangere en lacterende vrouwen en voor jonge 
kinderen. Waarschijnlijk is een tekort aan zink ook een belangrijk probleem en dit zou 
een oorzaak kunnen zijn van de groeivertraging zoals die vaak wordt waargenomen bij 
kinderen in Indonesie. Verder is de maternale sterfte en de kindersterfte nog steeds 
hoog, ondanks het feit dat er belangrijke vooruitgang is geboekt in de vaccinatie-
dekkingsgraad en de bereikbaarheid van de 'primary health care' centra. Er zijn 
verschillende programma's in Indonesie gericht op de preventie van tekorten van 
vitamine A en ijzer. Zo is er een nationaal programma van ijzer- en 
foliumzuursuppletie voor zwangere vrouwen en is er een programma waarin met 
tussenpozen aan kinderen kapsules met een hoge dosis vitamine A wordt verstrekt. De 
suppletie met vitamine A is erg succesvol geweest in het terugdringen van 
xerophthalmie, maar het voorkomen van marginale tekorten aan vitamine A blijft een 
probleem. Hele jonge kinderen (minder dan 6 maanden oud) en zwangere vrouwen zijn 
echter uitgesloten van het vitamine A-suppletieprogramma, omdat hogere doses 
vitamine A voor hun toxisch of teratogeen kunnen zijn. 
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In dit proefschrift worden 3 verschillende studies beschreven. Het doel van de 
eerste studie was het vaststellen van de prevalentie van tekorten aan vitamine A, ijzer 
en zink in lacterende moeders en hun kinderen. Ook werden de onderlinge verbanden 
tussen deze tekorten en de relatie met groei en immuniteit onderzocht. In de tweede 
studie werden de effecten onderzocht van suppletie van kinderen met P-caroteen, ijzer 
en zink op de voedingsstatus en de prevalentie van tekorten, alsmede op de groei en de 
immuniteit. In het derde onderzoek werden de effecten van suppletie van zwangere 
vrouwen met P-caroteen en zink (naast de standaardsuppletie met ijzer en foliumzuur) 
onderzocht op de zwangerschapsuitkomst, de voedingsstatus van moeder en kind en de 
groei van het kind gedurende de eerste 6 maanden onderzocht. 
De belangrijkste bevindingen van het onderzoek zullen hieronder thematisch 
worden samengevat, aan de hand van onderwerpen die van belang zijn voor de 
gezondheid van moeder en kind. Een belangrijke bevinding in alle drie de studies is dat 
tekorten aan vitamine A, ijzer en zink niet alleen vaak voorkomen, maar dat ze ook 
vaak tegelijkertijd voorkomen. Verder is de micronutrientenstatus van de moeder sterk 
gerelateerd aan die van haar kind, en is moedermelk een belangrijke verbindende 
faktor tussen de vitamine A-status van moeder en kind. 
Suppletie met ijzer en zink was effectief in het verminderen van het voorkomen 
van bloedarmoede en tekorten van ijzer en zink. Hoewel de werkzaamheid van 
suppletie wordt verminderd door het combineren van ijzersuppletie met zinksuppletie, 
was het gecombineerd suppleren nog steeds effectief in het verminderen van de 
prevalentie van bloedarmoede en ijzertekort, alsmede van zinktekort. Dit toont aan dat 
hoewel zink de opname van ijzer gedeeltelijk remt, zink toch een waardevolle 
toevoeging is aan ijzersupplementen. Het suppleren van vrouwen tijdens de 
zwangerschap met de combinatie van P-caroteen en zink verbeterde de vitamine A-
status van zowel moeders als hun kinderen 6 maanden post-partum, terwijl suppletie 
met alleen P-caroteen geen effect had. Dit wijst op een belangrijke rol van zink in de 
omzetting van P-caroteen naar retinol. Zink is dan ook noodzakelijk indien men de 
vitamine A-status van zwangere vrouwen wil verbeteren met behulp van P-
caroteensuppletie. Dit synergistische effect van zink op de effectiviteit van P-
caroteensuppletie is niet aanwezig in de gesuppleerde kinderen, maar het kan zijn dat 
kinderen een verminderde capaciteit hebben om P-caroteen te metaboliseren of op te 
slaan. Ijzersuppletie daarentegen Week een antagonistisch effect op de vitamine A-
status van kinderen te hebben, resulterend in een hogere prevalentie van vitamine A-
tekort in kinderen die ijzersupplementen kregen. Deze kinderen hadden echter 
tegelijkertijd ook grotere levervoorraden van vitamine A, wat er op wijst dat 
ijzersuppletie leidt tot een herverdeling van vitamine A vanuit het bloed naar de lever. 
Daarom zou ijzersuppletie gecombineerd moeten worden met maatregelen om 
tegelijkertijd de vitamine A-status te verbeteren. 
Het suppleren van zwangere vrouwen met P-caroteen en zink gaf een verhoging 
van het geboortegewicht van jongens, maar niet van meisjes. Daarentegen leidde het 
suppleren van zwangere vrouwen met alleen maar zink, naast de standaard ijzer- en 
foliumzuursuppletie, tot een toename van het aantal complicaties tijdens de bevalling. 
Gelet op het vaak gelijktijdig voorkomen van meerdere voedingstekorten, is het goed 
mogelijk dat het suppleren met alleen maar p-caroteen of alleen maar zink, naast de 
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standaard ijzer- en foliumzuursuppletie, niet voldoende is om te voorzien in alle 
micronutrienten waar tijdens de zwangerschap behoefte aan is. 
Alhoewel een tekort aan zink is genoemd als oorzaak van de verminderde groei 
van kinderen in ontwikkelingslanden, hielp suppletie van kinderen met zink niet in het 
verbeteren van de groei. Ook kinderen van moeders die tijdens de zwangerschap met 
zink gesuppleerd waren, groeiden niet beter dan andere kinderen. Blijkbaar zijn er 
andere faktoren die leiden tot de verminderde groei van deze kinderen. 
Verschillende micronutrienten hebben een duidelijk, maar verschillend effect 
op het immuunsysteem. Kinderen met een vitamine A-tekort hadden een lagere ex vivo 
produktie van type-1 cytokines. Kinderen met een zinktekort hadden minder witte 
bloedlichaampjes en ook een lagere ex vivo produktie van type-2 cytokines. Het 
suppleren van kinderen met ijzer leidde tot een hogere produktie van type-1 cytokines, 
en een lagere produktie van type-2 cytokines, terwijl suppletie met p-caroteen en zink 
het omgekeerde effect lijken te hebben. Tekorten aan micronutrienten kan het 
vermogen van het immuunsysteem om pro-inflammatoire cytokines te produceren in 
reactie op een infectie verminderen. Suppletie van verschillende micronutrienten heeft 
tegenovergestelde effecten op het immuunsysteem, maar de implicaties hiervan voor 
de afweer tegen infektie zijn minder duidelijk. 
Concluderend heeft het onderzoek zoals beschreven in dit proefschrift 
duidelijk en bij herhaling aangetoond dat het gelijktijdig voorkomen van tekorten aan 
meerdere micronutrienten eerder de regel dan de uitzondering is. Het suppleren met 
slechts 1 micronutrient is niet optimaal. Het verwachtte effect van suppletie van een 
micronutrient zal niet bereikt kunnen worden als opname en gebruik van het 
micronutrient verminderd worden door tekorten aan andere micronutrienten. Ook 
zullen verbeteringen in de (volks-)gezondheid achterblijven bij de verwachtingen 
zolang niets aan de andere tekorten gedaan wordt. Het suppleren met meerdere 
micronutrienten verdient dus de voorkeur, zowel wat betreft kinderen als zwangere 
vrouwen. 
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Penelitian yang digambarkan dalam tesis ini titik fokusnya adalah defisiensi 
vitamin A, zat besi, dan seng pada wanita hamil dan menyusui serta pada bayi. Yang 
diteliti adalah pengaruh suplementasi beta karotin, zat besi, dan seng terhadap status 
mikronutrien, pertumbuhan, hasil kehamilan, dan interaksi antar mikronutrien. 
Defisiensi vitamin A, zat besi, dan seng merupakan masalah kesehatan dunia. 
Defisiensi vitamin A dapat mengakibatkan, meningkatnya risiko morbiditas dan 
mortalitas, dan penambahan vitamin A dapat mengurangi kematian anak sampai 20-
30%, tanpa memperhatikan besarnya prevalensi xeroftalmia di masyarakat. Di negara-
negara berkembang, karotinoid pro-vitamin A - terutama betakarotin - dari tanaman 
pangan merupakan sumber utama vitamin A, tetapi bioavailabilitas dan konversinya 
sangat bervariasi dan kurang dari yang biasa diasumsikan. Defisiensi zat besi 
merupakan masalah defisiensi mikronutrien global yang paling umum, menjangkiti 
lebih 50% wanita di negara-negara berkembang. Defisiensi zat besi dapat 
menyebabkan anemia, sedangkan pada anak juga dapat menyebabkan lambatnya 
perkembanguan psikomotorik dan gangguan proses belajar, serta adanya kemungkinan 
dampak pada immunocompetence. Makanan yang kaya fitat dan rendah hewani 
menyebabkan kurang tersedianya zat besi dan cenderang mengakibatkan defisiensi zat 
besi. Ketersediaan seng juga dipengaruhi oleh faktor-faktor yang sama dengan zat besi, 
sehingga defisiensi seng juga diyakini tersebar luas. Namun, status seng sulit 
ditentukan karena sifatnya yang homeostasis dan tidak tersimpan dalam bentuk nyata. 
Defisiensi seng menyebabkan terutama gangguan pertumbuhan dan menurunnya daya 
tahan tubuh, meskipun beberapa fungsi metabolisme mungkin terganggu. 
Di Indonesia, baik defisiensi vitamin A maupun zat besi merupakan masalah 
kesehatan yang utama, yang mempengaruhi wanita hamil dan menyusui, serta bayi. 
Defisiensi seng juga merupakan masalah penting, yang telah menyebabkan gangguan 
pertumbuhan pada anak-anak Indonesia. Demikian juga, tingkat kematian ibu dan anak 
tetap tinggi, meskipun telah ada perbaikan yang signifikan dalam cakupan vaksinasi 
dan akses terhadap sarana kesehatan. Ada beberapa program di Indonesia yang 
bertujuan menanggulangi defisiensi vitamin A dan zat besi. Contohnya program 
nasional suplementasi zat besi dan asam folat bagi wanita hamil, program suplementasi 
vitamin A dosis tinggi dalam bentuk kapsul pada anak-anak. Program suplementasi 
vitamin A telah berhasil menurunkan prevalensi xeroftalmia, tetapi defisiensi vitamin 
A marginal masih tetap merupakan masalah. Dimikian juga, karena kemungkinan 
keracunan, bayi-bayi muda dan wanita hamil tidak diikutsertakan dalam program 
suplementasi vitamin A. 
Penelitian yang digambarkan dalam tesis ini terdiri dari tiga kajian. Tajuan dari 
kajian pertama adalah mengukur prevalensi defisiensi vitamin A, zat besi, dan seng 
pada wanita menyusui dan bayi mereka; hubungan timbal balik antara masing-masing 
defisiensi, dan dengan gangguan pertumbuhan serta fungsi kekebalan. Dalam kajian 
kedua diteliti pengaruh suplementasi betakarotin, zat besi, dan seng pada bayi terhadap 
defisiensi dan status mikronutrien, pertumbuhan, dan fungsi kekebalan. Dalam kajian 
ketiga, diteliti pengaruh suplementasi betakarotin dan seng pada ibu hamil sebagai 
tambahan pada zat besi dan asam folat terhadap hasil kehamilan, status mikronutrien 
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ibu dan bayi yang baru dilahirkan, serta pertumbuhan bayi selama enam bulan pertama 
setelah kelahiran. 
Temuan-temuan penting dari riset yang dijarbarkan dalam tesis ini dirangkum 
sesuai dengan topik-topik penting bagi kesehatan ibu dan anak. Temuan penting dari 
ketiga kajian tersebut tidak hanya bahwa defisiensi vitamin A, zat besi, dan seng 
prevalen pada bayi dan ibu, tetapi juga defisiensi tersebut terjadi secara bersamaan. 
Lebih jauh, status mikronutrien ibu mempunyai hubungan yang kuat dengan status 
bayinya, dan air susu ibu merupakan kunci faktor penghubung antara ibu dan bayi 
kuhususnya untuk status vitamin A. 
Suplementasi zat besi dan seng pada bayi akan efektif menuruukan prevalensi 
anemia, defisiensi zat besi dan seng. Meskipun suplementasi zat besi yang 
dikombinasikan dengan seng mengurangi efikasi suplementasi zat besi, kombinasi 
suplemen tersebut tetap efektif menurunkan prevalensi anemia dan defisiensi zat besi, 
dan selanjutnya menurunkan defisiensi seng. Hal ini menunjukkan bahwa meskipun 
seng secara terpisah menghambat zat besi, seng tetap merupakan tambahan penting 
bagi suplementasi zat besi. Suplementasi betakarotin selama kehamilan yang 
dikombinasikan dengan seng meningkatkan status vitamin A baik bagi ibu maupun 
bagi bayinya sampai enam bulan setelah kelahiran, sementara suplementasi hanya 
dengan betakarotin tidak mempunyai efek. Ini menunjukkan bahwa seng memainkan 
peran penting dalam konversi betakarotin menjadi retinol. Dengan demikian seng 
diperlukan untuk meningkatkan status vitamin A pada wanita hamil bersama dengan 
suplementasi betakarotin. Efek sinergis seng pada suplementasi betakarotin tidak 
nampak pada bayi, mungkin karena bayi memiliki kemampuan yang rendah dalam 
memetabolisir atau menyimpan betakarotin. Sebaliknya, suplementasi zat besi 
memiliki efek antagonis terhadap status vitamin A bayi, yaitu mengakibatkan 
menurunnya konsentrasi plasma retinol dan meningkatkan prevalensi defisiensi 
vitamin A pada bayi yang disuplementasi zat besi. Secara bersamaan, simpanan 
vitamin A dalam hati meningkat, yang berati bahwa penambahan zat besi 
menyebabkan redistribusi vitamin A dari plasma ke hati. Dengan demikian, 
suplementasi zat besi pada bayi sebaiknya tidak diberikan tanpa langkah perbaikan 
status vitamin A juga. 
Suplementasi betakarotin dan seng pada wanita hamil dapat meningkatkan 
berat badan lahir bayi, tetapi hanya pada payi laki-laki. Meskipun demikian, 
suplementasi seng saja sebagai tambahan pada zat besi dan asam folat meningkatkan 
angka komplikasi kelahiran. Dilihat dari defisiensi macam-macam mikronutrien yang 
terjadi secara simultan, suplementasi hanya seng atau hanya betakarotin saja sebagai 
tambahan pada zat besi dan asam folat, mungkin tidak dapat memenuhi semua 
mikronutrien yang dibutuhkan selama kehamilan. 
Meskipun defisiensi seng berdampak pada gangguan pertumbuhan bayi yang 
umum terdapat di negara berkembang, suplementasi seng pada bayi tidak memperbaiki 
keadaan pertumbuhan tersebut. Demikian juga, suplementasi seng pada wanita selama 
kehamilan tidak memperbaiki pertumbuhan bayi selama usia 6 bulan pertama. 
Nampaknya ada faktor-faktor lain yang juga berpengaruh dalam gangguan 
pertumbuhan bayi-bayi tersebut. 
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Berbagai mikronutrien memiliki efek yang besar dan berbeda-beda pada fungsi 
kekebalan. Bayi yang mengalami defisiensi vitamin A memiliki respon cytokine tipe-1 
ex vivo yang lebih rendah, tetapi memiliki aktifitas makrofag in vivo yang lebih tinggi. 
Defisiensi seng disertai oleh menurunnya jumlah sel darah putih dan lebih rendahnya 
produksi cytokine tipe-2 ex vivo. Suplementasi dengan zat besi mengakibatkan 
meningkatnya produksi cytokine tipe-1, dan menurunnya cytokine tipe-2, sementara 
suplementasi dengan betakarotin dan seng tampak memiliki efek yang berlawanan 
pada fungsi kekebalan. Defisiensi berbagai macam mikronutrien dapat menghambat 
kemampuan produksi cytokine pro-inflamasi dalam merespon infeksi. Suplementasi 
mikronutrien yang berbeda-beda dapa menyebabkan efek immunomodulatory yang 
berlawanan, tetapi dampak terhadap immunocompetence kurang terlihat jelas. 
Disimpulkan, kajian-kajian yang digambarkan dalam tesis ini yang secara jelas 
menunjukkan bahwa adanya defisiensi berbagai mikronutrien yang terjadi bersamaan 
lebih merupakan norma daripada eksepsi. Suplementasi dengan mikronutrien tunggal 
pada kasus yang disertai defisiensi mikronutrien lain, kurang efektif karena utilisasinya 
menjadi tidak optimal, dan keuntungan kesehatan (health benefits) tidak akan seperti 
yang diharapkan selama defisiensi lainnya tidak teratasi. Dengan demikian 
suplementasi lebih dari satu mikronutrien adalah lebih baik dan lebih efektif, tidak 
hanya bayi tetapi juga bagi wanita hamil. 
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